Back to Journals » Neuropsychiatric Disease and Treatment

Neuropsychiatric Disease and Treatment


Journal Articles:

- 3,000 records -

Management of Treatment-Resistant Depression in Real-World Clinical Practice Settings Across Asia

Wang G, Han C, Liu CY, Chan S, Kato T, Tan W, Zhang L, Feng Y, Ng CH

Neuropsychiatric Disease and Treatment 2020, 16:2943-2959

Published Date: 3 December 2020

Definition and Identification of Patients with Treatment-Resistant Depression in Real-World Clinical Practice Settings Across Asia

Han C, Wang G, Chan S, Kato T, Ng CH, Tan W, Zhang L, Feng Y, Liu CY

Neuropsychiatric Disease and Treatment 2020, 16:2929-2941

Published Date: 3 December 2020

Body Dysmorphic Disorder, Psychiatric Symptoms, and Quality of Life in Female Dermatological Patients

Chee IS, Kim HJ, Lee Y, Kim JW

Neuropsychiatric Disease and Treatment 2020, 16:2921-2928

Published Date: 3 December 2020

A Nomogram Model to Predict Malignant Cerebral Edema in Ischemic Stroke Patients Treated with Endovascular Thrombectomy: An Observational Study

Du M, Huang X, Li S, Xu L, Yan B, Zhang Y, Wang H, Liu X

Neuropsychiatric Disease and Treatment 2020, 16:2913-2920

Published Date: 2 December 2020

Impact of Supporting People with Advanced Parkinson’s Disease on Carer’s Quality of Life and Burden

Modugno N, Antonini A, Tessitore A, Marano P, Pontieri FE, Tambasco N, Canesi M, Fabbrini G, Sensi M, Quatrale R, Solla P, Defazio G, Melzi G, Gualberti G, Lopiano L

Neuropsychiatric Disease and Treatment 2020, 16:2899-2912

Published Date: 2 December 2020

Serum C-Reactive Protein in Patients with Deficit Schizophrenia and the Relationship with Cognitive Function

Pan LH, Qian M, Qu W, Tang Q, Yan Y

Neuropsychiatric Disease and Treatment 2020, 16:2891-2897

Published Date: 1 December 2020

Knowledge of Prevention Measures and Information About Coronavirus in Romanian Male Patients with Severe Mental Illness and Severe Alcohol Use Disorder

Matei V, Pavel A, Giurgiuca A, Roșca A, Sofia A, Duțu I, Tudose C

Neuropsychiatric Disease and Treatment 2020, 16:2857-2864

Published Date: 26 November 2020

Neuropsychological Comparison Between Patients with Social Anxiety and Healthy Controls: Weak Central Coherence and Visual Scanning Deficit

Okawa S, Hamatani S, Hayashi Y, Arai H, Nihei M, Yoshida T, Takahashi J, Shimizu E, Hirano Y

Neuropsychiatric Disease and Treatment 2020, 16:2849-2855

Published Date: 25 November 2020

Clozapine Use in Patients with Early-Stage Schizophrenia in a Chinese Psychiatric Hospital

Yi W, She S, Zhang J, Wu H, Zheng Y, Ning Y

Neuropsychiatric Disease and Treatment 2020, 16:2827-2836

Published Date: 24 November 2020

Reversible Neuropsychiatric Disturbances Caused by Nitrous Oxide Toxicity: Clinical, Imaging and Electrophysiological Profiles of 21 Patients with 6–12 Months Follow-up

Zheng R, Wang Q, Li M, Liu F, Zhang Y, Zhao B, Sun Y, Zhang D, Yan C, Zhao Y, Li W

Neuropsychiatric Disease and Treatment 2020, 16:2817-2825

Published Date: 23 November 2020

Telepsychiatry in the Arab World: A Viewpoint Before and During COVID-19

El Hayek S, Nofal M, Abdelrahman D, Adra A, Al Harthi M, Al Shamli S, AlNuaimi N, Bensid L, Cheaito MA, Emberish AM, Larnaout A, Radwan A, Slaih M, Kobeissy F, Bizri M

Neuropsychiatric Disease and Treatment 2020, 16:2805-2815

Published Date: 19 November 2020

Randomized Clinical Trial Examining the Impact of Lactobacillus rhamnosus GG Probiotic Supplementation on Cognitive Functioning in Middle-aged and Older Adults

Sanborn V, Azcarate-Peril MA, Updegraff J, Manderino L, Gunstad J

Neuropsychiatric Disease and Treatment 2020, 16:2765-2777

Published Date: 13 November 2020

MiRNA-532-5p Regulates CUMS-Induced Depression-Like Behaviors and Modulates LPS-Induced Proinflammatory Cytokine Signaling by Targeting STAT3

Yan X, Zeng D, Zhu H, Zhang Y, Shi Y, Wu Y, Tang H, Li D

Neuropsychiatric Disease and Treatment 2020, 16:2753-2764

Published Date: 12 November 2020

Spatial Patterns of Amyloid Deposition in Patients with Chronic Focal or Diffuse Traumatic Brain Injury Using 18F-FPYBF-2 PET

Ubukata S, Oishi N, Higashi T, Kagawa S, Yamauchi H, Okuyama C, Watanabe H, Ono M, Saji H, Aso T, Murai T, Ueda K

Neuropsychiatric Disease and Treatment 2020, 16:2719-2732

Published Date: 12 November 2020

Ketamine in Bipolar Disorder: A Review

Wilkowska A, Szałach Ł, Cubała WJ

Neuropsychiatric Disease and Treatment 2020, 16:2707-2717

Published Date: 12 November 2020

Serum Exosome-Derived miR-139-5p as a Potential Biomarker for Major Depressive Disorder

Liang JQ, Liao HR, Xu CX, Li XL, Wei ZX, Xie GJ, Cheng Y

Neuropsychiatric Disease and Treatment 2020, 16:2689-2693

Published Date: 10 November 2020

Montreal Cognitive Assessment — Single Cutoff Achieves Screening Purpose

Yeung PY, Wong LLL, Chan CC, Yung CY, Leung LMJ, Tam YY, Tang LN, Li HS, Lau ML

Neuropsychiatric Disease and Treatment 2020, 16:2681-2687

Published Date: 6 November 2020

Virtual Reality Exposure Therapy (VRET) for Anxiety Due to Fear of COVID-19 Infection: A Case Series

Zhang W, Paudel D, Shi R, Liang J, Liu J, Zeng X, Zhou Y, Zhang B

Neuropsychiatric Disease and Treatment 2020, 16:2669-2675

Published Date: 6 November 2020

Comparisons Between Infectious and Autoimmune Encephalitis: Clinical Signs, Biochemistry, Blood Counts, and Imaging Findings

Huang CN, Tian XB, Jiang SM, Chang SH, Wang N, Liu MQ, Zhang QX, Li T, Zhang LJ, Yang L

Neuropsychiatric Disease and Treatment 2020, 16:2649-2660

Published Date: 4 November 2020

Care Needs of Community-Residing Male Patients with Vascular Cognitive Impairment

Jhang KM, Wang WF, Chang HF, Liu YH, Chang MC, Wu HH

Neuropsychiatric Disease and Treatment 2020, 16:2613-2621

Published Date: 3 November 2020

Sensory Hypersensitivity Severity and Association with Obsessive-Compulsive Symptoms in Adults with Tic Disorder

Isaacs D, Key AP, Cascio CJ, Conley AC, Walker HC, Wallace MT, Claassen DO

Neuropsychiatric Disease and Treatment 2020, 16:2591-2601

Published Date: 2 November 2020

Psychometric Properties of the Chinese Version of the Intolerance of Uncertainty Inventory in Chinese College Students

Li S, Yang F, Li P, Wang X, Dai J, Deng Y

Neuropsychiatric Disease and Treatment 2020, 16:2579-2589

Published Date: 29 October 2020

Association of Serum Kynurenine Levels and Neural Networks in Patients with First-Episode, Drug-Naïve Major Depression: A Source-Based Morphometry Study

Okamoto N, Watanabe K, Ngyuyen LH, Ikenouchi A, Kishi T, Iwata N, Kakeda S, Korogi Y, Yoshimura R

Neuropsychiatric Disease and Treatment 2020, 16:2569-2577

Published Date: 29 October 2020

Validation of the Dutch Version of the Brief Negative Symptom Scale

Seelen-de Lang BL, Boumans CE, Nijman HLI

Neuropsychiatric Disease and Treatment 2020, 16:2563-2567

Published Date: 29 October 2020

Association Between Autistic Symptoms and Self-Stigma in Patients with Schizophrenia Spectrum Disorders

Komatsu H, Ono T, Maita Y, Ishida Y, Kikuchi T, Maki T, Hase S, Sakurai H, Oba A, Teshirogi O, Suzuki A, Mori Y, Shoji C, Fujita A, Takahashi S, Ebina T, Ozaki S, Honma R, Tomita H, Kakuto Y

Neuropsychiatric Disease and Treatment 2020, 16:2553-2561

Published Date: 29 October 2020

Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression

Szarmach J, Cubała WJ, Włodarczyk A, Gałuszko-Węgielnik M

Neuropsychiatric Disease and Treatment 2020, 16:2539-2551

Published Date: 29 October 2020

Individual Perceived Stress Mediates Psychological Distress in Medical Workers During COVID-19 Epidemic Outbreak in Wuhan

Zhang C, Peng D, Lv L, Zhuo K, Yu K, Shen T, Xu Y, Wang Z

Neuropsychiatric Disease and Treatment 2020, 16:2529-2537

Published Date: 28 October 2020

Serotonin Type 6 and 7 Receptors as a Novel Therapeutic Target for the Treatment of Schizophrenia

Tsegay EW, Demise DG, Hailu NA, Gufue ZH

Neuropsychiatric Disease and Treatment 2020, 16:2499-2509

Published Date: 28 October 2020

Biochemical Parameters in Cognitive Functions

Popiolek AK, Chyrek-Tomaszewska A, Stachowicz-Karpińska A, Bieliński MK, Borkowska A

Neuropsychiatric Disease and Treatment 2020, 16:2479-2489

Published Date: 27 October 2020

A Survey on Public Attitudes Toward Mental Illness and Mental Health Services Among Four Cities in Saudi Arabia

Alsubaie S, Almathami M, Alkhalaf H, Aboulyazid A, Abuhegazy H

Neuropsychiatric Disease and Treatment 2020, 16:2467-2477

Published Date: 27 October 2020

Incidence and Risk Factors of Depressive Symptoms in Chinese College Students

Song Y, Liu Z, Chen H, Guo Q, Huang Y

Neuropsychiatric Disease and Treatment 2020, 16:2449-2457

Published Date: 23 October 2020

Reliability and Validity of THINC-it in Evaluating Cognitive Function of Patients with Bipolar Depression

Zhang W, Zhu N, Lai J, Liu J, Ng CH, Chen J, Qian C, Du Y, Hu C, Chen J, Hu J, Wang Z, Zhou H, Xu Y, Fang Y, Shi C, Hu S

Neuropsychiatric Disease and Treatment 2020, 16:2419-2428

Published Date: 21 October 2020

Dissociative Symptoms and Self-Reported Childhood and Current Trauma in Male Incarcerated People with Borderline Personality Disorder – Results from a Small Cross-Sectional Study in Iran

Golshani S, Ghanbari S, Firoozabadi A, Shakeri J, Hookari S, Rahami B, Sadeghi Bahmani D, Brand S

Neuropsychiatric Disease and Treatment 2020, 16:2407-2417

Published Date: 21 October 2020

Psychometric Analysis of the Perceived Stress Scale Among Healthy University Students

Anwer S, Manzar MD, Alghadir AH, Salahuddin M, Abdul Hameed U

Neuropsychiatric Disease and Treatment 2020, 16:2389-2396

Published Date: 19 October 2020

Validity of the Korean Version of DIVA-5: A Semi-Structured Diagnostic Interview for Adult ADHD

Hong M, Kooij JJS, Kim B, Joung YS, Yoo HK, Kim EJ, Lee SI, Bhang SY, Lee SY, Han DH, Lee YS, Bahn GH

Neuropsychiatric Disease and Treatment 2020, 16:2371-2376

Published Date: 12 October 2020

Value of Combination of the A2DS2 Score and IL-6 in Predicting Stroke-Associated Pneumonia

Yang J, Dai Y, Zhang Z, Chen Y

Neuropsychiatric Disease and Treatment 2020, 16:2353-2359

Published Date: 9 October 2020

Can Quantitative Gait Analysis Be Used to Guide Treatment of Patients with Different Subtypes of Parkinson’s Disease?

Wu Z, Zhong M, Jiang X, Shen B, Zhu J, Pan Y, Dong J, Yan J, Xu P, Zhang W, Gao Y, Zhang L

Neuropsychiatric Disease and Treatment 2020, 16:2335-2341

Published Date: 9 October 2020

Post-Traumatic Stress Disorder and Associated Factors Among Internally Displaced People in South Ethiopia: A Cross-Sectional Study

Madoro D, Kerebih H, Habtamu Y, G/tsadik M, Mokona H, Molla A, Wondie T, Yohannes K

Neuropsychiatric Disease and Treatment 2020, 16:2317-2326

Published Date: 7 October 2020

Association Between Glutathione Peroxidase-1 (GPx-1) Polymorphisms and Schizophrenia in the Chinese Han Population

Shao X, Yan C, Sun D, Fu C, Tian C, Duan L, Zhu G

Neuropsychiatric Disease and Treatment 2020, 16:2297-2305

Published Date: 6 October 2020

Comparison of Cerebral Blood Flow Patterns in Patients with Phantom Bite Syndrome with Their Corresponding Clinical Features

Umezaki Y, Watanabe M, Shinohara Y, Sugawara S, Kawasaki K, Tu TTH, Watanabe T, Suga T, Miura A, Takenoshita M, Sato Y, Minami I, Oyama J, Toriihara A, Yoshikawa T, Naito T, Motomura H, Toyofuku A

Neuropsychiatric Disease and Treatment 2020, 16:2277-2284

Published Date: 6 October 2020

Long-Term Efficacy and Safety of Brexpiprazole in Elderly Japanese Patients with Schizophrenia: A Subgroup Analysis of an Open-Label Study

Inada K, Yamada S, Akiyoshi H, Kojima Y, Iwashita S, Ishigooka J

Neuropsychiatric Disease and Treatment 2020, 16:2267-2275

Published Date: 6 October 2020

Predictive Utility of Body Mass Index for Metabolic Syndrome Among Patients with Schizophrenia in Japan

Sugawara N, Yasui-Furukori N, Yamazaki M, Shimoda K, Mori T, Sugai T, Matsuda H, Suzuki Y, Ozeki Y, Okamoto K, Sagae T, Someya T

Neuropsychiatric Disease and Treatment 2020, 16:2229-2236

Published Date: 30 September 2020

Validity of the Shahin Mixed Depression Scale: A Self-Rated Instrument Designed to Measure the Non-DSM Mixed Features in Depression

Shahin I, Bonnin CDM, Saleh E, Helmy K, Youssef UM, Vieta E

Neuropsychiatric Disease and Treatment 2020, 16:2209-2219

Published Date: 28 September 2020

Electroconvulsive Therapy for Patients with Catatonia: Current Perspectives

Lloyd JR, Silverman ER, Kugler JL, Cooper JJ

Neuropsychiatric Disease and Treatment 2020, 16:2191-2208

Published Date: 25 September 2020

Relationship Among Sensory Over-Responsivity, Problem Behaviors, and Anxiety in Emerging Adults with Autism Spectrum Disorder

Syu YC, Huang PC, Wang TY, Chang YC, Lin LY

Neuropsychiatric Disease and Treatment 2020, 16:2181-2190

Published Date: 24 September 2020

Mu-Opioid Receptor Polymorphism Moderates Sensitivity to Parental Behaviors During Characterization of Personality Traits

Noto K, Suzuki A, Shirata T, Matsumoto Y, Takahashi N, Goto K, Otani K

Neuropsychiatric Disease and Treatment 2020, 16:2161-2167

Published Date: 22 September 2020

Elevated Neutrophil-to-Lymphocyte Ratio Predicts Depression After Intracerebral Hemorrhage

Gong X, Lu Z, Feng X, Yu C, Xue M, Yu L, Wang T, Cheng X, Lu J, Zhang M

Neuropsychiatric Disease and Treatment 2020, 16:2153-2159

Published Date: 21 September 2020

Magnitude, Symptom Presentation and Correlates of Psychological Distress Among People with Epilepsy in Southern Ethiopia: A Cross-Sectional Study

Mekuriaw B, Mantefardo B, Molla A, Berhanu G, Mehare T, Belayneh Z

Neuropsychiatric Disease and Treatment 2020, 16:2143-2151

Published Date: 18 September 2020

Cognitive Behavioral Therapy Reduces Benzodiazepine Anxiolytics Use in Japanese Patients with Mood and Anxiety Disorders: A Retrospective Observational Study

Nakajima A, Kanie A, Ito M, Hirabayashi N, Imamura F, Takebayashi Y, Horikoshi M

Neuropsychiatric Disease and Treatment 2020, 16:2135-2142

Published Date: 18 September 2020

Low Concentrations of Dehydroepiandrosterone Sulfate are Associated with Depression and Fatigue in Patients with Non-Small-Cell Lung Cancer After Chemotherapy

Fang YH, Hsieh MJ, Hung MS, Lin YC, Kuo LT, Lu ML, Tzang BS, Chen VCH

Neuropsychiatric Disease and Treatment 2020, 16:2103-2109

Published Date: 17 September 2020

Eating and Mealtime Behaviors in Patients with Autism Spectrum Disorder: Current Perspectives

Margari L, Marzulli L, Gabellone A, de Giambattista C

Neuropsychiatric Disease and Treatment 2020, 16:2083-2102

Published Date: 11 September 2020

Physical Comorbidities are Independently Associated with Higher Rates of Psychiatric Readmission in a Chinese Han Population

Yang C, Zhong X, Zhou H, Wu Z, Zhang M, Ning Y

Neuropsychiatric Disease and Treatment 2020, 16:2073-2082

Published Date: 10 September 2020

Treatment of Patients with Recently Exacerbated Schizophrenia with Paliperidone Palmitate: A Pilot Study of Efficacy and Tolerability

Gattaz WF, Saracco-Alvarez R, Daltio CS, Van de Bilt MT, Ortegón JJ, Villaseñor-Bayardo SJ, Louzã M, Elkis H, Soares B, Cabrera Jaramillo P, Lawson F, Díaz-Galvis L

Neuropsychiatric Disease and Treatment 2020, 16:2063-2072

Published Date: 10 September 2020

Metabolic Syndrome Predicts Poor Outcome in Acute Ischemic Stroke Patients After Endovascular Thrombectomy

Chen Z, Su M, Li Z, Du H, Zhang S, Pu M, Zhang Y

Neuropsychiatric Disease and Treatment 2020, 16:2045-2052

Published Date: 7 September 2020

Spotlight on Compulsive Sexual Behavior Disorder: A Systematic Review of Research on Women

Kowalewska E, Gola M, Kraus SW, Lew-Starowicz M

Neuropsychiatric Disease and Treatment 2020, 16:2025-2043

Published Date: 4 September 2020

Identification of Potential Metabolite Markers for Middle-Aged Patients with Post-Stroke Depression Using Urine Metabolomics

Xie J, Han Y, Hong Y, Li W, Pei Q, Zhou X, Zhang B, Wang Y

Neuropsychiatric Disease and Treatment 2020, 16:2017-2024

Published Date: 25 August 2020

Influence of Parenting Quality and Neuroticism on Perceived Job Stressors and Psychological and Physical Stress Response in Adult Workers from the Community

Seki T, Shimura A, Miyama H, Furuichi W, Ono K, Masuya J, Odagiri Y, Inoue S, Inoue T

Neuropsychiatric Disease and Treatment 2020, 16:2007-2015

Published Date: 24 August 2020

Association of Chronotypes and Sleep Disturbance with Perceived Job Stressors and Stress Response: A Covariance Structure Analysis

Miyama H, Shimura A, Furuichi W, Seki T, Ono K, Masuya J, Odagiri Y, Inoue S, Inoue T

Neuropsychiatric Disease and Treatment 2020, 16:1997-2005

Published Date: 21 August 2020

Functional Recovery Patterns of Hemorrhagic and Ischemic Stroke Patients Under Post-Acute Care Rehabilitation Program

Chu CL, Chen YP, Chen CCP, Chen CK, Chang HN, Chang CH, Pei YC

Neuropsychiatric Disease and Treatment 2020, 16:1975-1985

Published Date: 13 August 2020

Association Between IL-6 and Seizure Recurrence in Patients with the First Post-Ischemic Stroke Seizure

Jia Q, Jiang F, Ma D, Li J, Wang F, Wang Z

Neuropsychiatric Disease and Treatment 2020, 16:1955-1963

Published Date: 11 August 2020

Effects of Levetiracetam Compared to Valproate on Cognitive Functions of Patients with Epilepsy

El Sabaa RM, Hamdi E, Hamdy NA, Sarhan HA

Neuropsychiatric Disease and Treatment 2020, 16:1945-1953

Published Date: 11 August 2020

Cerebral Arteriovenous Malformation Treatment by Full Transcranial Neuroendoscopic Approaches

Cai Q, Ji B, Li Z, Wang W, Liu J, Chen Z

Neuropsychiatric Disease and Treatment 2020, 16:1899-1905

Published Date: 6 August 2020

Prevalence of Eating Disorders Among Medical Students in a Lebanese Medical School: A Cross-Sectional Study

Bizri M, Geagea L, Kobeissy F, Talih F

Neuropsychiatric Disease and Treatment 2020, 16:1879-1887

Published Date: 4 August 2020

Association of Pain Catastrophizing with Postnatal Depressive States in Nulliparous Parturients: A Prospective Study

Zeng Y, Tan CW, Sultana R, Chua TE, Chen HY, Sia ATH, Sng BL

Neuropsychiatric Disease and Treatment 2020, 16:1853-1862

Published Date: 30 July 2020

A Novel Diagnostic Prediction Model for Vestibular Migraine

Zhou C, Zhang L, Jiang X, Shi S, Yu Q, Chen Q, Yao D, Pan Y

Neuropsychiatric Disease and Treatment 2020, 16:1845-1852

Published Date: 29 July 2020

Levodopa-Carbidopa Intestinal Gel Infusion Therapy Discontinuation: A Ten-Year Retrospective Analysis of 204 Treated Patients

Constantin VA, Szász JA, Orbán-Kis K, Rosca EC, Popovici M, Cornea A, Bancu LA, Ciorba M, Mihály I, Nagy E, Szatmári S, Simu M

Neuropsychiatric Disease and Treatment 2020, 16:1835-1844

Published Date: 28 July 2020

Effects of Job Stressors, Stress Response, and Sleep Disturbance on Presenteeism in Office Workers

Furuichi W, Shimura A, Miyama H, Seki T, Ono K, Masuya J, Inoue T

Neuropsychiatric Disease and Treatment 2020, 16:1827-1833

Published Date: 27 July 2020

Liraglutide Attenuates Aβ42 Generation in APPswe/SH-SY5Y Cells Through the Regulation of Autophagy

Kong J, Wan L, Wang Y, Zhang H, Zhang W

Neuropsychiatric Disease and Treatment 2020, 16:1817-1825

Published Date: 27 July 2020

Gastrointestinal Problems in Chinese Children with Autism Spectrum Disorder

Lai KYC, Leung PWL, Hung SF, Shea CKS, Mo F, Che KKI, Tse CY, Lau FLF, Ma SL, Wu JCY, So S, Dadds MR

Neuropsychiatric Disease and Treatment 2020, 16:1807-1815

Published Date: 24 July 2020

MMSE Subscale Scores as Useful Predictors of AD Conversion in Mild Cognitive Impairment

Choe YM, Lee BC, Choi IG, Suh GH, Lee DY, Kim JW

Neuropsychiatric Disease and Treatment 2020, 16:1767-1775

Published Date: 24 July 2020

The Current State of Physical Activity and Exercise Programs in German-Speaking, Swiss Psychiatric Hospitals: Results from a Brief Online Survey [Corrigendum]

Brand S, Colledge F, Beeler N, Pühse U, Kalak N, Sadeghi Bahmani D, Mikoteit T, Holsboer-Trachsler E, Gerber M

Neuropsychiatric Disease and Treatment 2020, 16:1765-1766

Published Date: 23 July 2020

Lack of Association Between PLA2G6 Genetic Variation and Parkinson’s Disease: A Systematic Review

Liu H, Yao Y, Liu H, Peng Y, Ren J, Wu X, Mao R, Zhao J, Zhu Y, Niu Z, Yang T, Sun X, Jiang P, Zhang C, Fang Y

Neuropsychiatric Disease and Treatment 2020, 16:1755-1763

Published Date: 23 July 2020

Prediction of Amyloid Positivity in Mild Cognitive Impairment Using Fully Automated Brain Segmentation Software

Kang KM, Sohn CH, Byun MS, Lee JH, Yi D, Lee Y, Lee JY, Kim YK, Sohn BK, Yoo RE, Yun TJ, Choi SH, Kim J, Lee DY

Neuropsychiatric Disease and Treatment 2020, 16:1745-1754

Published Date: 22 July 2020

CSF VEGF Was Positively Associated with Neurogranin Independent of β-Amyloid Pathology

Huang Y, Wang J, Zhu B, Fu P

Neuropsychiatric Disease and Treatment 2020, 16:1737-1744

Published Date: 22 July 2020

Is Agomelatine Associated with Less Sedative-Hypnotic Usage in Patients with Major Depressive Disorder? A Nationwide, Population-Based Study

Hsing SC, Jin YT, Tzeng NS, Chung CH, Chen TY, Chang HA, Kao YC, Chien WC

Neuropsychiatric Disease and Treatment 2020, 16:1727-1736

Published Date: 22 July 2020

Clinical Characteristics of Pesticide Self-Harm as Associated with Suicide Attempt Repetition Status

Huang WC, Yen TH, Lin L, Lin C, Juang YY, Wang BH, Lee SH

Neuropsychiatric Disease and Treatment 2020, 16:1717-1726

Published Date: 16 July 2020

Evaluation of Fear in Idiopathic Epilepsy Using Population-Based Survey and Bhalla-Gharagozli Fear in Epilepsy Questionnaire (BG-FEQ)

Gharagozli K, Lotfalinezhad E, Amini F, Saii V, Bhalla D

Neuropsychiatric Disease and Treatment 2020, 16:1685-1693

Published Date: 10 July 2020

Does Subjective Cognitive Function Mediate the Effect of Affective Temperaments on Functional Disability in Japanese Adults?

Toyoshima K, Inoue T, Masuya J, Fujimura Y, Higashi S, Kusumi I

Neuropsychiatric Disease and Treatment 2020, 16:1675-1684

Published Date: 8 July 2020

Analysis of Risk Factors for Postoperative Delirium After Liver Transplantation

Chen J, Wang H, He Z, Li T

Neuropsychiatric Disease and Treatment 2020, 16:1645-1652

Published Date: 3 July 2020

Review of Clinical Outcome Assessments in Pediatric Attention-Deficit/Hyperactivity Disorder

Markowitz JT, Oberdhan D, Ciesluk A, Rams A, Wigal SB

Neuropsychiatric Disease and Treatment 2020, 16:1619-1643

Published Date: 1 July 2020

Bridging the Gap Between Physical Health and Autism Spectrum Disorder

Sala R, Amet L, Blagojevic-Stokic N, Shattock P, Whiteley P

Neuropsychiatric Disease and Treatment 2020, 16:1605-1618

Published Date: 30 June 2020

Depression Relationship with Dietary Patterns and Dietary Inflammatory Index in Women: Result from Ravansar Cohort Study

Moludi J, Moradinazar M, Hamzeh B, Najafi F, Soleimani D, Pasdar Y

Neuropsychiatric Disease and Treatment 2020, 16:1595-1603

Published Date: 29 June 2020

Effect of Mental Health Problems on the Quality of Life in Children with Lupus Nephritis

Putera AM, Irwanto I, Maramis MM, Prasetyo RV, Soemyarso NA, Noer MS

Neuropsychiatric Disease and Treatment 2020, 16:1583-1593

Published Date: 26 June 2020

Altered Intrinsic Functional Connectivity of the Primary Visual Cortex in Patients with Corneal Ulcer: A Resting-State fMRI Study

Hu SL, Tang LY, Fang JW, Su T, Ge QM, Lin Q, Li B, Shi WQ, Li QY, Liang RB, Shao Y

Neuropsychiatric Disease and Treatment 2020, 16:1571-1581

Published Date: 23 June 2020

Aberrant Executive Control and Auditory Networks in Recent-Onset Schizophrenia

Joo SW, Yoon W, Jo YT, Kim H, Kim Y, Lee J

Neuropsychiatric Disease and Treatment 2020, 16:1561-1570

Published Date: 22 June 2020

Serum BDNF Levels are Not Associated with the Antidepressant Effects of Nonconvulsive Electrotherapy

Zheng W, Jiang ML, He HB, Li RP, Li QL, Zhang CP, Zhou SM, Yan S, Ning YP, Huang X

Neuropsychiatric Disease and Treatment 2020, 16:1555-1560

Published Date: 22 June 2020

Impact of Expression and Genetic Variation of microRNA-34b/c on Cognitive Dysfunction in Patients with Major Depressive Disorder

Sun N, Yang C, He X, Liu Z, Liu S, Li X, Wang Y, Jin R, Zhang K

Neuropsychiatric Disease and Treatment 2020, 16:1543-1554

Published Date: 19 June 2020

Association Between Polymorphisms in the 5′ Region of the GALR1 Gene and Schizophrenia in the Northern Chinese Han Population: A Case–Control Study

Li Y, Gao M, Zeng K, Xing J, Xu F, Xuan J, Xia X, Liu Y, Yao J, Wang B

Neuropsychiatric Disease and Treatment 2020, 16:1519-1532

Published Date: 17 June 2020

New Users of Herbal Medicine Containing Aristolochic Acids and the Risk of Dementia in the Elderly: A Nationwide, Population-Based Study in Taiwan

Chiou YE, Chien WC, Chung CH, Chang HA, Kao YC, Tsay PK, Tzeng NS

Neuropsychiatric Disease and Treatment 2020, 16:1493-1504

Published Date: 12 June 2020

Decreased Serum Retinoic Acid May Predict Poor Outcome in Ischemic Stroke Patients

Xu M, Xu L, Du H, Shan W, Feng J, Zhai G, Yang X

Neuropsychiatric Disease and Treatment 2020, 16:1483-1491

Published Date: 10 June 2020

Atrophic Corpus Callosum Associated with Altered Functional Asymmetry in Major Depressive Disorder

Ran S, Zuo Z, Li C, Yin X, Qu W, Tang Q, Wang Y, Shi Y, Li H

Neuropsychiatric Disease and Treatment 2020, 16:1473-1482

Published Date: 10 June 2020

Change in Functional Brain Activation Patterns Induced by Olfactory Stimulation in Multiple Sclerosis

OuYang Q, Wang Y, Zhang Y, Yu M, Wang X

Neuropsychiatric Disease and Treatment 2020, 16:1451-1458

Published Date: 9 June 2020

Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder

Bhattacharjee S, Lee JK, Vadiei N, Patanwala AE, Malone DC, Knapp SM, Lo-Ciganic WH, Burke WJ

Neuropsychiatric Disease and Treatment 2020, 16:1433-1450

Published Date: 8 June 2020

Psychometric Properties of the Generalized Anxiety Disorder Scale Among Saudi University Male Students

Alghadir A, Manzar MD, Anwer S, Albougami A, Salahuddin M

Neuropsychiatric Disease and Treatment 2020, 16:1427-1432

Published Date: 8 June 2020

Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies

Wigal SB, Wigal T, Hobart M, Madera JJ, Baker RA, Kohegyi E, McKinney A, Wilens TE

Neuropsychiatric Disease and Treatment 2020, 16:1411-1426

Published Date: 8 June 2020

Can Maternal Autoantibodies Play an Etiological Role in ASD Development?

Dudova I, Horackova K, Hrdlicka M, Balastik M

Neuropsychiatric Disease and Treatment 2020, 16:1391-1398

Published Date: 3 June 2020

Lupeol Alleviates Cerebral Ischemia–Reperfusion Injury in Correlation with Modulation of PI3K/Akt Pathway

Wang Z, Han Y, Tian S, Bao J, Wang Y, Jiao J

Neuropsychiatric Disease and Treatment 2020, 16:1381-1390

Published Date: 2 June 2020

Influence of COVID-19 on Cerebrovascular Disease and its Possible Mechanism

Fan H, Tang X, Song Y, Liu P, Chen Y

Neuropsychiatric Disease and Treatment 2020, 16:1359-1367

Published Date: 28 May 2020

Hemodynamic and Morphological Analysis of Mirror Aneurysms Prior to Rupture

Yuan J, Huang C, Lai N, Li Z, Jiang X, Wang X, Zhao X, Wu D, Liu J, Xia D, Fang X

Neuropsychiatric Disease and Treatment 2020, 16:1339-1347

Published Date: 27 May 2020

The Long-Term Effects of Adolescent Social Defeat Stress on Oligodendrocyte Lineage Cells and Neuroinflammatory Mediators in Mice

Xu Y, Fang Z, Wu C, Xu H, Kong J, Huang Q, Zhang H

Neuropsychiatric Disease and Treatment 2020, 16:1321-1330

Published Date: 22 May 2020

Decreased Risk of Influenza in Child and Adolescent Patients with Attention-Deficit Hyperactivity Disorder Following Methylphenidate Treatment: A Nationwide Cohort Study in Taiwan

Lee H, Chen VCH, Yang YH, Kuo TY, Lin TC, Wu SI, Kao KL, Weng JC, Kelsen BA, Liang SHY

Neuropsychiatric Disease and Treatment 2020, 16:1309-1319

Published Date: 21 May 2020

Intranasal Delivery of miR-155-5p Antagomir Alleviates Acute Seizures Likely by Inhibiting Hippocampal Inflammation

Zhou X, Chen J, Tao H, Cai Y, Huang L, Zhou H, Chen Y, Cui L, Zhong W, Li K

Neuropsychiatric Disease and Treatment 2020, 16:1295-1307

Published Date: 20 May 2020

HMGB1/CXCL12-Mediated Immunity and Th17 Cells Might Underlie Highly Suspected Autoimmune Epilepsy in Elderly Individuals

Han Y, Yang L, Liu X, Feng Y, Pang Z, Lin Y

Neuropsychiatric Disease and Treatment 2020, 16:1285-1293

Published Date: 19 May 2020

Evidence for a Beneficial Effect of Oral N-acetylcysteine on Functional Outcomes and Inflammatory Biomarkers in Patients with Acute Ischemic Stroke

Sabetghadam M, Mazdeh M, Abolfathi P, Mohammadi Y, Mehrpooya M

Neuropsychiatric Disease and Treatment 2020, 16:1265-1278

Published Date: 18 May 2020

Association Between Attention Deficit Hyperactivity Disorder and Risk of Burn Injury: A Propensity-Matched Cohort Study

Yeh JY, Hou TY, Tseng WT, Chen VCH, Yang YH, Kuo TY, Weng JC, Lee CTC, Chen YL, Lee MJ

Neuropsychiatric Disease and Treatment 2020, 16:1249-1255

Published Date: 13 May 2020

Expression Profiles of Long Noncoding RNAs in Mice with High-Altitude Hypoxia-Induced Brain Injury Treated with Gymnadenia conopsea (L.) R. Br.

Zhang Y, Liu L, Liang C, Zhou L, Tan L, Zong Y, Wu L, Liu T

Neuropsychiatric Disease and Treatment 2020, 16:1239-1248

Published Date: 12 May 2020

CACNA1C Risk Variant and Mood Stabilizers Effects in the Prefrontal Cortical Thickness of Mexican Patients with Bipolar Disorder

Rodríguez-Ramírez AM, Meza-Urzúa F, Cedillo-Ríos V, Becerra-Palars C, Jiménez-Pavón J, Morales-Cedillo IP, Sanabrais-Jiménez MA, Hernández-Muñoz S, Camarena-Medellín B

Neuropsychiatric Disease and Treatment 2020, 16:1199-1206

Published Date: 12 May 2020

Risk Factors and a Nomogram for Predicting Intracranial Hemorrhage in Stroke Patients Undergoing Thrombolysis

Zhou Z, Yin X, Niu Q, Liang S, Mu C, Zhang Y

Neuropsychiatric Disease and Treatment 2020, 16:1189-1197

Published Date: 11 May 2020

Vagal Nerve Stimulation in Epilepsy: Experiences of Participants with Cognitive Deficits

Pipan E, Apostolou A, Bograkou M, Brooks P, Vigren P, Gauffin H

Neuropsychiatric Disease and Treatment 2020, 16:1181-1188

Published Date: 8 May 2020

Prevalence and Determinants of Long-Term Utilization of Antidepressant Drugs: A Retrospective Cohort Study

Lunghi C, Antonazzo IC, Burato S, Raschi E, Zoffoli V, Forcesi E, Sangiorgi E, Menchetti M, Roberge P, Poluzzi E

Neuropsychiatric Disease and Treatment 2020, 16:1157-1170

Published Date: 7 May 2020

Gene–Environment Interactions in Major Mental Disorders in the Czech Republic

Latalova K, Sery O, Hosakova K, Hosak L

Neuropsychiatric Disease and Treatment 2020, 16:1147-1156

Published Date: 6 May 2020

The Effect of Perceptual-Motor Training on Executive Functions in Children with Non-Verbal Learning Disorder

Soltani Kouhbanani S, Arabi SM, Zarenezhad S, Khosrorad R

Neuropsychiatric Disease and Treatment 2020, 16:1129-1137

Published Date: 5 May 2020

Orexin/Hypocretin Type 2 Receptor (HCRTR2) Gene as a Candidate Gene in Sertraline-Associated Insomnia in Depressed Patients

Firouzabadi N, Navabzadeh N, Moghimi-Sarani E, Haghnegahdar M

Neuropsychiatric Disease and Treatment 2020, 16:1121-1128

Published Date: 4 May 2020

Validation of the Chinese Version of the 16-Item Negative Symptom Assessment

Huang B, Wang Y, Miao Q, Yu X, Pu C, Shi C

Neuropsychiatric Disease and Treatment 2020, 16:1113-1120

Published Date: 4 May 2020

Effect of Depression and Antidepressants on Sexual Dysfunction in Men with Diabetes: A National Population-Based Cohort Study

Chung PL, Huang CW, Lee MJ, Yang YH, Chen KJ, Lu ML, Weng JC, Chen VCH

Neuropsychiatric Disease and Treatment 2020, 16:1105-1112

Published Date: 30 April 2020

Similar and Different Regional Homogeneity Changes Between Bipolar Disorder and Unipolar Depression: A Resting-State fMRI Study

Liu P, Li Q, Zhang A, Liu Z, Sun N, Yang C, Wang Y, Zhang K

Neuropsychiatric Disease and Treatment 2020, 16:1087-1093

Published Date: 28 April 2020

The Dual-Gate Lumen Model of Renal Monoamine Transport [Expression of Concern]

Hinz M, Stein A, Uncini T

Neuropsychiatric Disease and Treatment 2020, 16:1085-1086

Published Date: 23 April 2020

APRESS: Apical Regulatory Super System, Serotonin and Dopamine Interaction [Expression of Concern]

Hinz M, Stein A, Uncini T

Neuropsychiatric Disease and Treatment 2020, 16:1071-1072

Published Date: 23 April 2020

Parkinson’s Disease-Associated Melanin Steal [Expression of Concern]

Hinz M, Stein A, Cole T

Neuropsychiatric Disease and Treatment 2020, 16:1063-1064

Published Date: 23 April 2020

Parkinson’s Disease Managing Reversible Neurodegeneration [Expression of Concern]

Hinz M, Stein A, Cole T, McDougall B, Westaway M

Neuropsychiatric Disease and Treatment 2020, 16:1061-1062

Published Date: 23 April 2020

5-HTP Efficacy and Contraindications [Expression of Concern]

Hinz M, Stein A, Uncini T

Neuropsychiatric Disease and Treatment 2020, 16:1059-1060

Published Date: 23 April 2020

Cortisol and DHEAS Related to Metabolic Syndrome in Patients with Schizophrenia

Boiko AS, Mednova IA, Kornetova EG, Bokhan NA, Semke AV, Loonen AJM, Ivanova SA

Neuropsychiatric Disease and Treatment 2020, 16:1051-1058

Published Date: 22 April 2020

What Types of Internet Services Make Adolescents Addicted? Correlates of Problematic Internet Use

Kim KM, Kim H, Choi JW, Kim SY, Kim JW

Neuropsychiatric Disease and Treatment 2020, 16:1031-1041

Published Date: 20 April 2020

Characterization of Endothelial Cells Associated with Cerebral Arteriovenous Malformation

Jia YC, Fu JY, Huang P, Zhang ZP, Chao B, Bai J

Neuropsychiatric Disease and Treatment 2020, 16:1015-1022

Published Date: 20 April 2020

Investigating the Role of Glutamate in Obsessive-Compulsive Disorder: Current Perspectives

Karthik S, Sharma LP, Narayanaswamy JC

Neuropsychiatric Disease and Treatment 2020, 16:1003-1013

Published Date: 17 April 2020

Association Analysis Between SNPs in the Promoter Region of RGS4 and Schizophrenia in the Northern Chinese Han Population

Xu F, Yao J, Wu X, Xia X, Xing J, Xuan J, Liu Y, Wang B

Neuropsychiatric Disease and Treatment 2020, 16:985-992

Published Date: 16 April 2020

Clinical, Electrophysiological and Radiological Features of Nitrous Oxide-Induced Neurological Disorders

Bao L, Li Q, Li Q, Chen H, Zhang R, Shi H, Cui G

Neuropsychiatric Disease and Treatment 2020, 16:977-984

Published Date: 15 April 2020

Asymmetry of Subthalamic Neuronal Firing Rate and Oscillatory Characteristics in Parkinson’s Disease [Retraction]

Zhao XM, Zhuang P, Li Y, Zhang Y, Li J, Wang Y, Li J

Neuropsychiatric Disease and Treatment 2020, 16:975-976

Published Date: 16 April 2020

miR-138 Increases Depressive-Like Behaviors by Targeting SIRT1 in Hippocampus

Li C, Wang F, Miao P, Yan L, Liu S, Wang X, Jin Z, Gu Z

Neuropsychiatric Disease and Treatment 2020, 16:949-957

Published Date: 9 April 2020

Prediction of Risk Factors for the Evolution of Traumatic Subdural Effusion into Chronic Subdural Hematoma

Chen S, Peng H, Shao X, Yao L, Liu J, Tian J, Sun L, Dai Y, Jiang X, Cheng L

Neuropsychiatric Disease and Treatment 2020, 16:943-948

Published Date: 9 April 2020

APOE ϵ4 Allele Is Associated with Elevated Levels of CSF VILIP-1 in Preclinical Alzheimer’s Disease

Wang L, Zhang M, Wang Q, Jiang X, Li K, Liu J

Neuropsychiatric Disease and Treatment 2020, 16:923-931

Published Date: 8 April 2020

The Prevalence of Sarcopenia in Bipolar Disorder

Bulbul F, Koca I, Tamam L, Demirkol ME, Cakmak S, Ersahinoglu E

Neuropsychiatric Disease and Treatment 2020, 16:915-921

Published Date: 8 April 2020

The Clinical Effect of Electroconvulsive Therapy and Its Relationship with Serum Levels of MMP-9 and CXCL12 in Patients with Mania

Kashefi B, Mohammadi M, Rezaei F, Ghadami N, Jalili K, Jalili A

Neuropsychiatric Disease and Treatment 2020, 16:909-914

Published Date: 5 April 2020

BDNF and the Antidepressant Effects of Ketamine and Propofol in Electroconvulsive Therapy: A Preliminary Study

Huang XB, Huang X, He HB, Mei F, Sun B, Zhou SM, Yan S, Zheng W, Ning Y

Neuropsychiatric Disease and Treatment 2020, 16:901-908

Published Date: 5 April 2020

Intracerebral Hemorrhage Induced Brain Injury Is Mediated by the Interleukin-12 Receptor in Rats

Yue X, Liu L, Yan H, Gui Y, Zhao J, Zhang P

Neuropsychiatric Disease and Treatment 2020, 16:891-900

Published Date: 1 April 2020

Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI)

Tsuboi T, Suzuki T, Azekawa T, Adachi N, Ueda H, Edagawa K, Katsumoto E, Kubota Y, Goto E, Hongo S, Watanabe Y, Kato M, Yasui-Furukori N, Yoshimura R, Nakagawa A, Kikuchi T, Watanabe K

Neuropsychiatric Disease and Treatment 2020, 16:881-890

Published Date: 31 March 2020

Deltonin Ameliorates Cerebral Ischemia/Reperfusion Injury in Correlation with Modulation of Autophagy and Inflammation

Zhang Y, Tian Z, Wan H, Liu W, Kong F, Ma G

Neuropsychiatric Disease and Treatment 2020, 16:871-879

Published Date: 31 March 2020

Gut Microbiota Regulates Depression-Like Behavior in Rats Through the Neuroendocrine-Immune-Mitochondrial Pathway

Liu S, Guo R, Liu F, Yuan Q, Yu Y, Ren F

Neuropsychiatric Disease and Treatment 2020, 16:859-869

Published Date: 31 March 2020

Influence of Self-Esteem and Psychiatric Diagnosis on Health-Related Quality of Life in Children and Adolescents with School Refusal Behavior

Matsuura H, Iwasaka H, Nezu S, Ota T, Okazaki K, Yamamuro K, Nakanishi Y, Kishimoto N, Iida J, Kishimoto T

Neuropsychiatric Disease and Treatment 2020, 16:847-858

Published Date: 31 March 2020

Performance of the Arabic Population on the Adolescent-Adult Sensory Profile: An Observational Study [Corrigendum]

Al-Momani F, Alghadir AH, Al-Momani MO, Alharethy S, Al-Sharman A, Al-Dibii R, Anwer S

Neuropsychiatric Disease and Treatment 2020, 16:837-838

Published Date: 30 March 2020

Medication Profile and Treatment Cost Estimation Among Outpatients with Schizophrenia, Bipolar Disorder, Depression, and Anxiety Disorders in Indonesia

Puspitasari IM, Sinuraya RK, Rahayu C, Witriani W, Zannah U, Hafifah A, Ningtyas AR, Vildayanti H

Neuropsychiatric Disease and Treatment 2020, 16:815-828

Published Date: 26 March 2020

The Occurrence and Longitudinal Changes of Cognitive Impairment After Acute Ischemic Stroke

Liao X, Zuo L, Zhang N, Yang Y, Pan Y, Xiang X, Chen L, Meng X, Li H, Zhao X, Wang Y, Wang C, Shi J, Wang Y

Neuropsychiatric Disease and Treatment 2020, 16:807-814

Published Date: 26 March 2020

Cerebral Salt Wasting in Traumatic Brain Injury Is Associated with Increased Morbidity and Mortality

Chendrasekhar A, Chow PT, Cohen D, Akella K, Vadali V, Bapatla A, Patwari J, Rubinshteyn V, Harris L

Neuropsychiatric Disease and Treatment 2020, 16:801-806

Published Date: 25 March 2020

The Expression of GLAST and GLT1 in a Transient Cerebral Ischemia Mongolian Gerbil Model

Shen Y, Lu H, Xu R, Tian H, Xia X, Zhou FH, Wang L, Dong J, Sun L

Neuropsychiatric Disease and Treatment 2020, 16:789-800

Published Date: 23 March 2020

Drug Attitude, Insight, and Patient’s Knowledge About Prescribed Antipsychotics in Schizophrenia: A Cross-Sectional Survey

Nagai N, Tani H, Yoshida K, Gerretsen P, Suzuki T, Ikai-Tani S, Mimura M, Uchida H

Neuropsychiatric Disease and Treatment 2020, 16:781-787

Published Date: 23 March 2020

Genetic Effects of DISC1 and G72 (DAOA) on Visual Learning of Patients with Schizophrenia

Chang JP, Huang KH, Lin CH, Lane HY

Neuropsychiatric Disease and Treatment 2020, 16:771-780

Published Date: 20 March 2020

Commensal Microbiota Regulation of Metabolic Networks During Olfactory Dysfunction in Mice

Wang H, Liu L, Rao X, Chai T, Zeng B, Zhang X, Yu Y, Zhou C, Pu J, Zhou W, Li W, Zhang H, Wei H, Xie P

Neuropsychiatric Disease and Treatment 2020, 16:761-769

Published Date: 19 March 2020

Factors Associated with the Development of Postnatal Depression After Cesarean Delivery: A Prospective Study

Chan CLJ, Tan CW, Chan JJI, Sultana R, Chua TE, Chen HY, Sia ATH, Sng BL

Neuropsychiatric Disease and Treatment 2020, 16:715-727

Published Date: 12 March 2020

Number of Electroconvulsive Therapy Sessions required for Thai Psychiatric Patients: a Retrospective Study

Ittasakul P, Vora-arporn S, Waleeprakhon P, Tor PC

Neuropsychiatric Disease and Treatment 2020, 16:673-679

Published Date: 4 March 2020

Phosphorylation of Tau and α-Synuclein Induced Neurodegeneration in MPTP Mouse Model of Parkinson’s Disease

Hu S, Hu M, Liu J, Zhang B, Zhang Z, Zhou FH, Wang L, Dong J

Neuropsychiatric Disease and Treatment 2020, 16:651-663

Published Date: 4 March 2020

A Study of Antidepressant Effect and Mechanism on Intranasal Delivery of BDNF-HA2TAT/AAV to Rats with Post-Stroke Depression

Chen C, Dong Y, Liu F, Gao C, Ji C, Dang Y, Ma X, Liu Y

Neuropsychiatric Disease and Treatment 2020, 16:637-649

Published Date: 4 March 2020

Effectiveness of Family Stress-Relief Interventions for Patients with Dementia: A Systematic Evaluation of Literature

Stoia DCM, Ștefănuț A, Moldovan R, Hogea L, Giurgi-Oncu C, Bredicean C

Neuropsychiatric Disease and Treatment 2020, 16:629-635

Published Date: 4 March 2020

Removal of Aβ Oligomers from the Blood: A Potential Therapeutic System for Alzheimer’s Disease

Saito Y, Sakata M, Kobayakawa M, Kawachi H, Kawaguchi K, Hiki Y, Kato M, Mori M, Hasegawa M, Ohashi N, Yuzawa Y, Kitaguchi N

Neuropsychiatric Disease and Treatment 2020, 16:607-627

Published Date: 3 March 2020

Clinical and Neurocognitive Predictors of Functional Outcome in Depressed Patients with Partial Response to Treatment: One Year Follow-Up Study

Castellano S, Torrent C, Petralia MC, Godos J, Cantarella RA, Ventimiglia A, De Vivo S, Platania S, Guarnera M, Pirrone C, Drago F, Vieta E, Di Nuovo S, Popovic D, Caraci F

Neuropsychiatric Disease and Treatment 2020, 16:589-595

Published Date: 28 February 2020

Prevalence of Asymptomatic Venous Thromboembolism in Depressive Inpatients

Takeshima M, Ishikawa H, Umeta Y, Kudoh M, Umakoshi A, Yoshizawa K, Ito Y, Hosoya T, Tsutsui K, Ohta H, Mishima K

Neuropsychiatric Disease and Treatment 2020, 16:579-587

Published Date: 26 February 2020

Chronic Stress in a Rat Model of Depression Disturbs the Glutamine–Glutamate–GABA Cycle in the Striatum, Hippocampus, and Cerebellum

Xu S, Liu Y, Pu J, Gui S, Zhong X, Tian L, Song X, Qi X, Wang H, Xie P

Neuropsychiatric Disease and Treatment 2020, 16:557-570

Published Date: 24 February 2020

The Predictive Value of Endothelial Inflammatory Markers in the Onset of Schizophrenia

Radu G, Luca C, Petrescu L, Bordejevic DA, Tomescu MC, Andor M, Cîtu I, Mavrea A, Buda V, Tomescu C, Borcan F, Dehelean L

Neuropsychiatric Disease and Treatment 2020, 16:545-555

Published Date: 24 February 2020

Affective Symptoms and Health-Related Quality of Life Among Women with Stress Urinary Incontinence: Cross-Sectional Study

Steibliene V, Aniuliene R, Aniulis P, Raskauskiene N, Adomaitiene V

Neuropsychiatric Disease and Treatment 2020, 16:535-544

Published Date: 24 February 2020

Precision Medicine of Sodium Benzoate for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)

Lin CH, Yang HT, Chen PK, Wang SH, Lane HY

Neuropsychiatric Disease and Treatment 2020, 16:509-518

Published Date: 20 February 2020

Variants in the Upstream Region of the Insulin Receptor Substrate-1 Gene Is Associated with Major Depressive Disorder in the Han Chinese Population

Wang F, Yu S, Zhou R, Mao R, Zhao G, Guo X, Xu Q, Chen J, Zhang C, Fang Y

Neuropsychiatric Disease and Treatment 2020, 16:501-507

Published Date: 20 February 2020

Frontocingulate Dysfunction Is Associated with Depression and Decreased Serum PON1 in Methamphetamine-Dependent Patients

Ghavidel N, Khodagholi F, Ahmadiani A, Khosrowabadi R, Asadi S, Shams J

Neuropsychiatric Disease and Treatment 2020, 16:489-499

Published Date: 19 February 2020

Association Between Glutathione S-Transferase (GST) Polymorphisms and Schizophrenia in a Chinese Han Population

Yan C, Duan L, Fu C, Tian C, Zhang B, Shao X, Zhu G

Neuropsychiatric Disease and Treatment 2020, 16:479-487

Published Date: 18 February 2020

Indexing Executive Functions with Test Scores, Parent Ratings and ERPs: How Do the Measures Relate in Children versus Adolescents with ADHD?

Häger LA, Øgrim G, Danielsen M, Billstedt E, Gillberg C, Åsberg Johnels J

Neuropsychiatric Disease and Treatment 2020, 16:465-477

Published Date: 17 February 2020

Comparing Expert and Non-Expert Assessment of Patients Presenting with Neurological Symptoms to the Emergency Department: A Retrospective Observational Study

Hoyer C, Stein P, Ebert A, Rausch HW, Nagel S, Eisele P, Alonso A, Platten M, Szabo K

Neuropsychiatric Disease and Treatment 2020, 16:447-456

Published Date: 13 February 2020

ABCA7 Gene Expression and Genetic Association Study in Schizophrenia

Yamazaki K, Yoshino Y, Kawabe K, Ibuki T, Ochi S, Mori Y, Ozaki Y, Numata S, Iga J, Ohmori T, Ueno S

Neuropsychiatric Disease and Treatment 2020, 16:441-446

Published Date: 13 February 2020

Treatment-Seeking Behavior Towards Epilepsy Among Rural Residents in Ethiopia: A Cross-Sectional Study

Molla A, Mekuriaw B, Habtamu E, Mareg M

Neuropsychiatric Disease and Treatment 2020, 16:433-439

Published Date: 13 February 2020

The CYP2C19*2 and CYP2C19*17 Polymorphisms Influence Responses to Clozapine for the Treatment of Schizophrenia

Rodrigues-Silva C, Semedo AT, Neri HFS, Vianello RP, Galaviz-Hernández C, Sosa-Macías M, de Brito RB, Ghedini PC

Neuropsychiatric Disease and Treatment 2020, 16:427-432

Published Date: 11 February 2020

Comorbid Premenstrual Dysphoric Disorder in Women with Bipolar Disorder: Management Challenges

Sepede G, Brunetti M, Di Giannantonio M

Neuropsychiatric Disease and Treatment 2020, 16:415-426

Published Date: 10 February 2020

Impulsivity, Unplanned Pregnancies, and Contraception Among Women with Bipolar Disorder

Zengin Eroglu M, Lus MG

Neuropsychiatric Disease and Treatment 2020, 16:407-414

Published Date: 7 February 2020

Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects

Morano A, Fanella M, Albini M, Cifelli P, Palma E, Giallonardo AT, Di Bonaventura C

Neuropsychiatric Disease and Treatment 2020, 16:381-396

Published Date: 7 February 2020

Adjunctive Rufinamide in Children with Lennox-Gastaut Syndrome: A Literature Review

Balagura G, Riva A, Marchese F, Verrotti A, Striano P

Neuropsychiatric Disease and Treatment 2020, 16:369-379

Published Date: 5 February 2020

Family-Based Analysis Combined with Case–Controls Study Implicate Roles of PCNT in Tourette Syndrome

Liu W, Guo Y, Liu X, Zhang R, Dong J, Deng H, He F, Che F, Liu S, Yi M

Neuropsychiatric Disease and Treatment 2020, 16:349-354

Published Date: 31 January 2020

microRNA-182 Negatively Influences the Neuroprotective Effect of Apelin Against Neuronal Injury in Epilepsy

Dong H, Dong B, Zhang N, Liu S, Zhao H

Neuropsychiatric Disease and Treatment 2020, 16:327-338

Published Date: 30 January 2020

Assessments of Amino Acids, Ammonia and Oxidative Stress Among Cohort of Egyptian Autistic Children: Correlations with Electroencephalogram and Disease Severity [Corrigendum]

Saleem TH, Shehata GA, Toghan R, Sakhr HM, Bakri AH, Desoky T, Hamdan FRA, Mohamed NF, Hassan MH

Neuropsychiatric Disease and Treatment 2020, 16:325-326

Published Date: 30 January 2020

Asymmetry of Subthalamic Neuronal Firing Rate and Oscillatory Characteristics in Parkinson’s Disease

Zhao XM, Zhuang P, Li Y, Zhang Y, Li J, Wang Y, Li J

Neuropsychiatric Disease and Treatment 2020, 16:313-323

Published Date: 28 January 2020

Personal Construct Therapy vs Cognitive Behavioral Therapy in the Treatment of Depression in Women with Fibromyalgia: Study Protocol for a Multicenter Randomized Controlled Trial

Paz C, Aguilera M, Salla M, Compañ V, Medina JC, Bados A, García-Grau E, Castel A, Cañete Crespillo J, Montesano A, Medeiros-Ferreira L, Feixas G

Neuropsychiatric Disease and Treatment 2020, 16:301-311

Published Date: 24 January 2020

Effects of Remote Ischemic Conditioning on Cerebral Hemodynamics in Ischemic Stroke

Qin C, Yan X, Jin H, Zhang R, He Y, Sun X, Zhang Y, Guo ZN, Yang Y

Neuropsychiatric Disease and Treatment 2020, 16:283-299

Published Date: 23 January 2020

Aberrant Thalamic-Centered Functional Connectivity in Patients with Persistent Somatoform Pain Disorder

Sun X, Pan X, Ni K, Ji C, Wu J, Yan C, Luo Y

Neuropsychiatric Disease and Treatment 2020, 16:273-281

Published Date: 23 January 2020

Intranasal Delivery of Bone Marrow Stromal Cells Preconditioned with Fasudil to Treat a Mouse Model of Parkinson’s Disease

Tang Y, Han L, Bai X, Liang X, Zhao J, Huang F, Wang J

Neuropsychiatric Disease and Treatment 2020, 16:249-262

Published Date: 23 January 2020

Autonomic Nervous System Is Related to Inhibitory and Control Function Through Functional Inter-Region Connectivities of OFC in Major Depression

Zhou H, Hua L, Jiang H, Dai Z, Han Y, Lin P, Wang H, Lu Q, Yao Z

Neuropsychiatric Disease and Treatment 2020, 16:235-247

Published Date: 21 January 2020

Management of Treatment-Resistant Depression: Challenges and Strategies

Voineskos D, Daskalakis ZJ, Blumberger DM

Neuropsychiatric Disease and Treatment 2020, 16:221-234

Published Date: 21 January 2020

Development and Validation of a Japanese Version of the Emotion Regulation Questionnaire for Children and Adolescents

Namatame H, Fujisato H, Ito M, Sawamiya Y

Neuropsychiatric Disease and Treatment 2020, 16:209-219

Published Date: 21 January 2020

Post-Stroke Depression and Estimated Glomerular Filtration Rate: A Prospective Stroke Cohort

Lin S, Luan X, He W, Ruan Y, Yuan C, Fan A, Chen X, He J

Neuropsychiatric Disease and Treatment 2020, 16:201-208

Published Date: 21 January 2020

The Role of Cytokines in Predicting the Efficacy of Acute Stage Treatment in Patients with Schizophrenia

He X, Ma Q, Fan Y, Zhao B, Wang W, Zhu F, Ma X, Zhou L

Neuropsychiatric Disease and Treatment 2020, 16:191-199

Published Date: 21 January 2020

Left Ventricular End-Diastolic Diameter and Cardiac Mortality in Duchenne Muscular Dystrophy

Segawa K, Sugawara N, Maruo K, Kimura K, Komaki H, Takahashi Y, Sasaki M

Neuropsychiatric Disease and Treatment 2020, 16:171-178

Published Date: 16 January 2020

Transcranial Direct Current Stimulation in Patients with Anxiety: Current Perspectives

Stein DJ, Fernandes Medeiros L, Caumo W, Torres ILS

Neuropsychiatric Disease and Treatment 2020, 16:161-169

Published Date: 14 January 2020

Exosomal Long Non-Coding RNA Expression from Serum of Patients with Acute Minor Stroke

Xu X, Zhuang C, Chen L

Neuropsychiatric Disease and Treatment 2020, 16:153-160

Published Date: 13 January 2020

Unilateral Spatial Neglect After Stroke: Current Insights

Gammeri R, Iacono C, Ricci R, Salatino A

Neuropsychiatric Disease and Treatment 2020, 16:131-152

Published Date: 10 January 2020

Effects of AQP4 and KCNJ10 Gene Polymorphisms on Drug Resistance and Seizure Susceptibility in Chinese Han Patients with Focal Epilepsy

Zhu H, Zhang M, Fu Y, Long H, Xiao W, Feng L, Xiao B, Zhou L

Neuropsychiatric Disease and Treatment 2020, 16:119-129

Published Date: 9 January 2020

Effects of GSTA1 and GPX3 Polymorphisms on the Risk of Schizophrenia in Chinese Han Population

Liu C, Song S, Zhang J, Li X, Gao H

Neuropsychiatric Disease and Treatment 2020, 16:113-118

Published Date: 9 January 2020

Nonsuicidal Self-Injury: Diagnostic Challenges And Current Perspectives

Hooley JM, Fox KR, Boccagno C

Neuropsychiatric Disease and Treatment 2020, 16:101-112

Published Date: 10 January 2020

Alcohol and Dementia – What is the Link? A Systematic Review

Wiegmann C, Mick I, Brandl EJ, Heinz A, Gutwinski S

Neuropsychiatric Disease and Treatment 2020, 16:87-99

Published Date: 9 January 2020

Abnormal Baseline Brain Activity in Neuromyelitis Optica Patients Without Brain Lesion Detected by Resting-State Functional Magnetic Resonance Imaging

Liu Y, Xiong H, Li X, Zhang D, Yang C, Yu J, Liao R, Zhou B, Huang X, Tang Z

Neuropsychiatric Disease and Treatment 2020, 16:71-79

Published Date: 8 January 2020

Predictors of Current DSM-5 PTSD Diagnosis and Symptom Severity Among Deployed Veterans: Significance of Predisposition, Stress Exposure, and Genetics

Hu Y, Chu X, Urosevich TG, Hoffman SN, Kirchner HL, Adams RE, Dugan RJ, Boscarino JJ, Shi W, Withey CA, Figley CR, Boscarino JA

Neuropsychiatric Disease and Treatment 2020, 16:43-54

Published Date: 8 January 2020

Performance of the Arabic Population on the Adolescent-Adult Sensory Profile: An Observational Study

Al-Momani F, Alghadir AH, Al-Momani MO, Alharethy S, Al-Sharman A, Al-Dibii R, Anwer S

Neuropsychiatric Disease and Treatment 2020, 16:35-42

Published Date: 7 January 2020

Assessments of Amino Acids, Ammonia and Oxidative Stress Among Cohort of Egyptian Autistic Children: Correlations with Electroencephalogram and Disease Severity

Saleem TH, Shehata GA, Toghan R, Sakhr HM, Bakri AH, Desoky T, Hamdan FRA, Mohamed NF, Hassan MH

Neuropsychiatric Disease and Treatment 2020, 16:11-24

Published Date: 6 January 2020

Influence of Childhood Maltreatment, Adulthood Stressful Life Events, and Affective Temperaments on Premenstrual Mental Symptoms of Nonclinical Adult Volunteers

Wakatsuki Y, Inoue T, Hashimoto N, Fujimura Y, Masuya J, Ichiki M, Tanabe H, Kusumi I

Neuropsychiatric Disease and Treatment 2020, 16:1-10

Published Date: 6 January 2020

Neuroprotective effect and mechanism of baicalin on Parkinson’s disease model induced by 6-OHDA

Tu L, Wu ZY, Yang XL, Zhang Q, Gu R, Wang Q, Tian T, Yao H, Qu X, Tian JY

Neuropsychiatric Disease and Treatment 2019, 15:3615-3625

Published Date: 3 January 2020

The Relationship Between Course of Illness and β-Endorphin Plasma Levels in Patients with Schizophrenia

Urban-Kowalczyk M, Kotlicka-Antczak M, Strzelecki D, Rudecka E, Śmigielski J

Neuropsychiatric Disease and Treatment 2019, 15:3609-3614

Published Date: 3 January 2020

Therapeutic Dose of Amitriptyline for Older Patients with Burning Mouth Syndrome

Suga T, Takenoshita M, Watanabe T, Tu TTH, Mikuzuki L, Hong C, Miura K, Yoshikawa T, Nagamine T, Toyofuku A

Neuropsychiatric Disease and Treatment 2019, 15:3599-3607

Published Date: 30 December 2019

Managing Functional Neurological Disorders: Protocol of a Cohort Study on Psychogenic Non-Epileptic Seizures Study

Altalib HH, Galluzzo D, Argraves S, Goulet J, Bornovski Y, Cheung KH, Jackson-Shaheed E, Tolchin B, Fenton BT, Pugh MJ

Neuropsychiatric Disease and Treatment 2019, 15:3557-3568

Published Date: 27 December 2019

Widely Impaired White Matter Integrity and Altered Structural Brain Networks in Psychogenic Non-Epileptic Seizures

Sone D, Sato N, Ota M, Kimura Y, Matsuda H

Neuropsychiatric Disease and Treatment 2019, 15:3549-3555

Published Date: 24 December 2019

Real-World Effectiveness and Safety of Antipsychotics in Individuals at Clinical High-Risk for Psychosis: Study Protocol for a Prospective Observational Study (ShangHai at Risk for Psychosis-Phase 2)

Wu G, Gan R, Li Z, Xu L, Tang X, Wei Y, Hu Y, Cui H, Li H, Tang Y, Hui L, Liu X, Li C, Wang J, Zhang T

Neuropsychiatric Disease and Treatment 2019, 15:3541-3548

Published Date: 24 December 2019

Psychache and Suicidal History in Patients with Obsessive-Compulsive Disorder

Demirkol ME, Namlı Z, Eriş Davul Ö, Karaytuğ MO, Tamam L, Yılmaz H

Neuropsychiatric Disease and Treatment 2019, 15:3531-3539

Published Date: 24 December 2019

Type C Personality and Depression Among Newly Diagnosed Breast Cancer Patients: The Mediating Role of Sense of Coherence

Wei M, Guo L, Zhu Y, Guo Y, Yv S, Namassevayam G, Xue W, Li J, Li L, Shen Z, Yv J, Zhu Z, Wang W, Liu Y, Zhao J, Chen F

Neuropsychiatric Disease and Treatment 2019, 15:3519-3529

Published Date: 24 December 2019

Pilot Validation Study of the Japanese Translation of the Brief Negative Symptoms Scale (BNSS)

Hashimoto N, Toyomaki A, Oka M, Takanobu K, Okubo R, Narita H, Kitagawa K, Udo N, Maeda T, Watanabe S, Oyanagi Y, Miyazaki A, Ito K, Kusumi I

Neuropsychiatric Disease and Treatment 2019, 15:3511-3518

Published Date: 23 December 2019

Posttraumatic Stress Disorder and Associated Factors Among Drivers Surviving Road Traffic Crashes in Southwest Ethiopia

Alenko A, Berhanu H, Tareke AA, Reta W, Bariso M, Mulat E, Kenenisa C, Debebe W, Tolesa K, Girma S

Neuropsychiatric Disease and Treatment 2019, 15:3501-3509

Published Date: 24 December 2019

Decreased Vascular Pulsatility in Alzheimer’s Disease Dementia Measured by Transcranial Color-Coded Duplex Sonography

Ortner M, Hauser C, Schmaderer C, Muggenthaler C, Hapfelmeier A, Sorg C, Diehl-Schmid J, Kurz A, Förstl H, Ikenberg B, Kotliar K, Poppert H, Grimmer T

Neuropsychiatric Disease and Treatment 2019, 15:3487-3499

Published Date: 20 December 2019

Correlation of Health-Related Quality of Life in Clinically Stable Outpatients with Schizophrenia

Domenech C, Pastore A, Altamura AC, Bernasconi C, Corral R, Elkis H, Evans J, Malla A, Margari F, Krebs MO, Nordstroem AL, Zink M, Haro JM

Neuropsychiatric Disease and Treatment 2019, 15:3475-3486

Published Date: 20 December 2019

Exploration of Treatment-Resistant Schizophrenia Subtypes Based on a Survey of 204 US Psychiatrists

Correll CU, Brevig T, Brain C

Neuropsychiatric Disease and Treatment 2019, 15:3461-3473

Published Date: 19 December 2019

Co-Occurring Psychiatric and Substance Use Disorders: Clinical Survey Among a Rural Cohort of Italian Patients

Milano G, Vergani HM, Cattedra S, Carrozzino R, Mattioli F, Robbiano L, Martelli A

Neuropsychiatric Disease and Treatment 2019, 15:3453-3459

Published Date: 18 December 2019

Thromboelastography with Platelet Mapping Detects Platelet Dysfunction in Patients with Aneurysmal Subarachnoid Hemorrhage with Rebleeding

He Q, Zhou Y, Liu C, Zhang X, Huang N, Wang F, Liu G, Cheng Y, Xie Z

Neuropsychiatric Disease and Treatment 2019, 15:3443-3451

Published Date: 16 December 2019

Electroacupuncture Promoting Axonal Regeneration in Spinal Cord Injury Rats via Suppression of Nogo/NgR and Rho/ROCK Signaling Pathway

Xiao WP, Ding LLQ, Min YJ, Yang HY, Yao HH, Sun J, Zhou X, Zeng XB, Yu W

Neuropsychiatric Disease and Treatment 2019, 15:3429-3442

Published Date: 13 December 2019

The Effect of Counseling on Stigma in Psychiatric Patients Receiving Electroconvulsive Therapy: A Clinical Trial Study

Sadeghian E, Rostami P, Shamsaei F, Tapak L

Neuropsychiatric Disease and Treatment 2019, 15:3419-3427

Published Date: 6 December 2019

Experiences Of Immigrant Parents In Sweden Participating In A Community Assessment And Intervention Program For Preschool Children With Autism

Nilses Å, Jingrot M, Linnsand P, Gillberg C, Nygren G

Neuropsychiatric Disease and Treatment 2019, 15:3397-3410

Published Date: 6 December 2019

Validity and Reliability Study of the Chinese Traditional Version of the Devereux Early Childhood Assessment for Toddlers DECA T

Liang SHY, Chou JY, Wu YY, Lee CP, Kelsen BA, Lee YC

Neuropsychiatric Disease and Treatment 2019, 15:3375-3385

Published Date: 5 December 2019

Clinical Characteristics of Women with ADHD in Japan

Hayashi W, Suzuki H, Saga N, Arai G, Igarashi R, Tokumasu T, Ota H, Yamada H, Takashio O, Iwanami A

Neuropsychiatric Disease and Treatment 2019, 15:3367-3374

Published Date: 4 December 2019

Resting-State Functional MRI Study: Connection Strength of Brain Networks in DR Patients

Li L, Dai H, Ke J, Shi C, Jiang N, Yang CM

Neuropsychiatric Disease and Treatment 2019, 15:3359-3366

Published Date: 5 December 2019

Effect of Benzo[a]pyrene-DNA Adduct in Cord Blood on the Neurodevelopment of 12-Month-Old Infants in Qingdao City

Zhang Y, Yang Y, Zhang Q, Cui J, Rahaman A, Huang XR, Su Y, Gao R, Wang B, Baloch Z

Neuropsychiatric Disease and Treatment 2019, 15:3351-3357

Published Date: 2 December 2019

Employment-Related Factors of Forensic Psychiatric Outpatients with Psychotic Disorders

Takeda K, Sugawara N, Yamada Y, Nagata T, Kashiwagi H, Kono T, Hirabayashi N, Okada T

Neuropsychiatric Disease and Treatment 2019, 15:3341-3350

Published Date: 2 December 2019

Adaptive Affect: The Nature of Anxiety and Depression

Morris DW

Neuropsychiatric Disease and Treatment 2019, 15:3323-3326

Published Date: 2 December 2019

Reversible Affective Symptoms and Attention Executive Control Network Impairment Following Thyroid Function Normalization in Hyperthyroidism

Yuan L, Zhang Y, Luan D, Xu X, Yang Q, Zhao S, Zhou Z

Neuropsychiatric Disease and Treatment 2019, 15:3305-3312

Published Date: 26 November 2019

Empathy In Neurodegenerative Diseases: A Systematic Review

Pick E, Kleinbub JR, Mannarini S, Palmieri A

Neuropsychiatric Disease and Treatment 2019, 15:3287-3304

Published Date: 22 November 2019

Alterations Of Glycerophospholipid And Fatty Acyl Metabolism In Multiple Brain Regions Of Schizophrenia Microbiota Recipient Mice

Liang W, Huang Y, Tan X, Wu J, Duan J, Zhang H, Yin B, Li Y, Zheng P, Wei H, Xie P

Neuropsychiatric Disease and Treatment 2019, 15:3219-3229

Published Date: 19 November 2019

Psychometric Properties Of The Persian Version Of The Memory Impact Questionnaire In Older Adults

Ebadi A, Ebtekar F, Parizad N, Afkhamzadeh A, Dalvand S, Ghanei Gheshlagh R

Neuropsychiatric Disease and Treatment 2019, 15:3197-3204

Published Date: 14 November 2019

Profile Of Patients With Advanced Parkinson’s disease Suitable For Device-Aided Therapies: Restrospective Data Of A Large Cohort Of Romanian Patients

Szász JA, Constantin VA, Orbán-Kis K, Rácz A, Bancu LA, Georgescu D, Szederjesi J, Mihály I, Fárr AM, Kelemen K, Vajda T, Szatmári S

Neuropsychiatric Disease and Treatment 2019, 15:3187-3195

Published Date: 13 November 2019

Traditional Chinese Medicine Shenmayizhi Decoction Ameliorates Memory And Cognitive Impairment Induced By Scopolamine Via Preventing Hippocampal Cholinergic Dysfunction In Rats

Wu Q, Cao Y, Liu M, Liu F, Brantner AH, Yang Y, Wei Y, Zhou Y, Wang Z, Ma L, Wang F, Pei H, Li H

Neuropsychiatric Disease and Treatment 2019, 15:3167-3176

Published Date: 12 November 2019

No Association Between Human Immunodeficiency Virus Infections And Dementia: A Nationwide Cohort Study In Taiwan

Yang CC, Chien WC, Chung CH, Liu YP, Yeh CB, Chen KH, Yang SN, Chang HA, Kao YC, Lu WC, Tzeng NS

Neuropsychiatric Disease and Treatment 2019, 15:3155-3166

Published Date: 12 November 2019

Mindfulness-Based Intervention For Nurses In AIDS Care In China: A Pilot Study

Pan C, Wang H, Chen M, Cai Y, Xiao C, Tang Q, Koniak-Griffin D

Neuropsychiatric Disease and Treatment 2019, 15:3131-3141

Published Date: 8 November 2019

The Efficacy, Feasibility And Acceptability Of A Remotely Accessible Use Of CIRCuiTS, A Computerized Cognitive Remediation Therapy Program For Schizophrenia: A Pilot Study

Palumbo D, Mucci A, Giordano GM, Piegari G, Aiello C, Pietrafesa D, Annarumma N, Chieffi M, Cella M, Galderisi S

Neuropsychiatric Disease and Treatment 2019, 15:3103-3113

Published Date: 8 November 2019

Is visuomotor training an effective intervention for children with autism spectrum disorders?

Arabi M, Saberi Kakhki A, Sohrabi M, Soltani Kouhbanani S, Jabbari Nooghabi M

Neuropsychiatric Disease and Treatment 2019, 15:3089-3102

Published Date: 8 November 2019

Improvement Of Frontal Lobe Dysfunction And White Matter Integrity By rTMS In Treatment-Resistant Depression

Tateishi H, Nishihara M, Kawaguchi A, Matsushima J, Murakawa T, Haraguchi Y, Kunitake Y, Maekawa T, Kato TA, Asami T, Mizoguchi Y, Monji A

Neuropsychiatric Disease and Treatment 2019, 15:3079-3087

Published Date: 6 November 2019

Sex Differences In Psychoeducation For Patients With Depression: A Comparison Of Frequency And Efficacy Of Psychoeducation

Tomita T, Kudo S, Sugawara N, Fujii A, Tsuruga K, Sato Y, Ishioka M, Nakamura K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2019, 15:3069-3078

Published Date: 6 November 2019

Differential Diagnosis Of Multiple-System Atrophy With Parkinson’s Disease By External Anal- And Urethral-Sphincter Electromyography

Qiu F, Wang K, Li T, Song D, Wang Z, Zhang H, Liu J, Ren M, Qi X

Neuropsychiatric Disease and Treatment 2019, 15:3061-3067

Published Date: 5 November 2019

Correlations And Correlates Of Post-Traumatic Growth And Post-Traumatic Stress Symptoms In Patients With Breast Cancer

Chen HM, Chen VCH, Hsiao HP, Weng YP, Hsu YT, Weng JC, Su JA, Chen YL

Neuropsychiatric Disease and Treatment 2019, 15:3051-3060

Published Date: 1 November 2019

Reversion From Mild Cognitive Impairment To Normal Cognition: False-Positive Error Or True Restoration Thanks To Cognitive Control Ability?

Chung JY, Yoon HJ, Kim H, Choi KY, Lee JJ, Lee KH, Seo EH

Neuropsychiatric Disease and Treatment 2019, 15:3021-3032

Published Date: 25 October 2019

Association study of genetic variants of the ANGPTL3 gene and susceptibility to ischemic stroke

Gong Q, Ye L, Gui H, Liu J, Li H, Sun Q

Neuropsychiatric Disease and Treatment 2019, 15:3015-3020

Published Date: 24 October 2019

Evaluation Of Subjective Cognitive Function Using The Cognitive Complaints In Bipolar Disorder Rating Assessment (COBRA) In Japanese Adults

Toyoshima K, Inoue T, Masuya J, Ichiki M, Fujimura Y, Kusumi I

Neuropsychiatric Disease and Treatment 2019, 15:2981-2990

Published Date: 18 October 2019

Efficacy Of Dual-Task Training With Two Different Priorities Instructional Sets On Gait Parameters In Patients With Chronic Stroke

Sengar S, Raghav D, Verma M, Alghadir AH, Iqbal A

Neuropsychiatric Disease and Treatment 2019, 15:2959-2969

Published Date: 17 October 2019

Nicotine consumption during the prodromal phase of schizophrenia – a review of the literature

Gogos A, Skokou M, Ferentinou E, Gourzis P

Neuropsychiatric Disease and Treatment 2019, 15:2943-2958

Published Date: 16 October 2019

CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients

Lin Y, Yang X, Lv J, Liu X, Wang S

Neuropsychiatric Disease and Treatment 2019, 15:2909-2915

Published Date: 11 October 2019

Clozapine As Transformative Treatment In Bipolar Patients

Wilkowska A, Cubała WJ

Neuropsychiatric Disease and Treatment 2019, 15:2901-2905

Published Date: 9 October 2019

Changes In Plasma NPY, IL-1β And Hypocretin In People Who Died By Suicide

Lu J, Li S, Li H, Mou T, Zhou L, Huang B, Huang M, Xu Y

Neuropsychiatric Disease and Treatment 2019, 15:2893-2900

Published Date: 10 October 2019

Is Autism Inborn And Lifelong For Everyone?

Whiteley P, Carr K, Shattock P

Neuropsychiatric Disease and Treatment 2019, 15:2885-2891

Published Date: 7 October 2019

Associations Of Personality Traits With The Capacity-Performance Discrepancy Of Functional Outcome In Patients With Schizophrenia

Uchino T, Nemoto T, Yamaguchi T, Katagiri N, Tsujino N, Murakami Y, Tanaka K, Mizuno M

Neuropsychiatric Disease and Treatment 2019, 15:2869-2877

Published Date: 3 October 2019

Cerebrospinal Fluid Proteomics For Identification Of α2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson’s Disease And Schizophrenia

Gupta AK, Pokhriyal R, Khan MI, Kumar DR, Gupta R, Chadda RK, Ramachandran R, Goyal V, Tripathi M, Hariprasad G

Neuropsychiatric Disease and Treatment 2019, 15:2853-2867

Published Date: 2 October 2019

Diffusion Tensor Imaging And Tractography In Autistic, Dysphasic, And Healthy Control Children

Hrdlicka M, Sanda J, Urbanek T, Kudr M, Dudova I, Kickova S, Pospisilova L, Mohaplova M, Maulisova A, Krsek P, Kyncl M, Blatny M, Komarek V

Neuropsychiatric Disease and Treatment 2019, 15:2843-2852

Published Date: 3 October 2019

Victimization In Childhood Affects Depression In Adulthood Via Neuroticism: A Path Analysis Study

Tachi S, Asamizu M, Uchida Y, Katayama S, Naruse M, Masuya J, Ichiki M, Inoue T

Neuropsychiatric Disease and Treatment 2019, 15:2835-2841

Published Date: 3 October 2019

Public Awareness, Beliefs, And Attitudes Toward Bipolar Disorder In Saudi Arabia

Alosaimi FD, AlAteeq DA, Bin Hussain SI, Alhenaki RS, Bin Salamah AA, AlModihesh NA

Neuropsychiatric Disease and Treatment 2019, 15:2809-2818

Published Date: 27 September 2019

Association Of Cigarette Smoking With Anxiety, Depression, And Suicidal Ideation Among Brazilian Adolescents

Slomp FM, Bara TS, Picharski GL, Cordeiro ML

Neuropsychiatric Disease and Treatment 2019, 15:2799-2808

Published Date: 25 September 2019

The Risk Of Seizure-Related Hospitalization Among Older Adults On Levetiracetam Monotherapy: A Retrospective Comparative Cohort Study

Alzahrani H, Almalag HM, AlRuthia Y, Al-hussain F, Balkhi B, Almutairi L, Algasem R, De Vol EB, Almarzouqi MR, Alsemari A

Neuropsychiatric Disease and Treatment 2019, 15:2781-2788

Published Date: 24 September 2019

Monitoring And Managing Depression In Adolescents With Epilepsy: Current Perspectives

Coppola G, Operto FF, Matricardi S, Verrotti A

Neuropsychiatric Disease and Treatment 2019, 15:2773-2780

Published Date: 24 September 2019

Subthreshold Depression Needs A Prime Time In Old Age Psychiatry? A Narrative Review Of Current Evidence

Biella MM, Borges MK, Strauss J, Mauer S, Martinelli JE, Aprahamian I

Neuropsychiatric Disease and Treatment 2019, 15:2763-2772

Published Date: 23 September 2019

Transcranial magnetic stimulation for the treatment of anxiety disorder

Rodrigues PA, Zaninotto AL, Neville IS, Hayashi CY, Brunoni AR, Teixeira MJ, Paiva WS

Neuropsychiatric Disease and Treatment 2019, 15:2743-2761

Published Date: 23 September 2019

Catatonia in Down syndrome: systematic approach to diagnosis, treatment and outcome assessment based on a case series of seven patients

Miles JH, Takahashi N, Muckerman J, Nowell KP, Ithman M

Neuropsychiatric Disease and Treatment 2019, 15:2723-2741

Published Date: 20 September 2019

Differentiation Between Dementia With Lewy Bodies And Alzheimer’s Disease Using Voxel-Based Morphometry Of Structural MRI: A Multicenter Study

Matsuda H, Yokoyama K, Sato N, Ito K, Nemoto K, Oba H, Hanyu H, Kanetaka H, Mizumura S, Kitamura S, Shinotoh H, Shimada H, Suhara T, Terada H, Nakatsuka T, Kawakatsu S, Hayashi H, Asada T, Ono T, Goto T, Shigemori K

Neuropsychiatric Disease and Treatment 2019, 15:2715-2722

Published Date: 19 September 2019

Analysis of correlation between cerebral perfusion and KIM score of white matter lesions in patients with Alzheimer’s disease

Li RR, He YS, Liu M, Nie ZY, Huang LH, Lu Z, Jin LJ, Li YX

Neuropsychiatric Disease and Treatment 2019, 15:2705-2714

Published Date: 18 September 2019

Transcranial direct current stimulation for Obsessive-Compulsive Disorder: patient selection and perspectives

da Silva RMF, Brunoni AR, Miguel EC, Shavitt RG

Neuropsychiatric Disease and Treatment 2019, 15:2663-2669

Published Date: 16 September 2019

Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment

Wang BR, Zheng HF, Xu C, Sun Y, Zhang YD, Shi JQ

Neuropsychiatric Disease and Treatment 2019, 15:2647-2653

Published Date: 13 September 2019

Disrupted Brain Entropy And Functional Connectivity Patterns Of Thalamic Subregions In Major Depressive Disorder

Xue SW, Wang D, Tan Z, Wang Y, Lian Z, Sun Y, Hu X, Wang X, Zhou X

Neuropsychiatric Disease and Treatment 2019, 15:2629-2638

Published Date: 11 September 2019

C-reactive protein is associated with severity of thought and language dysfunction in patients with schizophrenia

Chang CH, Lane HY, Liu CY, Cheng PC, Chen SJ, Lin CH

Neuropsychiatric Disease and Treatment 2019, 15:2621-2627

Published Date: 10 September 2019

Borderline personality disorder, trauma, and the hypothalamus–pituitary–adrenal axis

Thomas N, Gurvich C, Kulkarni J

Neuropsychiatric Disease and Treatment 2019, 15:2601-2612

Published Date: 9 September 2019

Repetitive transcranial magnetic stimulation significantly influences the eating behavior in depressive patients

Jaššová K, Albrecht J, Čerešňáková S, Papežová H, Anders M

Neuropsychiatric Disease and Treatment 2019, 15:2579-2586

Published Date: 6 September 2019

Evaluating optic nerve diameter as a possible biomarker for disability in patients with multiple sclerosis

Koraysha NA, Kishk N, Hassan A, Samy El Gendy NM, Shehata HS, Al-Azayem SA, Kamal YS

Neuropsychiatric Disease and Treatment 2019, 15:2571-2578

Published Date: 6 September 2019

A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future

Citrome L, McEvoy JP, Todtenkopf MS, McDonnell D, Weiden PJ

Neuropsychiatric Disease and Treatment 2019, 15:2559-2569

Published Date: 5 September 2019

Efficacy of ginkgo biloba extract as augmentation of venlafaxine in treating post-stroke depression

Liang ZH, Jia YB, Wang ML, Li ZR, Li M, Yun YL, Zhu RX

Neuropsychiatric Disease and Treatment 2019, 15:2551-2557

Published Date: 3 September 2019

Affective theory of mind in Parkinson’s disease: the effect of cognitive performance

Romosan AM, Dehelean L, Romosan RS, Andor M, Bredicean AC, Simu MA

Neuropsychiatric Disease and Treatment 2019, 15:2521-2535

Published Date: 30 August 2019

Risk taking behaviors in relation to Attention Deficit and Hyperactivity Disorder in Iranian male workers: a latent class analysis

Abbasi-Ghahramanloo A, Janani L, Malakouti SK, Rabetian M, Rimaz S

Neuropsychiatric Disease and Treatment 2019, 15:2513-2520

Published Date: 28 August 2019

Dementia care in the Danube Region. A multi-national expert survey

Mehrabian S, Schwarzkopf L, Auer S, Holmerova I, Kramberger MG, Boban M, Stefanova E, Tudose C, Bachinskaya N, Kovács T, Koranda P, Kunchev T, Traykov L, Diehl-Schmid J, Milecka K, Kurz A

Neuropsychiatric Disease and Treatment 2019, 15:2503-2511

Published Date: 29 August 2019

Disrupted topological organization of human brain connectome in diabetic retinopathy patients

Huang X, Tong Y, Qi CX, Xu YT, Dan HD, Shen Y

Neuropsychiatric Disease and Treatment 2019, 15:2487-2502

Published Date: 27 August 2019

Complex effects of childhood abuse, affective temperament, and subjective social status on depressive symptoms of adult volunteers from the community

Higashiyama M, Hayashida T, Sakuta K, Fujimura Y, Masuya J, Ichiki M, Tanabe H, Kusumi I, Inoue T

Neuropsychiatric Disease and Treatment 2019, 15:2477-2485

Published Date: 27 August 2019

The association between cortisol:C-reactive protein ratio and depressive fatigue is a function of CRP rather than cortisol

Sharpley CF, Bitsika V, McMillan ME, Jesulola E, Agnew LL

Neuropsychiatric Disease and Treatment 2019, 15:2467-2475

Published Date: 27 August 2019

Association between ADORA2A gene polymorphisms and schizophrenia in the North Chinese Han population

Miao J, Liu L, Yan C, Zhu X, Fan M, Yu P, Ji K, Huang Y, Wang Y, Zhu G

Neuropsychiatric Disease and Treatment 2019, 15:2451-2458

Published Date: 28 August 2019

Clinical improvement following vitamin D3 supplementation in children with chronic tic disorders

Li HH, Xu ZD, Wang B, Feng JY, Dong HY, Jia FY

Neuropsychiatric Disease and Treatment 2019, 15:2443-2450

Published Date: 26 August 2019

A single-nucleotide polymorphism influences brain morphology in drug-naïve patients with major depressive disorder

Katsuki A, Kakeda S, Watanabe K, Igata R, Otsuka Y, Kishi T, Nguyen L, Ueda I, Iwata N, Korogi Y, Yoshimura R

Neuropsychiatric Disease and Treatment 2019, 15:2425-2432

Published Date: 23 August 2019

Functional capacity as a predictor of postoperative delirium in transurethral resection of prostate patients in Northeast Brazil

Braga ILS, Castelo-Filho J, Pinheiro RSB, de Azevedo RB, Ponte AT, da Silveira RA, Braga-Neto P, Campos AR

Neuropsychiatric Disease and Treatment 2019, 15:2395-2401

Published Date: 22 August 2019

Rare compound heterozygous missense SPATA7 variations and risk of schizophrenia; whole-exome sequencing in a consanguineous family with affected siblings, follow-up sequencing and a case-control study

Igeta H, Watanabe Y, Morikawa R, Ikeda M, Otsuka I, Hoya S, Koizumi M, Egawa J, Hishimoto A, Iwata N, Someya T

Neuropsychiatric Disease and Treatment 2019, 15:2353-2363

Published Date: 19 August 2019

Psychological status of nursing survivors in China and its associated factors: 6 years after the 2008 Sichuan earthquake

Liao J, Ma X, Gao B, Zhang M, Zhang Y, Liu M, Li X

Neuropsychiatric Disease and Treatment 2019, 15:2301-2311

Published Date: 14 August 2019

Macrocytosis among patients with heroin use disorder

Ng MH, Chen VCH, Ting H, Lin TY, Chang SH, Gossop M

Neuropsychiatric Disease and Treatment 2019, 15:2293-2298

Published Date: 12 August 2019

Genetic polymorphisms in Sox17 associated with intracranial aneurysm in Chinese Han people: a genotype-phenotype study [Erratum]

Li M, Wang W, Zhang L, Xin W, Zhao Y, Huan L, Yu J, Zhang H, Zhang J, Yang S, Liang D, Yang W, Yang X

Neuropsychiatric Disease and Treatment 2019, 15:2291-2292

Published Date: 12 August 2019

The burden of suicidal ideation across Europe: a cross-sectional survey in five countries

Jaffe DH, Rive B, Denee TR

Neuropsychiatric Disease and Treatment 2019, 15:2257-2271

Published Date: 7 August 2019

Insula H-coil deep transcranial magnetic stimulation in severe and enduring anorexia nervosa (SE-AN): a pilot study

Knyahnytska YO, Blumberger DM, Daskalakis ZJ, Zomorrodi R, Kaplan AS

Neuropsychiatric Disease and Treatment 2019, 15:2247-2256

Published Date: 6 August 2019

Microglial activation and neurobiological alterations in experimental autoimmune prostatitis-induced depressive-like behavior in mice

Du HX, Chen XG, Zhang L, Liu Y, Zhan CS, Chen J, Zhang Y, Yu ZQ, Zhang J, Yang HY, Zhong K, Liang CZ

Neuropsychiatric Disease and Treatment 2019, 15:2231-2245

Published Date: 6 August 2019

Reduced plasma orexin-A levels in patients with bipolar disorder

Tsuchimine S, Hattori K, Ota M, Hidese S, Teraishi T, Sasayama D, Hori H, Noda T, Yoshida S, Yoshida F, Kunugi H

Neuropsychiatric Disease and Treatment 2019, 15:2221-2230

Published Date: 6 August 2019

Impact of non-motor symptoms in Parkinson’s disease: a PMDAlliance survey

Hermanowicz N, Jones SA, Hauser RA

Neuropsychiatric Disease and Treatment 2019, 15:2205-2212

Published Date: 5 August 2019

Orthostatic hypotension and dementia incidence: links and implications

Robertson AD, Udow SJ, Espay AJ, Merola A, Camicioli R, Lang AE, Masellis M

Neuropsychiatric Disease and Treatment 2019, 15:2181-2194

Published Date: 2 August 2019

Social communication deficits and restricted repetitive behavior symptoms in Tourette syndrome

Eapen V, McPherson S, Karlov L, Nicholls L, Črnčec R, Mulligan A

Neuropsychiatric Disease and Treatment 2019, 15:2151-2160

Published Date: 26 July 2019

Atypical antipsychotics for Parkinson’s disease psychosis: a systematic review and meta-analysis

Zhang H, Wang L, Fan Y, Yang L, Wen X, Liu Y, Liu Z

Neuropsychiatric Disease and Treatment 2019, 15:2137-2149

Published Date: 29 July 2019

Alterations of amplitude of low-frequency fluctuation in treatment-resistant versus non-treatment-resistant depression patients

Zhang A, Li G, Yang C, Liu P, Wang Y, Kang L, Wang Y, Zhang K

Neuropsychiatric Disease and Treatment 2019, 15:2119-2128

Published Date: 25 July 2019

Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia

Gupta AK, Pokhriyal R, Das U, Khan MI, Ratna Kumar D, Gupta R, Chadda RK, Ramachandran R, Goyal V, Tripathi M, Hariprasad G

Neuropsychiatric Disease and Treatment 2019, 15:2073-2085

Published Date: 19 July 2019

An intervention targeting social, communication and daily activity skills in children and adolescents with Down syndrome and autism: a pilot study

Wester Oxelgren U, Westerlund J, Myrelid Å, Annerén G, Johansson L, Åberg M, Gustafsson J, Fernell E

Neuropsychiatric Disease and Treatment 2019, 15:2049-2056

Published Date: 18 July 2019

Relationships between sleep patterns and metabolic profile in patients maintained on antipsychotics: a cross-sectional comparative study

Kiwan N, Mahfoud Z, Ghuloum S, Yehya A, Hammoudeh S, Hani Y, Chamali R, Amro I, Mook-Kanamori D, Al-Amin H

Neuropsychiatric Disease and Treatment 2019, 15:2035-2047

Published Date: 19 July 2019

Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization

Mar J, Arrospide A, Soto-Gordoa M, Iruin Á, Tainta M, Gabilondo A, Mar-Barrutia L, Calvo M, Mateos M, Ibarrondo O

Neuropsychiatric Disease and Treatment 2019, 15:2027-2034

Published Date: 17 July 2019

Early-onset Alzheimer’s disease patient with prion (PRNP) p.Val180Ile mutation

Bagyinszky E, Kang MJ, Pyun J, Giau VV, An SSA, Kim S

Neuropsychiatric Disease and Treatment 2019, 15:2003-2013

Published Date: 16 July 2019

Simvastatin pretreatment ameliorates t-PA–induced hemorrhage transformation and MMP-9/TIMP-1 imbalance in thromboembolic cerebral ischemic rats

Yin B, Li DD, Xu SY, Huang H, Lin J, Sheng HS, Fang JH, Song JN, Zhang M

Neuropsychiatric Disease and Treatment 2019, 15:1993-2002

Published Date: 16 July 2019

Development of the 12-item questionnaire for quantitative assessment of depressive mixed state (DMX-12)

Shinzato H, Koda M, Nakamura A, Kondo T

Neuropsychiatric Disease and Treatment 2019, 15:1983-1991

Published Date: 15 July 2019

Psychological factors associated with smoking and quitting: addiction map of Turkey study

Ünübol H, Hızlı Sayar G

Neuropsychiatric Disease and Treatment 2019, 15:1971-1982

Published Date: 11 July 2019

Heart rate variability and incidence of depression during the first six months following first myocardial infarction

Wilkowska A, Rynkiewicz A, Wdowczyk J, Landowski J, Cubała WJ

Neuropsychiatric Disease and Treatment 2019, 15:1951-1956

Published Date: 10 July 2019

Factors related to lithium blood concentrations in Chinese Han patients with bipolar disorder

Xu YY, Xia QH, Liang J, Cao Y, Shan F, Liu Y, Yan CY, Xia QR

Neuropsychiatric Disease and Treatment 2019, 15:1929-1937

Published Date: 10 July 2019

Apolipoprotein E e4 allele is associated with extrapyramidal symptoms in Alzheimer’s disease

Chang YP, Chou MC, Lai CL, Chien I, Yang YH

Neuropsychiatric Disease and Treatment 2019, 15:1915-1919

Published Date: 9 July 2019

Febrile infection-related epilepsy syndrome (FIRES): prevalence, impact and management strategies

Serino D, Santarone ME, Caputo D, Fusco L

Neuropsychiatric Disease and Treatment 2019, 15:1897-1903

Published Date: 9 July 2019

Developmental coordination disorder and dysgraphia: signs and symptoms, diagnosis, and rehabilitation

Biotteau M, Danna J, Baudou É, Puyjarinet F, Velay JL, Albaret JM, Chaix Y

Neuropsychiatric Disease and Treatment 2019, 15:1873-1885

Published Date: 8 July 2019

Antipsychotics and risk of natural death in patients with schizophrenia

Chen Y, Yang X, Qin X, Yang Q, Fan H, Li J, Song X, Xu S, Guo W, Deng W, Wang Q, Li T, Ma X

Neuropsychiatric Disease and Treatment 2019, 15:1863-1871

Published Date: 5 July 2019

Validation of the Chinese version of the Health Cognitions Questionnaire in Chinese college students

Dai L, Xu Z, Yin M, Wang X, Deng Y

Neuropsychiatric Disease and Treatment 2019, 15:1845-1854

Published Date: 5 July 2019

Resting-state functional magnetic resonance imaging (fMRI) and functional connectivity density mapping in patients with corneal ulcer

Zhu F, Tang L, Zhu P, Lin Q, Yuan Q, Shi W, Li B, Ye L, Min Y, Su T, Shao Y

Neuropsychiatric Disease and Treatment 2019, 15:1833-1844

Published Date: 5 July 2019

QT and P-wave dispersion during the manic phase of bipolar disorder

Gurok MG, Korkmaz H, Yıldız S, Bakış D, Atmaca M

Neuropsychiatric Disease and Treatment 2019, 15:1805-1811

Published Date: 3 July 2019

Patients’ experiences of long-acting injectable antipsychotics: a qualitative study

Chiu LL, Liu CH, Chu CL, Lin HL, Lii SC

Neuropsychiatric Disease and Treatment 2019, 15:1797-1804

Published Date: 3 July 2019

Impact of serotonin transporter gene on rTMS augmentation of SSRIs for obsessive compulsive disorder

Zhang K, Fan X, Yuan J, Yin J, Su H, Hashimoto K, Wang G

Neuropsychiatric Disease and Treatment 2019, 15:1771-1779

Published Date: 2 July 2019

Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China

Wang G, Si TM, Li L, Fang Y, Wang CX, Wang LN, Tan KHX, Ettrup A, Eriksen HLF, Luo S, Ge L

Neuropsychiatric Disease and Treatment 2019, 15:1723-1736

Published Date: 1 July 2019

Association between mitochondrial DNA and cognitive impairment in schizophrenia: study protocol for a Mexican population

García-de la Cruz DD, Juárez-Rojop IE, Tovilla-Zárate CA, Martínez-Magaña JJ, Genis-Mendoza AD, Nicolini H, González-Castro TB, Guzmán-Priego CG, López-Martínez NA, Hernández-Cisneros JA, Caballero-Prado F

Neuropsychiatric Disease and Treatment 2019, 15:1717-1722

Published Date: 28 June 2019

The level of IL-6 was associated with sleep disturbances in patients with major depressive disorder

Wang M, Wei J, Yang X, Ni P, Wang Y, Zhao L, Deng W, Guo W, Wang Q, Li T, Ma X

Neuropsychiatric Disease and Treatment 2019, 15:1695-1700

Published Date: 27 June 2019

Long-term efficacy and safety of paliperidone palmitate once-monthly in Chinese patients with recent-onset schizophrenia

Si T, Zhuo J, Feng Y, Lu H, Hong D, Zhang L

Neuropsychiatric Disease and Treatment 2019, 15:1685-1694

Published Date: 27 June 2019

Reduction in apathy following epilepsy surgery

Mah L, Swearer J, Phillips CA, Benjamin S

Neuropsychiatric Disease and Treatment 2019, 15:1679-1684

Published Date: 28 June 2019

The role of long noncoding RNA in traumatic brain injury

Li Z, Han K, Zhang D, Chen J, Xu Z, Hou L

Neuropsychiatric Disease and Treatment 2019, 15:1671-1677

Published Date: 28 June 2019

The effect of aripiprazole once-monthly on personal and social functioning: post hoc analyses of acute and long-term studies

Peters-Strickland T, Baker RA, Such P, Zhang P, Madera JJ

Neuropsychiatric Disease and Treatment 2019, 15:1659-1669

Published Date: 24 June 2019

Quality of life in euthymic patients with unipolar major depressive disorder and bipolar disorder

Bo Q, Tian L, Li F, Mao Z, Wang Z, Ma X, Wang C

Neuropsychiatric Disease and Treatment 2019, 15:1649-1657

Published Date: 24 June 2019

The efficacy of a “cocktail therapy” on Parkinson’s disease with dementia

Zhang C, Zang Y, Song Q, Li H, Hu L, Zhao W, Feng S, Gu F, Zhao F, Zhang C

Neuropsychiatric Disease and Treatment 2019, 15:1639-1647

Published Date: 24 June 2019

Correlation between precontemplation and alpha activity in gambling disorder

Lee J, Choi SW, Kim KM, Lee YS, Kim JW

Neuropsychiatric Disease and Treatment 2019, 15:1629-1637

Published Date: 21 June 2019

Machine learning techniques in a structural and functional MRI diagnostic approach in schizophrenia: a systematic review

de Filippis R, Carbone EA, Gaetano R, Bruni A, Pugliese V, Segura-Garcia C, De Fazio P

Neuropsychiatric Disease and Treatment 2019, 15:1605-1627

Published Date: 19 June 2019

Symptomatic stability with aripiprazole once-monthly: efficacy analyses from acute and long-term studies

Madera JJ, Such P, Zhao C, Baker RA

Neuropsychiatric Disease and Treatment 2019, 15:1593-1604

Published Date: 18 June 2019

Status epilepticus in patients with genetic (idiopathic) generalized epilepsy

Bosak M, Pawełczak D, Słowik A

Neuropsychiatric Disease and Treatment 2019, 15:1585-1592

Published Date: 20 June 2019

Serum lipid profiles and post-stroke depression in acute ischemic stroke patients

Shen H, Tu X, Luan X, Zeng Y, He J, Tang W

Neuropsychiatric Disease and Treatment 2019, 15:1573-1583

Published Date: 17 June 2019

COMT polymorphism regulates the hippocampal subfield volumes in first-episode, drug-naive patients with major depressive disorder

Otsuka Y, Kakeda S, Sugimoto K, Katsuki A, Nguyen LH, Igata R, Watanabe K, Ueda I, Kishi T, Iwata N, Korogi Y, Yoshimura R

Neuropsychiatric Disease and Treatment 2019, 15:1537-1545

Published Date: 6 June 2019

GABAB receptor activation ameliorates spatial memory impairments in stress-exposed rats

Sahraei H, Askaripour M, Esmaeilpour K, Shahsavari F, Rajabi S, Moradi-Kor N

Neuropsychiatric Disease and Treatment 2019, 15:1497-1506

Published Date: 30 May 2019

Patient and physician perceptions of disease management in Parkinson’s disease: results from a US-based multicenter survey

Hermanowicz N, Castillo-Shell M, McMean A, Fishman J, D’Souza J

Neuropsychiatric Disease and Treatment 2019, 15:1487-1495

Published Date: 30 May 2019

Cross-sectional study of psychiatric comorbidities in patients with atopic dermatitis and nonatopic eczema, urticaria, and psoriasis

Ahn HJ, Shin MK, Seo JK, Jeong SJ, Cho AR, Choi SH, Lew BL

Neuropsychiatric Disease and Treatment 2019, 15:1469-1478

Published Date: 28 May 2019

HO-1 protects the nerves of rats with cerebral hemorrhage by regulating the PI3K/AKT signaling pathway

Zhao Q, Qu R, Teng L, Yin C, Yuan Y

Neuropsychiatric Disease and Treatment 2019, 15:1459-1468

Published Date: 28 May 2019

Clinical association of vitamin D and serotonin levels among patients with fibromyalgia syndrome

Amin OA, Abouzeid SM, Ali SA, Amin BA, Alswat KA

Neuropsychiatric Disease and Treatment 2019, 15:1421-1426

Published Date: 27 May 2019

The relationship between serum cobalamin, folic acid, and homocysteine and the risk of post-cardiac surgery delirium

Vahdat Shariatpanahi M, Velayati A, Jamalian SA, Babevaynejad M, Vahdat Shariatpanahi Z

Neuropsychiatric Disease and Treatment 2019, 15:1413-1419

Published Date: 23 May 2019

Vascular cognitive impairment: pathophysiological mechanisms, insights into structural basis, and perspectives in specific treatments

Parfenov VA, Ostroumova OD, Ostroumova TM, Kochetkov AI, Fateeva VV, Khacheva KK, Khakimova GR, Epstein OI

Neuropsychiatric Disease and Treatment 2019, 15:1381-1402

Published Date: 21 May 2019

Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia

Mathews M, Gopal S, Nuamah I, Hargarter L, Savitz AJ, Kim E, Tan W, Soares B, Correll CU

Neuropsychiatric Disease and Treatment 2019, 15:1365-1379

Published Date: 21 May 2019

Structural changes in white matter lesion patients and their correlation with cognitive impairment

Wang J, Liang Y, Chen H, Wang W, Wang Y, Liang Y, Zhang Y

Neuropsychiatric Disease and Treatment 2019, 15:1355-1363

Published Date: 21 May 2019

What are the links between hypoxia and Alzheimer’s disease?

Lall R, Mohammed R, Ojha U

Neuropsychiatric Disease and Treatment 2019, 15:1343-1354

Published Date: 21 May 2019

Cognitive impairment in eating disorder patients of short and long-term duration: a case–control study

Grau A, Magallón-Neri E, Faus G, Feixas G

Neuropsychiatric Disease and Treatment 2019, 15:1329-1341

Published Date: 21 May 2019

Risk factors for delirium: are therapeutic interventions part of it?

Xing J, Yuan Z, Jie Y, Liu Y, Wang M, Sun Y

Neuropsychiatric Disease and Treatment 2019, 15:1321-1327

Published Date: 17 May 2019

A patient with Korsakoff syndrome of psychiatric and alcoholic etiology presenting as DSM-5 mild neurocognitive disorder

Nikolakaros G, Kurki T, Myllymäki A, Ilonen T

Neuropsychiatric Disease and Treatment 2019, 15:1311-1320

Published Date: 22 May 2019

Cardiac dysautonomia in depression – heart rate variability biofeedback as a potential add-on therapy

Pinter A, Szatmari Jr S, Horvath T, Penzlin AI, Barlinn K, Siepmann M, Siepmann T

Neuropsychiatric Disease and Treatment 2019, 15:1287-1310

Published Date: 17 May 2019

Deep brain stimulation in the treatment of obsessive-compulsive disorder: current perspectives

Tastevin M, Spatola G, Régis J, Lançon C, Richieri R

Neuropsychiatric Disease and Treatment 2019, 15:1259-1272

Published Date: 15 May 2019

Cognitive impairment in depression: recent advances and novel treatments

Perini G, Cotta Ramusino M, Sinforiani E, Bernini S, Petrachi R, Costa A

Neuropsychiatric Disease and Treatment 2019, 15:1249-1258

Published Date: 10 May 2019

Quality and utilization of the Finnish clinical practice guideline in schizophrenia: evaluation using AGREE II and the vignette approach

Vähäniemi A, Välimäki M, Pekurinen V, Anttila M, Lantta T

Neuropsychiatric Disease and Treatment 2019, 15:1239-1248

Published Date: 9 May 2019

Rumination, posttraumatic stress disorder, and mood symptoms in borderline personality disorder

Dell’Osso L, Cremone IM, Carpita B, Dell’Oste V, Muti D, Massimetti G, Barlati S, Vita A, Fagiolini A, Carmassi C, Gesi C

Neuropsychiatric Disease and Treatment 2019, 15:1231-1238

Published Date: 13 May 2019

Chronic stress increases susceptibility to food addiction by increasing the levels of DR2 and MOR in the nucleus accumbens

Wei NL, Quan ZF, Zhao T, Yu XD, Xie Q, Zeng J, Ma FK, Wang F, Tang QS, Wu H, Zhu JH

Neuropsychiatric Disease and Treatment 2019, 15:1211-1229

Published Date: 8 May 2019

Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial

Rodríguez C, García T, Areces D, Fernández E, García-Noriega M, Domingo JC

Neuropsychiatric Disease and Treatment 2019, 15:1193-1209

Published Date: 8 May 2019

The prognosis and changes of regional brain gray matter volume in MDD with gastrointestinal symptoms

Liu P, Li G, Zhang A, Sun N, Kang L, Yang C, Wang Y, Zhang K

Neuropsychiatric Disease and Treatment 2019, 15:1181-1191

Published Date: 9 May 2019

The relationships between video game experience and cognitive abilities in adolescents

Özçetin M, Gümüştaş F, Çağ Y, Gökbay İZ, Özmel A

Neuropsychiatric Disease and Treatment 2019, 15:1171-1180

Published Date: 8 May 2019

Health, functionality, and social support in families with a child with a neurodevelopmental disorder – a pilot study

Cavonius-Rintahaka D, Aho AL, Voutilainen A, Billstedt E, Gillberg C

Neuropsychiatric Disease and Treatment 2019, 15:1151-1161

Published Date: 8 May 2019

Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial

Zhuo K, Tang Y, Song Z, Wang Y, Wang J, Qian Z, Li H, Xiang Q, Chen T, Yang Z, Xu Y, Fan X, Wang J, Liu D

Neuropsychiatric Disease and Treatment 2019, 15:1141-1150

Published Date: 8 May 2019

Personality associated with depressive status in individuals with type 2 diabetes mellitus

Yasui-Furukori N, Murakami H, Otaka H, Nakayama H, Murabayashi M, Mizushiri S, Matsumura K, Tanabe J, Matsuhashi Y, Yanagimachi M, Nakamura K, Daimon M, Sugawara N

Neuropsychiatric Disease and Treatment 2019, 15:1133-1139

Published Date: 3 May 2019

Effects of transection of cervical sympathetic trunk on cognitive function of traumatic brain injury rats

Long J, He CJ, Dai H, Kang XG, Zou JF, Ye SL, Yu Q

Neuropsychiatric Disease and Treatment 2019, 15:1121-1131

Published Date: 3 May 2019

Detection of cognitive impairment using a machine-learning algorithm [Corrigendum]

Youn YC, Choi SH, Shin HW, Kim KW, Jang JW, Jung JJ, Hsiung GY, Kim SY

Neuropsychiatric Disease and Treatment 2019, 15:1119-1120

Published Date: 1 May 2019

Metabonomics reveals peripheral and central short-chain fatty acid and amino acid dysfunction in a naturally occurring depressive model of macaques

Deng F, Pan J, Zheng P, Xia J, Yin B, Liang W, Li Y, Wu J, Xu F, Wu Q, Qu C, Li W, Wang H, Xie P

Neuropsychiatric Disease and Treatment 2019, 15:1077-1088

Published Date: 1 May 2019

Deep brain stimulation in Tourette’s syndrome: evidence to date

Casagrande SCB, Cury RG, Alho EJL, Fonoff ET

Neuropsychiatric Disease and Treatment 2019, 15:1061-1075

Published Date: 29 April 2019

The modern perspective for long-acting injectables antipsychotics in the patient-centered care of schizophrenia

Pietrini F, Albert U, Ballerini A, Calò P, Maina G, Pinna F, Vaggi M, Boggian I, Fontana M, Moro C, Carpiniello B

Neuropsychiatric Disease and Treatment 2019, 15:1045-1060

Published Date: 30 April 2019

2D-DIGE as a strategy to identify serum protein biomarkers to monitor pharmacological efficacy in dopamine-dictated states of Parkinson’s disease and schizophrenia

Gupta AK, Kumar GK, Rani K, Pokhriyal R, Khan MI, Kumar DR, Goyal V, Tripathi M, Gupta R, Chadda RK, Vanamail P, Mohanty AK, Hariprasad G

Neuropsychiatric Disease and Treatment 2019, 15:1031-1044

Published Date: 24 April 2019

Aldehyde dehydrogenase 2 rs671G>A polymorphism and ischemic stroke risk in Chinese population: a meta-analysis

Xu YL, Hu YY, Li JW, Zhou L, Li L, Niu YM

Neuropsychiatric Disease and Treatment 2019, 15:1015-1029

Published Date: 23 April 2019

The influence of non-breathing-related sleep fragmentation on cognitive function in patients with cerebral small vessel disease

Wang J, Chen X, Liao J, Zhou L, Liao S, Shan Y, Lu Z, Tao J

Neuropsychiatric Disease and Treatment 2019, 15:1009-1014

Published Date: 18 April 2019

Abnormal resting-state functional connectivity of amygdala subregions in patients with obstructive sleep apnea

Yu H, Chen L, Li H, Xin H, Zhang J, Wei Z, Peng D

Neuropsychiatric Disease and Treatment 2019, 15:977-987

Published Date: 17 April 2019

Early symptom non-improvement and aggravation are associated with the treatment response to SSRIs in MDD: a real-world study

Yuan H, Zhu X, Luo Q, Halim A, Halim M, Yao H, Cai Y, Shi S

Neuropsychiatric Disease and Treatment 2019, 15:957-966

Published Date: 16 April 2019

Cortical thinning and flattening in schizophrenia and their unaffected parents

Yan J, Cui Y, Li Q, Tian L, Liu B, Jiang T, Zhang D, Yan H

Neuropsychiatric Disease and Treatment 2019, 15:935-946

Published Date: 12 April 2019

Minimally invasive evacuation of spontaneous supratentorial intracerebral hemorrhage by transcranial neuroendoscopic approach

Cai Q, Guo Q, Li Z, Wang W, Zhang W, Ji B, Chen Z, Liu J

Neuropsychiatric Disease and Treatment 2019, 15:919-925

Published Date: 11 April 2019

Fluvoxamine treatment response prediction in obsessive-compulsive disorder: association rule mining approach

Hasanpour H, Ghavamizadeh Meibodi R, Navi K, Shams J, Asadi S, Ahmadiani A

Neuropsychiatric Disease and Treatment 2019, 15:895-904

Published Date: 10 April 2019

Objective diagnosis of post-stroke depression using NMR-based plasma metabonomics

Hu Z, Fan S, Liu M, Zhong J, Cao D, Zheng P, Wang Y, Wei Y, Fang L, Xie P

Neuropsychiatric Disease and Treatment 2019, 15:867-881

Published Date: 10 April 2019

Fear of cancer recurrence, anxiety and depressive symptoms in adolescent and young adult cancer patients

Sun H, Yang Y, Zhang J, Liu T, Wang H, Garg S, Zhang B

Neuropsychiatric Disease and Treatment 2019, 15:857-865

Published Date: 8 April 2019

Lifetime predictors of stroke in subjects without a diagnosis of hypertension: the aerobics center longitudinal study

Cavero-Redondo I, Sui X, Blair SN, Lavie CJ, Álvarez-Bueno C, Martínez-Vizcaíno V

Neuropsychiatric Disease and Treatment 2019, 15:849-856

Published Date: 8 April 2019

Proton magnetic resonance spectroscopy changes in a longitudinal schizophrenia study: a pilot study in eleven patients

Galińska-Skok B, Szulc A, Małus A, Konarzewska B, Cwalina U, Tarasów E, Waszkiewicz N

Neuropsychiatric Disease and Treatment 2019, 15:839-847

Published Date: 8 April 2019

Therapeutic strategies in the early stages of Parkinson’s disease: a cross-sectional evaluation of 15 years’ experience with a large cohort of Romanian patients

Szász JA, Orbán-Kis K, Constantin VA, Péter C, Bíró I, Mihály I, Szegedi K, Balla A, Szatmári S

Neuropsychiatric Disease and Treatment 2019, 15:831-838

Published Date: 5 April 2019

Cognitive function, depression, and anxiety in patients undergoing radical prostatectomy with and without adjuvant treatment

Jarzemski P, Brzoszczyk B, Popiołek A, Stachowicz-Karpińska A, Gołota S, Bieliński M, Borkowska A

Neuropsychiatric Disease and Treatment 2019, 15:819-829

Published Date: 5 April 2019

Genetic polymorphisms in Sox17 associated with intracranial aneurysm in Chinese Han people: a genotype-phenotype study

Li M, Wang W, Zhang L, Xin W, Zhao Y, Huan L, Yu J, Zhang H, Zhang J, Yang S, Liang D, Yang W, Yang X

Neuropsychiatric Disease and Treatment 2019, 15:779-783

Published Date: 2 April 2019

Relationships between Internet addiction and clinicodemographic and behavioral factors

ElSalhy M, Miyazaki T, Noda Y, Nakajima S, Nakayama H, Mihara S, Kitayuguchi T, Higuchi S, Muramatsu T, Mimura M

Neuropsychiatric Disease and Treatment 2019, 15:739-752

Published Date: 26 March 2019

Predictors of achieving remission in schizophrenia patients treated with paliperidone palmitate 3-month formulation

Nash AI, Turkoz I, Savitz AJ, Mathews M, Kim E

Neuropsychiatric Disease and Treatment 2019, 15:731-737

Published Date: 22 March 2019

Impaired comprehension of metaphorical expressions in very mild Alzheimer’s disease

Fujimoto N, Nakamura H, Tsuda T, Wakutani Y, Takao T

Neuropsychiatric Disease and Treatment 2019, 15:713-720

Published Date: 20 March 2019

Repetitive transcranial magnetic stimulation in trauma-related conditions

Namgung E, Kim M, Yoon S

Neuropsychiatric Disease and Treatment 2019, 15:701-712

Published Date: 19 March 2019

Identification of key genes, pathways and miRNA/mRNA regulatory networks of CUMS-induced depression in nucleus accumbens by integrated bioinformatics analysis

Ma K, Zhang HX, Wei GH, Dong ZF, Zhao HJ, Han XC, Song XB, Zhang HL, Zong X, Baloch Z, Wang SJ

Neuropsychiatric Disease and Treatment 2019, 15:685-700

Published Date: 14 March 2019

The association of maternal diabetes with attention deficit and hyperactivity disorder in offspring: a meta-analysis

Zhao L, Li X, Liu G, Han B, Wang J, Jiang X

Neuropsychiatric Disease and Treatment 2019, 15:675-684

Published Date: 12 March 2019

Effects of prenatal exposure to temephos on behavior and social interaction

Martins Laurentino AO, Durante de Medeiros F, de Oliveira J, da Rosa N, Mateus Gomes T, de Medeiros Peretti E, Somariva Prophiro J, Fortunato JJ

Neuropsychiatric Disease and Treatment 2019, 15:669-673

Published Date: 11 March 2019

Effects of melatonin in children with attention-deficit/hyperactivity disorder with sleep disorders after methylphenidate treatment

Masi G, Fantozzi P, Villafranca A, Tacchi A, Ricci F, Ruglioni L, Inguaggiato E, Pfanner C, Cortese S

Neuropsychiatric Disease and Treatment 2019, 15:663-667

Published Date: 7 March 2019

GSK-3β and BDNF genes may not be associated with venlafaxine treatment response in Chinese of Han ethnicity

Sun Q, Yuan F, Ren D, Ma G, Yang F, Wu X, He L, He G

Neuropsychiatric Disease and Treatment 2019, 15:657-661

Published Date: 7 March 2019

Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations [Corrigendum]

Mayerova M, Ustohal L, Jarkovsky J, Pivnicka J, Kasparek T, Ceskova E

Neuropsychiatric Disease and Treatment 2019, 15:655-656

Published Date: 5 March 2019

Odor perception and hedonics in chronic schizophrenia and in first episode psychosis

Urban-Kowalczyk M, Strzelecki D, Śmigielski J, Kotlicka-Antczak M

Neuropsychiatric Disease and Treatment 2019, 15:647-654

Published Date: 5 March 2019

Vascular risk modulates the relationship between cerebral amyloid deposition and subjective memory complaints

Kim JW, Byun MS, Yi D, Lee JH, Ko K, Jung G, Lee DY

Neuropsychiatric Disease and Treatment 2019, 15:637-645

Published Date: 4 March 2019

Prevalence and outcomes of Guillain-Barré syndrome among pediatrics in Saudi Arabia: a 10-year retrospective study

Asiri S, Altwaijri WA, Ba-Armah D, Al Rumayyan A, Alrifai MT, Salam M, Almutairi AF

Neuropsychiatric Disease and Treatment 2019, 15:627-635

Published Date: 1 March 2019

Social cognitive training for adults with Noonan syndrome: a feasibility study

Roelofs RL, Wingbermühle E, Kessels RPC, Egger JIM

Neuropsychiatric Disease and Treatment 2019, 15:611-626

Published Date: 26 February 2019

Racial and ethnic differences in depression: current perspectives

Bailey RK, Mokonogho J, Kumar A

Neuropsychiatric Disease and Treatment 2019, 15:603-609

Published Date: 22 February 2019

Histamine H3 receptor antagonist E177 attenuates amnesia induced by dizocilpine without modulation of anxiety-like behaviors in rats

Alachkar A, Khan N, Łażewska D, Kieć-Kononowicz K, Sadek B

Neuropsychiatric Disease and Treatment 2019, 15:531-542

Published Date: 20 February 2019

The interactive effects of stress and coping style on cognitive function in patients with schizophrenia

Zhu X, Xu X, Xu C, Zhang J, Zhang X, Ma L, Liu J, Wang K

Neuropsychiatric Disease and Treatment 2019, 15:523-530

Published Date: 21 February 2019

Diabetes and elevated preoperative HbA1c level as risk factors for postoperative delirium after cardiac surgery: an observational cohort study

Kotfis K, Szylińska A, Listewnik M, Brykczyński M, Ely EW, Rotter I

Neuropsychiatric Disease and Treatment 2019, 15:511-521

Published Date: 20 February 2019

Aberrant attentive and inattentive brain activity to auditory negative words, and its relation to persecutory delusion in patients with schizophrenia

Iwashiro N, Takano Y, Natsubori T, Aoki Y, Yahata N, Gonoi W, Kunimatsu A, Abe O, Kasai K, Yamasue H

Neuropsychiatric Disease and Treatment 2019, 15:491-502

Published Date: 14 February 2019

Stimuli may have little impact on the deficit of visual working memory accuracy in first-episode schizophrenia

She S, Zhang B, Mi L, Li H, Kuang Q, Bi T, Zheng Y

Neuropsychiatric Disease and Treatment 2019, 15:481-489

Published Date: 18 February 2019

Radio electric asymmetric conveyer neuromodulation in depression, anxiety, and stress

Rinaldi A, Rinaldi C, Coelho Pereira JA, Lotti Margotti M, Bittencourt MN, Barcessat ARP, Fontani V, Rinaldi S

Neuropsychiatric Disease and Treatment 2019, 15:469-480

Published Date: 13 February 2019

Durability of symptomatic responses obtained with adjunctive vagus nerve stimulation in treatment-resistant depression

Kumar A, Bunker MT, Aaronson ST, Conway CR, Rothschild AJ, Mordenti G, Rush AJ

Neuropsychiatric Disease and Treatment 2019, 15:457-468

Published Date: 13 February 2019

The effect of night shift on sleep quality and depressive symptoms among Chinese nurses

Dai C, Qiu H, Huang Q, Hu P, Hong X, Tu J, Xie Q, Li H, Ren W, Ni S, Chen F

Neuropsychiatric Disease and Treatment 2019, 15:435-440

Published Date: 7 February 2019

Stimulus intensity determined by dose-titration versus age-based methods in electroconvulsive therapy in Thai patients

Ittasakul P, Likitnukul A, Pitidhammabhorn U, Waleeprakhon P, Goldman MB

Neuropsychiatric Disease and Treatment 2019, 15:429-434

Published Date: 7 February 2019

Analysis of motor performance in individuals with cerebral palsy using a non-immersive virtual reality task – a pilot study

Martins FPA, Massetti T, Crocetta TB, Bianchi Lopes P, da Silva AA, Figueiredo EF, de Abreu LC, da Silva TD, Monteiro CBM

Neuropsychiatric Disease and Treatment 2019, 15:417-428

Published Date: 4 February 2019

HDAC4 gene silencing alleviates epilepsy by inhibition of GABA in a rat model

Zhang YN, Dong HT, Duan L, Niu L, Yuan GQ, Dai JQ, Hou BR, Pan YW

Neuropsychiatric Disease and Treatment 2019, 15:405-416

Published Date: 4 February 2019

Psychiatric comorbidities in patients with intentional methanol intoxication

Yang WS, Yen TH, Juang YY, Lee SH, Wang BH, Lee CP

Neuropsychiatric Disease and Treatment 2019, 15:397-402

Published Date: 31 January 2019

Clinical factors influencing resilience in patients with anorexia nervosa

Kane C, Tomotake M, Hamatani S, Chiba S, Kameoka N, Watanabe S, Nakataki M, Numata S, Ohmori T

Neuropsychiatric Disease and Treatment 2019, 15:391-395

Published Date: 30 January 2019

Evacuation of chronic and subacute subdural hematoma via transcranial neuroendoscopic approach

Cai Q, Guo Q, Zhang F, Sun D, Zhang W, Ji B, Chen Z, Mao S

Neuropsychiatric Disease and Treatment 2019, 15:385-390

Published Date: 30 January 2019

Genetic effects on white matter integrity in drug-naive patients with major depressive disorder: a diffusion tensor imaging study of 17 genetic loci associated with depressive symptoms

Kakeda S, Watanabe K, Katsuki A, Sugimoto K, Ueda I, Igata N, Kishi T, Iwata N, Abe O, Yoshimura R, Korogi Y

Neuropsychiatric Disease and Treatment 2019, 15:375-383

Published Date: 29 January 2019

A novel approach to cardiovascular disturbances in patients with schizophrenia spectrum disorders treated with long-acting injectable medication

Andor M, Dehelean L, Romosan AM, Buda V, Radu G, Caruntu F, Bordejevic A, Manea MM, Papava I, Bredicean CA, Romosan RS, Tomescu M

Neuropsychiatric Disease and Treatment 2019, 15:349-355

Published Date: 25 January 2019

The association between HTR1B gene rs13212041 polymorphism and onset of alcohol abuse

Svob Strac D, Nedic Erjavec G, Nikolac Perkovic M, Nenadic-Sviglin K, Konjevod M, Grubor M, Pivac N

Neuropsychiatric Disease and Treatment 2019, 15:339-347

Published Date: 24 January 2019

Effects of early administration of insulin-like growth factor-1 on cognitive function in septic encephalopathy

Yang Y, Liang S, Li Y, Gao F, Cao Y, Zhao X, Gao G, Li L

Neuropsychiatric Disease and Treatment 2019, 15:323-337

Published Date: 23 January 2019

Depressed mood induction in early cigarette withdrawal is unaffected by acute monoamine precursor supplementation

Dowlati Y, de Jesus DR, Selby P, Fan I, Meyer JH

Neuropsychiatric Disease and Treatment 2019, 15:311-321

Published Date: 23 January 2019

Cytokines and chemokines expression in serum of patients with neuromyelitis optica

Ai NP, Liu HJ, Zhou HF, Lin DH, Wang JQ, Yang M, Song HG, Sun MM, Xu QG, Wei SH

Neuropsychiatric Disease and Treatment 2019, 15:303-310

Published Date: 21 January 2019

Negative and positive self-thoughts predict subjective quality of life in people with schizophrenia

Takeda T, Nakataki M, Ohta M, Hamatani S, Matsuura K, Yoshida R, Kameoka N, Tominaga T, Umehara H, Kinoshita M, Watanabe S, Numata S, Sumitani S, Ohmori T

Neuropsychiatric Disease and Treatment 2019, 15:293-301

Published Date: 21 January 2019

Altered intrinsic brain activity in patients with toothaches using the amplitude of low-frequency fluctuations: a resting-state fMRI study

Yang J, Li B, Yu QY, Ye L, Zhu PW, Shi WQ, Yuan Q, Min YL, He YL, Shao Y

Neuropsychiatric Disease and Treatment 2019, 15:283-291

Published Date: 18 January 2019

Frequency-dependent neural activity in primary angle-closure glaucoma

Jiang F, Yu C, Zuo MJ, Zhang C, Wang Y, Zhou FQ, Zeng XJ

Neuropsychiatric Disease and Treatment 2019, 15:271-282

Published Date: 18 January 2019

Association between anxious distress in a major depressive episode and bipolarity

Sugawara H, Tsutsumi T, Inada K, Ishigooka J, Hashimoto M, Takebayashi M, Nishimura K

Neuropsychiatric Disease and Treatment 2019, 15:267-270

Published Date: 15 January 2019

Serum BICC1 levels are significantly different in various mood disorders

Chen S, Jiang H, Xu Z, Zhao J, Wang M, Lu Y, Li J, Sun F, Yuan Y

Neuropsychiatric Disease and Treatment 2019, 15:259-265

Published Date: 15 January 2019

Disturbances of mitochondrial parameters to distinguish patients with depressive episode of bipolar disorder and major depressive disorder

Zvěřová M, Hroudová J, Fišar Z, Hansíková H, Kališová L, Kitzlerová E, Lambertová A, Raboch J

Neuropsychiatric Disease and Treatment 2019, 15:233-240

Published Date: 14 January 2019

Lower vitamin D levels are associated with depression in patients with gout

Zhou Q, Shao Y, Gan Z, Fang L

Neuropsychiatric Disease and Treatment 2019, 15:227-231

Published Date: 14 January 2019

Health-related quality of life and its correlates in Japanese patients with myotonic dystrophy type 1

Endo M, Odaira K, Ono R, Kurauchi G, Koseki A, Goto M, Sato Y, Kon S, Watanabe N, Sugawara N, Takada H, Kimura E

Neuropsychiatric Disease and Treatment 2019, 15:219-226

Published Date: 14 January 2019

Association analysis of polymorphisms in STARD6 and near ECHDC3 in Alzheimer’s disease patients carrying the APOE ε4 Allele

Yin J, Feng W, Yuan H, Yuan J, Wu Y, Liu X, Jin C, Cheng Z

Neuropsychiatric Disease and Treatment 2019, 15:213-218

Published Date: 11 January 2019

Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan

Sugawara N, Kudo S, Ishioka M, Sato Y, Kubo K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2019, 15:205-211

Published Date: 9 January 2019

Prevalence and associated factors of comorbid anxiety disorders in late-life depression: findings from geriatric tertiary outpatient settings

Suradom C, Wongpakaran N, Wongpakaran T, Lerttrakarnnon P, Jiraniramai S, Taemeeyapradit U, Lertkachatarn S, Arunpongpaisal S

Neuropsychiatric Disease and Treatment 2019, 15:199-204

Published Date: 7 January 2019

The impact of short and long sleep duration on instrumental activities of daily living among stroke survivors

Seixas AA, Chung DP, Richards SL, Madhavaram S, Raghavan P, Gago J, Casimir G, Jean-Louis G

Neuropsychiatric Disease and Treatment 2019, 15:177-182

Published Date: 4 January 2019

Risk factors for developing dementia in type 2 diabetes mellitus patients with mild cognitive impairment

Albai O, Frandes M, Timar R, Roman D, Timar B

Neuropsychiatric Disease and Treatment 2019, 15:167-175

Published Date: 3 January 2019

Risk factors for the difficulties in general activities across the day in Chinese children and adolescents with attention-deficit/hyperactivity disorder

Ke X, Du Y, Zheng Y, Su L, Chen Y, Zhang YL, Chen K, Cheng Y, Chen W

Neuropsychiatric Disease and Treatment 2019, 15:157-166

Published Date: 31 December 2018

Association between the SLC6A4 gene and schizophrenia: an updated meta-analysis

Xu F, Wang B, Yao J

Neuropsychiatric Disease and Treatment 2019, 15:143-155

Published Date: 28 December 2018

Differences in etiological beliefs about schizophrenia among patients, family, and medical staff

Tarakita N, Yoshida K, Sugawara N, Kubo K, Furukori H, Fujii A, Nakamura K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2019, 15:137-142

Published Date: 27 December 2018

Effects of cerebrolysin on functional outcome of patients with traumatic brain injury: a systematic review and meta-analysis

Ghaffarpasand F, Torabi S, Rasti A, Niakan MH, Aghabaklou S, Pakzad F, Beheshtian MS, Tabrizi R

Neuropsychiatric Disease and Treatment 2019, 15:127-135

Published Date: 27 December 2018

Frequent attenders in general medical practice in Italy: a preliminary report on clinical variables related to low functioning

Carmassi C, Dell’Oste V, Ceresoli D, Moscardini S, Bianchi E, Landi R, Massimetti G, Nisita C, Dell’Osso L

Neuropsychiatric Disease and Treatment 2019, 15:115-125

Published Date: 24 December 2018

Poststroke epilepsy: current perspectives on diagnosis and treatment

Sarecka-Hujar B, Kopyta I

Neuropsychiatric Disease and Treatment 2019, 15:95-103

Published Date: 24 December 2018

Associations of BRAP polymorphisms with the risk of alcohol dependence and scores on the Alcohol Use Disorders Identification Test

Kim JW, Choe YM, Shin JG, Park BL, Shin HD, Choi IG, Lee BC

Neuropsychiatric Disease and Treatment 2019, 15:83-94

Published Date: 24 December 2018

Intrinsic thalamocortical connectivity varies in the age of onset subtypes in major depressive disorder

Brown EC, Clark DL, Hassel S, MacQueen G, Ramasubbu R

Neuropsychiatric Disease and Treatment 2019, 15:75-82

Published Date: 21 December 2018

The factor structure, reliability and validity of the Chinese version of the Van Dream Anxiety Scale

Wang X, Dai L, Yin M, Deng YL

Neuropsychiatric Disease and Treatment 2019, 15:57-67

Published Date: 21 December 2018

Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm

Dong H, Fan S, Luo Y, Peng B

Neuropsychiatric Disease and Treatment 2019, 15:33-36

Published Date: 19 December 2018

Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles

Yi ZM, Wen C, Cai T, Xu L, Zhong XL, Zhan SY, Zhai SD

Neuropsychiatric Disease and Treatment 2019, 15:1-19

Published Date: 17 December 2018

Influence of olanzapine on serum prolactin levels and BMI in female patients with schizophrenia

Yang F, Chen L, Fang X, Zheng K, Zhu C, Xu C, Zhang C, Tang W

Neuropsychiatric Disease and Treatment 2018, 14:3373-3379

Published Date: 13 December 2018

Sensory function in cluster headache: an observational study comparing the symptomatic and asymptomatic sides

Malo-Urriés M, Hidalgo-García C, Estébanez-de-Miguel E, Tricás-Moreno JM, Santos-Lasaosa S, Jahanshahi M

Neuropsychiatric Disease and Treatment 2018, 14:3363-3371

Published Date: 10 December 2018

Possible association of Firmicutes in the gut microbiota of patients with major depressive disorder

Huang YC, Shi X, Li ZY, Shen Y, Shi XX, Wang LY, Li GF, Yuan Y, Wang JX, Zhang YC, Zhao L, Zhang M, Kang Y, Liang Y

Neuropsychiatric Disease and Treatment 2018, 14:3329-3337

Published Date: 3 December 2018

Altered functional connectivity of primary visual cortex in late blindness

Wen Z, Zhou FQ, Huang X, Dan HD, Xie BJ, Shen Y

Neuropsychiatric Disease and Treatment 2018, 14:3317-3327

Published Date: 3 December 2018

Regional differences in the risk of insomnia symptoms among patients from general hospital outpatient clinics

Zheng W, Luo XN, Li HY, Ke XY, Dai Q, Zhang CJ, Zhang XY, Ning YP

Neuropsychiatric Disease and Treatment 2018, 14:3307-3315

Published Date: 30 November 2018

Effects of personality on the association between paroxetine plasma concentration and response

Tomita T, Yasui-Furukori N, Nakagami T, Tsuchimine S, Ishioka M, Kaneda A, Nakamura K

Neuropsychiatric Disease and Treatment 2018, 14:3299-3306

Published Date: 29 November 2018

Developmental lead (Pb)-induced deficits in hippocampal protein translation at the synapses are ameliorated by ascorbate supplementation

Ahmad F, Salahuddin M, Alsamman K, AlMulla AA, Salama KF

Neuropsychiatric Disease and Treatment 2018, 14:3289-3298

Published Date: 29 November 2018

Influence of trait anxiety, child maltreatment, and adulthood life events on depressive symptoms

Uchida Y, Takahashi T, Katayama S, Masuya J, Ichiki M, Tanabe H, Kusumi I, Inoue T

Neuropsychiatric Disease and Treatment 2018, 14:3279-3287

Published Date: 27 November 2018

Children screening positive for language delay at 2.5 years: language disorder and developmental profiles

Schachinger-Lorentzon U, Kadesjö B, Gillberg C, Miniscalco C

Neuropsychiatric Disease and Treatment 2018, 14:3267-3277

Published Date: 28 November 2018

Association of HLA alleles with autism

Sayad A, Akbari MT, Noroozi R, Omrani MD, Inoko H, Taheri M, Ghafouri-Fard S

Neuropsychiatric Disease and Treatment 2018, 14:3259-3265

Published Date: 27 November 2018

Dissociative states in borderline personality disorder and their relationships to psychotropic medication

Pec O, Bob P, Simek J, Raboch J

Neuropsychiatric Disease and Treatment 2018, 14:3253-3257

Published Date: 23 November 2018

The association between depression, anxiety and substance use among Canadian post-secondary students

Esmaeelzadeh S, Moraros J, Thorpe L, Bird Y

Neuropsychiatric Disease and Treatment 2018, 14:3241-3251

Published Date: 23 November 2018

Clinical effects of repetitive transcranial magnetic stimulation combined with atomoxetine in the treatment of attention-deficit hyperactivity disorder

Cao P, Xing J, Cao Y, Cheng Q, Sun X, Kang Q, Dai L, Zhou X, Song Z

Neuropsychiatric Disease and Treatment 2018, 14:3231-3240

Published Date: 26 November 2018

Aberrantly expressed long noncoding RNAs and genes in Parkinson's disease

Zhou Y, Gu C, Li J, Zhu L, Huang G, Dai J, Huang H

Neuropsychiatric Disease and Treatment 2018, 14:3219-3229

Published Date: 22 November 2018

Optimized regimens of combined medications for the treatment of major depressive disorder: a double-blind, randomized-controlled trial

Zuilhof Z, Norris S, Blondeau C, Tessier P, Blier P

Neuropsychiatric Disease and Treatment 2018, 14:3209-3218

Published Date: 22 November 2018

Brain structural networks and connectomes: the brain–obesity interface and its impact on mental health

Chen VCH, Liu YC, Chao SH, McIntyre RS, Cha DS, Lee Y, Weng JC

Neuropsychiatric Disease and Treatment 2018, 14:3199-3208

Published Date: 26 November 2018

The hospital anxiety and depression scale, in patients with multiple sclerosis

Pais-Ribeiro JL, Martins da Silva A, Vilhena E, Moreira I, Santos E, Mendonça D

Neuropsychiatric Disease and Treatment 2018, 14:3193-3197

Published Date: 22 November 2018

The subjective perception of past, present, and future time in patients with Alzheimer's disease: a qualitative study

Shiromaru-Sugimoto A, Murakami H, Futamura A, Honma M, Kuroda T, Kawamura M, Ono K

Neuropsychiatric Disease and Treatment 2018, 14:3185-3192

Published Date: 22 November 2018

Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study

Takeshima M, Ishikawa H, Kanbayashi T, Shimizu T

Neuropsychiatric Disease and Treatment 2018, 14:3179-3184

Published Date: 22 November 2018

Elevated circulating magnesium levels in patients with Parkinson’s disease: a meta-analysis

Jin X, Liu MY, Zhang DF, Gao H, Wei MJ

Neuropsychiatric Disease and Treatment 2018, 14:3159-3168

Published Date: 19 November 2018

Aberrant prefrontal–parietal–cerebellar circuits in alcohol dependence

Liu R, Liu BX, Ma M, Kong D, Li G, Yang J, Wu X, Zheng J, Dong Y

Neuropsychiatric Disease and Treatment 2018, 14:3143-3150

Published Date: 16 November 2018

Activation of ERK/CREB/BDNF pathway involved in abnormal behavior of neonatally Borna virus-infected rats

Li C, Xu X, Zhang X, Cheng K, Guo Y, Jie J, Guo H, He Y, Zhou C, Gui S, Zhong X, Wang H, Xie P

Neuropsychiatric Disease and Treatment 2018, 14:3121-3132

Published Date: 15 November 2018

RIP1 and RIP3 mediate hemin-induced cell death in HT22 hippocampal neuronal cells

Su X, Wang H, Lin Y, Chen F

Neuropsychiatric Disease and Treatment 2018, 14:3111-3119

Published Date: 15 November 2018

Efficacy of light therapy on nonseasonal depression among elderly adults: a systematic review and meta-analysis

Chang CH, Liu CY, Chen SJ, Tsai HC

Neuropsychiatric Disease and Treatment 2018, 14:3091-3102

Published Date: 14 November 2018

Prevalence of poststroke depression in Iranian patients: a systematic review and meta-analysis

Dalvand S, Ghanei Gheshlagh R, Kurdi A

Neuropsychiatric Disease and Treatment 2018, 14:3073-3080

Published Date: 13 November 2018

Aripiprazole in acute treatment of children and adolescents with autism spectrum disorder: a systematic review and meta-analysis

Maneeton N, Maneeton B, Putthisri S, Suttajit S, Likhitsathian S, Srisurapanont M

Neuropsychiatric Disease and Treatment 2018, 14:3063-3072

Published Date: 12 November 2018

Economic analysis of acupuncture for migraine prophylaxis

Pokladnikova J, Maresova P, Dolejs J, Park AL, Wang B, Guan X, Musil F

Neuropsychiatric Disease and Treatment 2018, 14:3053-3061

Published Date: 12 November 2018

The Chinese herbal formula Fuzheng Quxie Decoction attenuates cognitive impairment and protects cerebrovascular function in SAMP8 mice

Wang F, Feng J, Yang Y, Liu J, Liu M, Wang Z, Pei H, Wei Y, Li H

Neuropsychiatric Disease and Treatment 2018, 14:3037-3051

Published Date: 9 November 2018

Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report

Kulaksizoğlu B, Kara H, Bodur B, Kuloğlu M

Neuropsychiatric Disease and Treatment 2018, 14:3033-3035

Published Date: 9 November 2018

Cognitive functioning in patients treated with electroconvulsive therapy

Kalisova L, Kubinova M, Michalec J, Albrecht J, Madlova K, Raboch J

Neuropsychiatric Disease and Treatment 2018, 14:3025-3031

Published Date: 8 November 2018

Identification of a novel mutation in APP gene in a Thai subject with early-onset Alzheimer's disease

Giau VV, Senanarong V, Bagyinszky E, Limwongse C, An SSA, Kim SY

Neuropsychiatric Disease and Treatment 2018, 14:3015-3023

Published Date: 8 November 2018

A prescription for “nature” – the potential of using virtual nature in therapeutics

White MP, Yeo NL, Vassiljev P, Lundstedt R, Wallergård M, Albin M, Lõhmus M

Neuropsychiatric Disease and Treatment 2018, 14:3001-3013

Published Date: 8 November 2018

Biomarkers in traumatic brain injury (TBI): a review

Dadas A, Washington J, Diaz-Arrastia R, Janigro D

Neuropsychiatric Disease and Treatment 2018, 14:2989-3000

Published Date: 8 November 2018

Association study between COMT, DRD2, and DRD3 gene variants and antipsychotic treatment response in Mexican patients with schizophrenia

Escamilla R, Camarena B, Saracco-Alvarez R, Fresán A, Hernández S, Aguilar-García A

Neuropsychiatric Disease and Treatment 2018, 14:2981-2987

Published Date: 5 November 2018

Parents’ impaired emotion recognition abilities are related to children’s autistic symptoms in autism spectrum disorder

Hu X, Yin L, Situ M, Guo K, Yang P, Zhang M, Huang Y

Neuropsychiatric Disease and Treatment 2018, 14:2973-2980

Published Date: 5 November 2018

Low levels of serum magnesium are associated with poststroke cognitive impairment in ischemic stroke patients

Tu X, Qiu H, Lin S, He W, Huang G, Zhang X, Wu Y, He J

Neuropsychiatric Disease and Treatment 2018, 14:2947-2954

Published Date: 2 November 2018

Detection of cognitive impairment using a machine-learning algorithm

Youn YC, Choi SH, Shin HW, Kim KW, Jang JW, Jung JJ, Hsiung GY, Kim SY

Neuropsychiatric Disease and Treatment 2018, 14:2939-2945

Published Date: 1 November 2018

Removal of blood amyloid-β with hemodialysis reduced brain amyloid-β, confirmed by brain imaging: a case report

Kitaguchi N, Kato T, Matsunaga S, Hirano K, Iwata K, Kawaguchi K, Fujita K, Takechi H, Hasegawa M, Yuzawa Y, Ito K

Neuropsychiatric Disease and Treatment 2018, 14:2931-2937

Published Date: 1 November 2018

Structural and functional brain abnormalities in drug-naive, first-episode, and chronic patients with schizophrenia: a multimodal MRI study

Wu F, Zhang Y, Yang Y, Lu X, Fang Z, Huang J, Kong L, Chen J, Ning Y, Li X, Wu K

Neuropsychiatric Disease and Treatment 2018, 14:2889-2904

Published Date: 30 October 2018

Short duration of focal onset awareness and impaired awareness seizure are characteristic features of epilepsy in elderly patients

Fujimoto A, Okanishi T, Masuda Y, Sato K, Nishimura M, Baba S, Itamura S, Homma Y, Enoki H

Neuropsychiatric Disease and Treatment 2018, 14:2879-2887

Published Date: 30 October 2018

Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder

Lam RW, Lamy FX, Danchenko N, Yarlas A, White MK, Rive B, Saragoussi D

Neuropsychiatric Disease and Treatment 2018, 14:2861-2877

Published Date: 29 October 2018

Sexual dysfunction in cervical dystonia and blepharospasm

Marek M, Grobe-Einsler M, Bedarf JR, Wabbels B, Paus S

Neuropsychiatric Disease and Treatment 2018, 14:2847-2852

Published Date: 26 October 2018

Neuroprogression: the hidden mechanism of depression

Labra Ruiz NA, Santamaría del Ángel D, Juárez Olguín H, Lindoro Silva M

Neuropsychiatric Disease and Treatment 2018, 14:2837-2845

Published Date: 30 October 2018

Neuromodulation in eating disorders and obesity: a promising way of treatment?

Jáuregui-Lobera I, Martínez-Quiñones JV

Neuropsychiatric Disease and Treatment 2018, 14:2817-2835

Published Date: 26 October 2018

Violence in persons with and without psychosis in the Czech Republic: risk and protective factors

Černý M, Hodgins S, Kučíková R, Kážmér L, Lambertová A, Nawka A, Nawková L, Parzelka A, Raboch J, Bob P, Vevera J

Neuropsychiatric Disease and Treatment 2018, 14:2793-2805

Published Date: 23 October 2018

Social adjustment and family function after drug switch from IR -methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder

Chou WJ, Wang LJ, Lin CH, Liang SY, Chen VCH, Hou YM, Huang RR, Chou MC, Shang CY, Ho CP, Lai MC

Neuropsychiatric Disease and Treatment 2018, 14:2783-2791

Published Date: 23 October 2018

microRNA-451 protects neurons against ischemia/reperfusion injury-induced cell death by targeting CELF2

Liu Q, Hu Y, Zhang M, Yan Y, Yu H, Ge L

Neuropsychiatric Disease and Treatment 2018, 14:2773-2782

Published Date: 23 October 2018

Abnormal intrinsic brain activities in stable patients with COPD: a resting-state functional MRI study

Wang W, Li H, Peng D, Luo J, Xin H, Yu H, Yu J

Neuropsychiatric Disease and Treatment 2018, 14:2763-2772

Published Date: 17 October 2018

Depression, anxiety, and stress and their association with khat use: a cross-sectional study among Jazan University students, Saudi Arabia

Al Bahhawi T, Albasheer OB, Makeen AM, Arishi AM, Hakami OM, Maashi SM, Al-Khairat HK, Alganmy OM, Sahal YA, Sharif AA, Mahfouz MS

Neuropsychiatric Disease and Treatment 2018, 14:2755-2761

Published Date: 17 October 2018

Lithium treatment in bipolar adolescents: a follow-up naturalistic study

Masi G, Milone A, Scrinzi G, Mucci M, Viglione V, Bruni G, Berloffa S, Pisano S

Neuropsychiatric Disease and Treatment 2018, 14:2749-2753

Published Date: 17 October 2018

Are 24-hour motor activity patterns associated with continued rapid response to ketamine?

Duncan Jr WC, Slonena EE, Hejazi NS, Brutsche N, Park LT, Henter ID, Ballard ED, Zarate Jr CA

Neuropsychiatric Disease and Treatment 2018, 14:2739-2748

Published Date: 16 October 2018

Neuronal connectivity in major depressive disorder: a systematic review

Helm K, Viol K, Weiger TM, Tass PA, Grefkes C, del Monte D, Schiepek G

Neuropsychiatric Disease and Treatment 2018, 14:2715-2737

Published Date: 17 October 2018

Minocycline as adjunct therapy for a male patient with deficit schizophrenia

Chen X, Xiong Z, Li Z, Yang Y, Zheng Z, Li Y, Xie Y, Li Z

Neuropsychiatric Disease and Treatment 2018, 14:2697-2701

Published Date: 12 October 2018

Effects of cognitive behavioral therapy for depression on improving insomnia and quality of life in Chinese women with breast cancer: results of a randomized, controlled, multicenter trial

Qiu H, Ren W, Yang Y, Zhu X, Mao G, Mao S, Lin Y, Shen S, Li C, Shi H, Jiang S, He J, Zhao K, Fu Y, Hu X, Gu Y, Wang K, Guo X, He J

Neuropsychiatric Disease and Treatment 2018, 14:2665-2673

Published Date: 10 October 2018

Menstrual disorders and their determinants among women with epilepsy

Bosak M, Słowik A, Turaj W

Neuropsychiatric Disease and Treatment 2018, 14:2657-2664

Published Date: 10 October 2018

Neuropsychiatric disturbances in atypical parkinsonian disorders

Belvisi D, Berardelli I, Suppa A, Fabbrini A, Pasquini M, Pompili M, Fabbrini G

Neuropsychiatric Disease and Treatment 2018, 14:2643-2656

Published Date: 9 October 2018

Enduring effects of a five-week behavioral activation program for subthreshold depression among late adolescents: an exploratory randomized controlled trial

Takagaki K, Okamoto Y, Jinnin R, Mori A, Nishiyama Y, Yamamura T, Yokoyama S, Shiota S, Okamoto Y, Miyake Y, Ogata A, Kunisato Y, Shimoda H, Kawakami N, Furukawa TA, Yamawaki S

Neuropsychiatric Disease and Treatment 2018, 14:2633-2641

Published Date: 9 October 2018

Inefficient understanding of non-factive mental verbs with social aspect in adults: comparison to cognitive factive verb processing

Nazlidou E, Moraitou D, Natsopoulos D, Papaliagkas V, Masoura E, Papantoniou G

Neuropsychiatric Disease and Treatment 2018, 14:2617-2631

Published Date: 10 October 2018

Characteristics of brain functional and structural connectivity in alexithymic students

Fang Y, Li M, Mei M, Sun X, Han D

Neuropsychiatric Disease and Treatment 2018, 14:2609-2615

Published Date: 9 October 2018

Internalized stigma and its correlates among patients with severe mental illness

Szcześniak D, Kobyłko A, Wojciechowska I, Kłapciński M, Rymaszewska J

Neuropsychiatric Disease and Treatment 2018, 14:2599-2608

Published Date: 8 October 2018

Postseizure aphasia in Wernicke's encephalopathy: a case report and review of literature

Devaraj S, Muralles SA, Gill CE, Meresh E

Neuropsychiatric Disease and Treatment 2018, 14:2593-2598

Published Date: 8 October 2018

Upregulation of vitamin D-related genes in schizophrenic patients

Asadzadeh Manjili F, Kalantar SM, Arsang-Jang S, Ghafouri-Fard S, Taheri M, Sayad A

Neuropsychiatric Disease and Treatment 2018, 14:2583-2591

Published Date: 9 October 2018

Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials

Kishi T, Oya K, Matsui Y, Nomura I, Sakuma K, Okuya M, Matsuda Y, Fujita K, Funahashi T, Yoshimura R, Iwata N

Neuropsychiatric Disease and Treatment 2018, 14:2519-2530

Published Date: 1 October 2018

Association between reduced quality of life and depression in patients with type 2 diabetes mellitus: a cohort study in a Mexican population

Juárez-Rojop IE, Fortuny-Falconi CM, González-Castro TB, Tovilla-Zárate CA, Villar-Soto M, Rodríguez Sanchez E, Hernández-Díaz Y, López-Narvaez ML, Ble-Castillo JL, Pérez-Hernández N, Rodríguez-Pérez JM

Neuropsychiatric Disease and Treatment 2018, 14:2511-2518

Published Date: 4 October 2018

Construct validity and reliability of the Tachikawa Resilience Scale in the Japan Ground Self-Defense Force personnel

Saito T, Nagamine M, Shigemura J, Tanichi M, Toda H, Shimizu K, Yoshino A

Neuropsychiatric Disease and Treatment 2018, 14:2505-2510

Published Date: 2 October 2018

HPA-axis genes as potential risk variants for neurocognitive decline in trauma-exposed, HIV-positive females

Jacobs S, Moxley K, Womersley JS, Spies G, Hemmings SMJ, Seedat S

Neuropsychiatric Disease and Treatment 2018, 14:2497-2504

Published Date: 28 September 2018

The role of COMT gene Val108/158Met polymorphism in suicidal behavior: systematic review and updated meta-analysis

González-Castro TB, Hernández-Díaz Y, Juárez-Rojop IE, López-Narváez ML, Tovilla-Zárate CA, Ramirez-Bello J, Pérez-Hernández N, Genis-Mendoza AD, Fresan A, Guzmán-Priego CG

Neuropsychiatric Disease and Treatment 2018, 14:2485-2496

Published Date: 28 September 2018

Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline

Huang J, Wang Y, Chen J, Zhang Y, Yuan Z, Yue L, Haro JM, Moneta MV, Novick D, Fang YR

Neuropsychiatric Disease and Treatment 2018, 14:2473-2484

Published Date: 26 September 2018

Modulatory interactions of resting-state brain functional connectivity in major depressive disorder

Tu Z, Jia YY, Wang T, Qu H, Pan JX, Jie J, Xu XY, Wang HY, Xie P

Neuropsychiatric Disease and Treatment 2018, 14:2461-2472

Published Date: 28 September 2018

Subjective memory complaint as a useful tool for the early detection of Alzheimer’s disease

Choe YM, Byun MS, Lee JH, Sohn BK, Lee DY, Kim JW

Neuropsychiatric Disease and Treatment 2018, 14:2451-2460

Published Date: 24 September 2018

Automatic epilepsy detection using fractal dimensions segmentation and GP–SVM classification

Jirka J, Prauzek M, Krejcar O, Kuca K

Neuropsychiatric Disease and Treatment 2018, 14:2439-2449

Published Date: 21 September 2018

The microglial activation profile and associated factors after experimental spinal cord injury in rats

Zhou Y, Li N, Zhu L, Lin Y, Cheng H

Neuropsychiatric Disease and Treatment 2018, 14:2401-2413

Published Date: 20 September 2018

Gender differences in the relationships among neurosteroid serum levels, cognitive function, and quality of life

Chen CY, Wu CC, Huang YC, Hung CF, Wang LJ

Neuropsychiatric Disease and Treatment 2018, 14:2389-2399

Published Date: 19 September 2018

Low hedonic tone and attention-deficit hyperactivity disorder: risk factors for treatment resistance in depressed adults

Sternat T, Fotinos K, Fine A, Epstein I, Katzman MA

Neuropsychiatric Disease and Treatment 2018, 14:2379-2387

Published Date: 17 September 2018

PTSD patients show increasing cytokine levels during treatment despite reduced psychological distress

Toft H, Bramness JG, Lien L, Abebe DS, Wampold BE, Tilden T, Hestad KA, Neupane SP

Neuropsychiatric Disease and Treatment 2018, 14:2367-2378

Published Date: 17 September 2018

Effects of long-acting injectable antipsychotics versus oral antipsychotics on autonomic nervous system activity in schizophrenic patients

Suda A, Hattori S, Kishida I, Miyauchi M, Shiraishi Y, Fujibayashi M, Tsujita N, Ishii C, Ishii N, Moritani T, Hirayasu Y

Neuropsychiatric Disease and Treatment 2018, 14:2361-2366

Published Date: 17 September 2018

Altered spontaneous brain activity patterns in strabismus with amblyopia patients using amplitude of low-frequency fluctuation: a resting-state fMRI study

Min YL, Su T, Shu YQ, Liu WF, Chen LL, Shi WQ, Jiang N, Zhu PW, Yuan Q, Xu XW, Ye L, Shao Y

Neuropsychiatric Disease and Treatment 2018, 14:2351-2359

Published Date: 17 September 2018

A randomized controlled trial of mindfulness-based Tai Chi Chuan for subthreshold depression adolescents

Zhang JY, Qin SD, Zhou YQ, Meng LN, Su H, Zhao S

Neuropsychiatric Disease and Treatment 2018, 14:2313-2321

Published Date: 10 September 2018

Increased serum levels of sortilin-derived propeptide after electroconvulsive therapy in treatment-resistant depressed patients

Roulot M, Minelli A, Bortolomasi M, Maffioletti E, Gennarelli M, Borsotto M, Heurteaux C, Mazella J

Neuropsychiatric Disease and Treatment 2018, 14:2307-2312

Published Date: 6 September 2018

Children with autism spectrum disorders and selective mutism [Corrigendum]

Steffenburg H, Steffenburg S, Gillberg C, Billstedt E

Neuropsychiatric Disease and Treatment 2018, 14:2305-2306

Published Date: 6 September 2018

Prescreening clinical trial volunteers using an online personality questionnaire

Patrick F, Young AH, Williams SCR, Perkins AM

Neuropsychiatric Disease and Treatment 2018, 14:2297-2303

Published Date: 5 September 2018

Trajectories of callous–unemotional traits from childhood to adolescence in referred youth with a disruptive behavior disorder who received intensive multimodal therapy in childhood

Masi G, Pisano S, Brovedani P, Maccaferri G, Manfredi A, Milone A, Nocentini A, Polidori L, Ruglioni L, Muratori P

Neuropsychiatric Disease and Treatment 2018, 14:2287-2296

Published Date: 5 September 2018

Do eyes with and without optic neuritis in multiple sclerosis age equally?

Lizrova Preiningerova J, Grishko A, Sobisek L, Andelova M, Benova B, Kucerova K, Havrdova EK

Neuropsychiatric Disease and Treatment 2018, 14:2281-2285

Published Date: 5 September 2018

Victimization and posttraumatic stress disorder in homeless women with mental illness are associated with depression, suicide, and quality of life

Tinland A, Boyer L, Loubière S, Greacen T, Girard V, Boucekine M, Fond G, Auquier P

Neuropsychiatric Disease and Treatment 2018, 14:2269-2279

Published Date: 4 September 2018

Vulnerability or resilience of motopsin knockout mice to maternal separation stress depending on adulthood behaviors

Hidaka C, Kashio T, Uchigaki D, Mitsui S

Neuropsychiatric Disease and Treatment 2018, 14:2255-2268

Published Date: 4 September 2018

Association between platelet distribution width and poor outcome of acute ischemic stroke after intravenous thrombolysis

Gao F, Chen C, Lyu J, Zheng J, Ma XC, Yuan XY, Huo K, Han JF

Neuropsychiatric Disease and Treatment 2018, 14:2233-2239

Published Date: 3 September 2018

Platelet membrane receptor P2Y12 H1/H2 polymorphisms is highly associated with cerebral infarction: a case-control study

Lu SJ, Zhou XS, Zheng Q, Chen HL, Geng YL

Neuropsychiatric Disease and Treatment 2018, 14:2225-2231

Published Date: 30 August 2018

Relationship between social and cognitive functions in people with schizophrenia

Tominaga T, Tomotake M, Takeda T, Ueoka Y, Tanaka T, Watanabe SY, Kameoka N, Nakataki M, Numata S, Izaki Y, Sumitani S, Kubo H, Kaneda Y, Ohmori T

Neuropsychiatric Disease and Treatment 2018, 14:2215-2224

Published Date: 30 August 2018

Investigation of alexithymia and levels of anxiety and depression among patients with restless legs syndrome

Yılmaz O, Şengül Y, Şengül HS, Parlakkaya FB, Öztürk A

Neuropsychiatric Disease and Treatment 2018, 14:2207-2214

Published Date: 29 August 2018

Dexmedetomidine attenuates the propofol-induced long-term neurotoxicity in the developing brain of rats by enhancing the PI3K/Akt signaling pathway

Xiao Y, Zhou L, Tu Y, Li Y, Liang Y, Zhang X, Lv J, Zhong Y, Xie Y

Neuropsychiatric Disease and Treatment 2018, 14:2191-2206

Published Date: 28 August 2018

Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level

Zhi P, Wang Y, Quan W, Su Y, Zhang H

Neuropsychiatric Disease and Treatment 2018, 14:2175-2179

Published Date: 27 August 2018

EEG correlates of induced anxiety in obsessive–compulsive patients: comparison of autobiographical and general anxiety scenarios

Kamaradova D, Brunovsky M, Prasko J, Horacek J, Hajda M, Grambal A, Latalova K

Neuropsychiatric Disease and Treatment 2018, 14:2165-2174

Published Date: 27 August 2018

Effects of behavioral activation program without psychotropic medication treatment for depression in late adolescence: case report

Takagaki K, Okamoto Y, Jinnin R, Yokoyama S, Yoshino A, Kagawa F, Okamoto Y, Miyake Y, Yamawaki S

Neuropsychiatric Disease and Treatment 2018, 14:2159-2164

Published Date: 27 August 2018

ESSENCE-Q: Slavic language versions for developmental screening in young children

Stevanovic D, Knez R, Zorcec T, Anderluh M, Kodrič J, Petrov P, Hadžagić Ćatibušić F, Deljković A, Brkic Cvetkovic S, Vrljičak Davidovic N, Kuzmanić Šamija R, Đorić A, Gillberg C

Neuropsychiatric Disease and Treatment 2018, 14:2141-2148

Published Date: 23 August 2018

Chinese version of Montreal Cognitive Assessment Basic for discrimination among different severities of Alzheimer’s disease

Huang L, Chen KL, Lin BY, Tang L, Zhao QH, Lv YR, Guo QH

Neuropsychiatric Disease and Treatment 2018, 14:2133-2140

Published Date: 21 August 2018

Construction of an Arabic computerized battery for cognitive rehabilitation of children with specific learning disabilities

Farghaly WMA, Ahmed MA, El-Tallawy HN, Elmestikawy TAH, Badry R, Farghaly MS, Omar MS, Hussein ASR, Salamah M, Mohammed AT

Neuropsychiatric Disease and Treatment 2018, 14:2123-2131

Published Date: 21 August 2018

Investigation of chromosome Y loss in men with schizophrenia

Hirata T, Hishimoto A, Otsuka I, Okazaki S, Boku S, Kimura A, Horai T, Sora I

Neuropsychiatric Disease and Treatment 2018, 14:2115-2122

Published Date: 20 August 2018

The interactive effects of ketamine and ethanol on dopamine expression in the ventral tegmental area of rats

Zhang ZB, Xu TY, You DY, Yi S, Liu Q, Li HJ, Gu JY

Neuropsychiatric Disease and Treatment 2018, 14:2105-2114

Published Date: 20 August 2018

Dosage-related nature of escitalopram treatment-emergent mania/hypomania: a case series

Yamaguchi Y, Kimoto S, Nagahama T, Kishimoto T

Neuropsychiatric Disease and Treatment 2018, 14:2099-2104

Published Date: 17 August 2018

Safety and effectiveness of escitalopram in an 8-week open study in Chinese patients with depression and anxiety

Wang G, You X, Wang X, Xu X, Bai L, Xie J, Yao Z, Yi Q, Ma J, Wang J, Zhuo J, Hu C

Neuropsychiatric Disease and Treatment 2018, 14:2087-2097

Published Date: 14 August 2018

Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases

Bagyinszky E, Giau VV, Youn YC, An SSA, Kim SY

Neuropsychiatric Disease and Treatment 2018, 14:2067-2085

Published Date: 14 August 2018

Clinical characteristics and course of oral somatic delusions: a retrospective chart review of 606 cases in 5 years

Umezaki Y, Miura A, Shinohara Y, Mikuzuki L, Sugawara S, Kawasaki K, Tu TTH, Watanabe T, Suga T, Watanabe M, Takenoshita M, Yoshikawa T, Uezato A, Nishikawa T, Hoshiko K, Naito T, Motomura H, Toyofuku A

Neuropsychiatric Disease and Treatment 2018, 14:2057-2065

Published Date: 13 August 2018

Schizophrenia and risk of dementia: a meta-analysis study

Cai LS, Huang JW

Neuropsychiatric Disease and Treatment 2018, 14:2047-2055

Published Date: 13 August 2018

Social communication disorder: a narrative review on current insights

Topal Z, Demir Samurcu N, Taskiran S, Tufan AE, Semerci B

Neuropsychiatric Disease and Treatment 2018, 14:2039-2046

Published Date: 13 August 2018

Novel ensemble method for the prediction of response to fluvoxamine treatment of obsessive–compulsive disorder

Hasanpour H, Ghavamizadeh Meibodi R, Navi K, Asadi S

Neuropsychiatric Disease and Treatment 2018, 14:2027-2038

Published Date: 10 August 2018

Associations between stress and depression symptom profiles vary according to serotonin transporter polymorphism in rural Australians

Sharpley CF, Bitsika V, McMillan ME, Jesulola E, Agnew LL

Neuropsychiatric Disease and Treatment 2018, 14:2007-2016

Published Date: 10 August 2018

Assessment of relevant factors with respect to psychosocial properties in potential living donor candidates before liver transplantation

Wu MK, Hsu LW, Huang KT, Lin CC, Wang CC, Lin TL, Li WF, Goto S, Chen CL, Chen CC

Neuropsychiatric Disease and Treatment 2018, 14:1999-2005

Published Date: 8 August 2018

Resting-state functional changes in the precuneus within first-episode drug-naive patients with MDD

Li G, Rossbach K, Zhang A, Liu P, Zhang K

Neuropsychiatric Disease and Treatment 2018, 14:1991-1998

Published Date: 7 August 2018

Evaluation of BPPV with vertebral artery values

Yazıcı A, İnanç Y

Neuropsychiatric Disease and Treatment 2018, 14:1975-1979

Published Date: 6 August 2018

Impact of aerobic exercise on muscle mass in patients with major depressive disorder: a randomized controlled trial

Kerling A, Hartung D, Stubbs B, Kück M, Tegtbur U, Grams L, Weber-Spickschen TS, Kahl KG

Neuropsychiatric Disease and Treatment 2018, 14:1969-1974

Published Date: 6 August 2018

Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review

Maneeton B, Maneeton N, Likhitsathian S, Woottiluk P, Wiriyacosol P, Boonyanaruthee V, Srisurapanont M

Neuropsychiatric Disease and Treatment 2018, 14:1953-1961

Published Date: 2 August 2018

Aberrant cortical thickness in neurologically asymptomatic patients with end-stage renal disease

Dong J, Ma X, Lin W, Liu M, Fu S, Yang L, Jiang G

Neuropsychiatric Disease and Treatment 2018, 14:1929-1939

Published Date: 2 August 2018

Tinnitus distress is associated with enhanced resting-state functional connectivity within the default mode network

Chen YC, Chen H, Bo F, Xu JJ, Deng Y, Lv H, Cai Y, Xia W, Yin X, Gu JP, Lu GM

Neuropsychiatric Disease and Treatment 2018, 14:1919-1927

Published Date: 1 August 2018

Cognitive and metacognitive factors among alcohol-dependent patients during a residential rehabilitation program: a pilot study

Torselli E, Ottonello M, Franceschina E, Palagi E, Bertolotti G, Fiabane E

Neuropsychiatric Disease and Treatment 2018, 14:1907-1917

Published Date: 31 July 2018

Cytological and cytometric analysis of oral mucosa in patients with Alzheimer’s and Parkinson’s disease

Kose Ozlece H, Findik Guvendi G, Huseyinoglu N, Ehi Y, Kivrak Y

Neuropsychiatric Disease and Treatment 2018, 14:1901-1906

Published Date: 31 July 2018

Profiling undergraduate students from a Romanian medical university

Romosan RS, Dehelean L, Enatescu VR, Bredicean AC, Papava I, Giurgi-Oncu C, Romosan AM

Neuropsychiatric Disease and Treatment 2018, 14:1891-1899

Published Date: 24 July 2018

Frontal lobe metabolic alterations in autism spectrum disorder: a 1H-magnetic resonance spectroscopy study

Margari L, De Giacomo A, Craig F, Palumbi R, Peschechera A, Margari M, Picardi F, Caldarola M, Maghenzani MA, Dicuonzo F

Neuropsychiatric Disease and Treatment 2018, 14:1871-1876

Published Date: 20 July 2018

Cortical gyrification in schizophrenia: current perspectives

Matsuda Y, Ohi K

Neuropsychiatric Disease and Treatment 2018, 14:1861-1869

Published Date: 19 July 2018

Atrial natriuretic peptide and posterior pituitary neurohormone changes in patients with acute schizophrenia

Guzel D, Yazici AB, Mutu Pek T, Doganay S, Saykan Simsek AB, Saglam K, Turan C, Yazici E

Neuropsychiatric Disease and Treatment 2018, 14:1855-1860

Published Date: 16 July 2018

Detection, diagnosis, and treatment of Alzheimer’s disease dementia stratified by severity as reported by caregivers in Japan

Montgomery W, Goren A, Kahle-Wrobleski K, Nakamura T, Ueda K

Neuropsychiatric Disease and Treatment 2018, 14:1843-1854

Published Date: 16 July 2018

Association between peripheral manganese levels and attention-deficit/hyperactivity disorder: a preliminary meta-analysis

Shih JH, Zeng BY, Lin PY, Chen TY, Chen YW, Wu CK, Tseng PT, Wu MK

Neuropsychiatric Disease and Treatment 2018, 14:1831-1842

Published Date: 18 July 2018

A preliminary assessment of a combination of rhodiola and saffron in the management of mild–moderate depression

Bangratz M, Ait Abdellah S, Berlin A, Blondeau C, Guilbot A, Dubourdeaux M, Lemoine P

Neuropsychiatric Disease and Treatment 2018, 14:1821-1829

Published Date: 13 July 2018

Risperidone for children and adolescents with autism spectrum disorder: a systematic review

Maneeton N, Maneeton B, Putthisri S, Woottiluk P, Narkpongphun A, Srisurapanont M

Neuropsychiatric Disease and Treatment 2018, 14:1811-1820

Published Date: 11 July 2018

Association between insomnia and coping style in Japanese patients with type 2 diabetes mellitus

Yoshida K, Otaka H, Murakami H, Nakayama H, Murabayashi M, Mizushiri S, Matsumura K, Tanabe J, Matsuhashi Y, Yanagimachi M, Sugawara N, Nakamura K, Daimon M, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2018, 14:1803-1809

Published Date: 10 July 2018

Gender differences in the protective effects of green tea against amnestic mild cognitive impairment in the elderly Han population

Xu H, Wang Y, Yuan Y, Zhang X, Zuo XY, Cui L, Liu Y, Chen W, Su N, Wang H, Yan F, Li X, Wang T, Xiao S

Neuropsychiatric Disease and Treatment 2018, 14:1795-1801

Published Date: 10 July 2018

Relation of high neuroticism with increased methylation of the BDNF gene

Shirata T, Suzuki A, Matsumoto Y, Takahashi N, Noto K, Goto K, Otani K

Neuropsychiatric Disease and Treatment 2018, 14:1787-1793

Published Date: 9 July 2018

Preschool-onset obsessive-compulsive disorder with complete remission

Miyawaki D, Goto A, Iwakura Y, Hirai K, Miki Y, Asada N, Terakawa H, Inoue K

Neuropsychiatric Disease and Treatment 2018, 14:1747-1753

Published Date: 3 July 2018

Transcranial magnetic stimulation in the treatment of obsessive–compulsive disorder: current perspectives

Lusicic A, Schruers KRJ, Pallanti S, Castle DJ

Neuropsychiatric Disease and Treatment 2018, 14:1721-1736

Published Date: 29 June 2018

Frequency of inborn errors of metabolism screening for children with unexplained acute encephalopathy at an emergency department

Abdel Maksoud M, ELsayed SM, Shatla RH, Imam AA, Elsayed RM, Mosabah AA, Sherif AM

Neuropsychiatric Disease and Treatment 2018, 14:1715-1720

Published Date: 29 June 2018

The effect of depression on fracture healing and osteoblast differentiation in rats

Nie C, Wang Z, Liu X

Neuropsychiatric Disease and Treatment 2018, 14:1705-1713

Published Date: 29 June 2018

Neuropsychiatric assessments in patients with multiple sclerosis in early phases and with low disability

Schmidt SL, Santos da Silva M, Schmidt JJ, Carvalho ALN, Vasconcelos CCF, Paes RA, Boechat YEM, Neder R, Alvarenga RP

Neuropsychiatric Disease and Treatment 2018, 14:1665-1670

Published Date: 22 June 2018

COMT Val 108/158 Met polymorphism and treatment response to aripiprazole in patients with acute schizophrenia

Kaneko H, Miura I, Kanno-Nozaki K, Horikoshi S, Hino M, Yabe H

Neuropsychiatric Disease and Treatment 2018, 14:1657-1663

Published Date: 22 June 2018

The detection of white matter alterations in obsessive–compulsive disorder revealed by TRActs Constrained by UnderLying Anatomy (TRACULA)

Watanabe A, Nakamae T, Sakai Y, Nishida S, Abe Y, Yamada K, Yokota I, Narumoto J

Neuropsychiatric Disease and Treatment 2018, 14:1635-1643

Published Date: 19 June 2018

The role of MAPT gene in Chinese dementia patients: a P301L pedigree study and brief literature review

He S, Chen S, Xia MR, Sun ZK, Huang Y, Zhang JW

Neuropsychiatric Disease and Treatment 2018, 14:1627-1633

Published Date: 18 June 2018

Vibration therapy in patients with cerebral palsy: a systematic review

Ritzmann R, Stark C, Krause A

Neuropsychiatric Disease and Treatment 2018, 14:1607-1625

Published Date: 18 June 2018

Mindfulness-based cognitive therapy in patients with depression: current perspectives

MacKenzie MB, Abbott KA, Kocovski NL

Neuropsychiatric Disease and Treatment 2018, 14:1599-1605

Published Date: 18 June 2018

Structural equation modeling approach between salience network dysfunction, depressed mood, and subjective quality of life in schizophrenia: an ICA resting-state fMRI study

Ohta M, Nakataki M, Takeda T, Numata S, Tominaga T, Kameoka N, Kubo H, Kinoshita M, Matsuura K, Otomo M, Takeichi N, Harada M, Ohmori T

Neuropsychiatric Disease and Treatment 2018, 14:1585-1597

Published Date: 15 June 2018

Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations

Mayerova M, Ustohal L, Jarkovsky J, Pivnicka J, Kasparek T, Ceskova E

Neuropsychiatric Disease and Treatment 2018, 14:1535-1543

Published Date: 14 June 2018

Risk assessment of night-eating syndrome occurrence in women in Poland, considering the obesity factor in particular

Olejniczak D, Bugajec D, Staniszewska A, Panczyk M, Kielan A, Czerw A, Mańczuk M, Juszczyk G, Skonieczna J, Brytek-Matera A

Neuropsychiatric Disease and Treatment 2018, 14:1521-1526

Published Date: 13 June 2018

The effect of evening primrose oil on fatigue and quality of life in patients with multiple sclerosis

Majdinasab N, Namjoyan F, Taghizadeh M, Saki H

Neuropsychiatric Disease and Treatment 2018, 14:1505-1512

Published Date: 12 June 2018

Electroencephalogram alpha asymmetry in patients with depressive disorders: current perspectives

Kaiser AK, Gnjezda MT, Knasmüller S, Aichhorn W

Neuropsychiatric Disease and Treatment 2018, 14:1493-1504

Published Date: 11 June 2018

Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2

Sajatovic M, Ross R, Legacy SN, Byerly M, Kane JM, DiBiasi F, Fitzgerald H, Correll CU

Neuropsychiatric Disease and Treatment 2018, 14:1475-1492

Published Date: 8 June 2018

Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics – expert consensus survey part 1

Sajatovic M, Ross R, Legacy SN, Correll CU, Kane JM, DiBiasi F, Fitzgerald H, Byerly M

Neuropsychiatric Disease and Treatment 2018, 14:1463-1474

Published Date: 8 June 2018

Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics

Gui SW, Liu YY, Zhong XG, Liu XY, Zheng P, Pu JC, Zhou J, Chen JJ, Zhao LB, Liu LX, Xu GW, Xie P

Neuropsychiatric Disease and Treatment 2018, 14:1451-1461

Published Date: 6 June 2018

A review of ketamine’s role in ECT and non-ECT settings

Jankauskas V, Necyk C, Chue J, Chue P

Neuropsychiatric Disease and Treatment 2018, 14:1437-1450

Published Date: 6 June 2018

Misdiagnosed atypical paroxysmal kinesigenic dyskinesia: a case report

Pan F, Li S, Li H, Xu Y, Huang M

Neuropsychiatric Disease and Treatment 2018, 14:1433-1435

Published Date: 5 June 2018

Investigation on dysfunctional beliefs and attitudes about sleep in Chinese college students

Jin LR, Zhou J, Peng H, Ding SS, Yuan H

Neuropsychiatric Disease and Treatment 2018, 14:1425-1432

Published Date: 1 June 2018

Suicidality, self-stigma, social anxiety and personality traits in stabilized schizophrenia patients – a cross-sectional study

Vrbova K, Prasko J, Ociskova M, Holubova M, Kantor K, Kolek A, Grambal A, Slepecky M

Neuropsychiatric Disease and Treatment 2018, 14:1415-1424

Published Date: 1 June 2018

Memantine induces manic episode in a 73-year-old patient with vascular neurocognitive disorder: a case report

Duan JF, Lao CM, Chen JK, Pan F, Zhang CL, Xu WJ, Zhou WH, Hu JB, Shang DS, Huang ML, Xu Y

Neuropsychiatric Disease and Treatment 2018, 14:1395-1398

Published Date: 30 May 2018

Mothers and fathers of children with epilepsy: gender differences in post-traumatic stress symptoms and correlations with mood spectrum symptoms

Carmassi C, Corsi M, Bertelloni CA, Carpita B, Gesi C, Pedrinelli V, Massimetti G, Peroni DG, Bonuccelli A, Orsini A, Dell’Osso L

Neuropsychiatric Disease and Treatment 2018, 14:1371-1379

Published Date: 25 May 2018

Incidence of venous thromboembolism in psychiatric inpatients: a chart review

Takeshima M, Ishikawa H, Shimizu K, Kanbayashi T, Shimizu T

Neuropsychiatric Disease and Treatment 2018, 14:1363-1370

Published Date: 23 May 2018

Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study

Saragoussi D, Christensen MC, Hammer-Helmich L, Rive B, Touya M, Haro JM

Neuropsychiatric Disease and Treatment 2018, 14:1339-1350

Published Date: 22 May 2018

The characteristics of understanding of depression among older patients treated with antidepressants: a comparison between older and younger patients

Tomita T, Kudo S, Sugawara N, Fujii A, Tsuruga K, Sato Y, Ishioka M, Nakamura K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2018, 14:1319-1327

Published Date: 22 May 2018

Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]

Omori Y, Kanbayashi T, Imanishi A, Tsutsui K, Sagawa Y, Kikuchi YS, Takeshima M, Yoshizawa K, Uemura S, Shimizu T

Neuropsychiatric Disease and Treatment 2018, 14:1307-1308

Published Date: 22 May 2018

Differences in psychopathology and behavioral characteristics of patients affected by conversion motor disorder and organic dystonia

Pastore A, Pierri G, Fabio G, Ferramosca S, Gigante A, Superbo M, Pellicciari R, Margari F

Neuropsychiatric Disease and Treatment 2018, 14:1287-1295

Published Date: 18 May 2018

Low dose of aripiprazole advanced sleep rhythm and reduced nocturnal sleep time in the patients with delayed sleep phase syndrome: an open-labeled clinical observation

Omori Y, Kanbayashi T, Sagawa Y, Imanishi A, Tsutsui K, Takahashi Y, Takeshima M, Takaki M, Nishino S, Shimizu T

Neuropsychiatric Disease and Treatment 2018, 14:1281-1286

Published Date: 18 May 2018

Harm avoidance and depression, anxiety, insomnia, and migraine in fifth-year medical students in Taiwan

Chen CY, Yu NW, Huang TH, Wang WS, Fang JT

Neuropsychiatric Disease and Treatment 2018, 14:1273-1280

Published Date: 16 May 2018

Synchronization within, and interactions between, the default mode and dorsal attention networks in relapsing-remitting multiple sclerosis

Huang M, Zhou F, Wu L, Wang B, Wan H, Li F, Zeng X, Gong H

Neuropsychiatric Disease and Treatment 2018, 14:1241-1252

Published Date: 14 May 2018

Disrupted interhemispheric functional connectivity in chronic insomnia disorder: a resting-state fMRI study

Zhou F, Zhao Y, Huang M, Zeng X, Wang B, Gong H

Neuropsychiatric Disease and Treatment 2018, 14:1229-1240

Published Date: 14 May 2018

Acupuncture in migraine prophylaxis in Czech patients: an open-label randomized controlled trial

Musil F, Pokladnikova J, Pavelek Z, Wang B, Guan X, Valis M

Neuropsychiatric Disease and Treatment 2018, 14:1221-1228

Published Date: 10 May 2018

Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review

Masopust J, Protopopová D, Vališ M, Pavelek Z, Klímová B

Neuropsychiatric Disease and Treatment 2018, 14:1211-1220

Published Date: 9 May 2018

Prefrontoparietal dysfunction during emotion regulation in anxiety disorder: a meta-analysis of functional magnetic resonance imaging studies

Wang HY, Zhang XX, Si CP, Xu Y, Liu Q, Bian HT, Zhang BW, Li XL, Yan ZR

Neuropsychiatric Disease and Treatment 2018, 14:1183-1198

Published Date: 9 May 2018

The impact of total sleep deprivation upon cognitive functioning in firefighters

Kujawski S, Słomko J, Tafil-Klawe M, Zawadka-Kunikowska M, Szrajda J, Newton JL, Zalewski P, Klawe JJ

Neuropsychiatric Disease and Treatment 2018, 14:1171-1181

Published Date: 8 May 2018

Children with autism spectrum disorders and selective mutism

Steffenburg H, Steffenburg S, Gillberg C, Billstedt E

Neuropsychiatric Disease and Treatment 2018, 14:1163-1169

Published Date: 7 May 2018

The effects of Maras powder use on patients with migraine

İnanç Y, Orhan FÖ, İnanç Y

Neuropsychiatric Disease and Treatment 2018, 14:1143-1148

Published Date: 7 May 2018

Allergy to chlorpromazine and valproic acid following carbamazepine hypersensitivity in a patient with an HLA-B*4601 allele

Sakurada K, Kozaru T, Yamada K, Nibuya M, Nagata K, Suzuki E

Neuropsychiatric Disease and Treatment 2018, 14:1139-1142

Published Date: 4 May 2018

Antidopaminergic medication in healthy subjects provokes subjective and objective mental impairments tightly correlated with perturbation of biogenic monoamine metabolism and prolactin secretion

Veselinović T, Vernaleken I, Cumming P, Henning U, Winkler L, Kaleta P, Paulzen M, Luckhaus C, Gründer G

Neuropsychiatric Disease and Treatment 2018, 14:1125-1138

Published Date: 27 April 2018

Antidepressant medication use and nasopharyngeal cancer risk: a nationwide population-based study

Lin C, Chan HL, Hsieh YH, Liang H, Chiu WC, Lee Y, McIntyre RS, Chen VC

Neuropsychiatric Disease and Treatment 2018, 14:1101-1106

Published Date: 30 April 2018

New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab

Frau J, Coghe G, Lorefice L, Fenu G, Cocco E

Neuropsychiatric Disease and Treatment 2018, 14:1093-1099

Published Date: 23 April 2018

Comparison of changes in oxygenated hemoglobin during the tree-drawing task between patients with schizophrenia and healthy controls

Nakano S, Shoji Y, Morita K, Igimi H, Sato M, Ishii Y, Kondo A, Uchimura N

Neuropsychiatric Disease and Treatment 2018, 14:1071-1082

Published Date: 20 April 2018

Aberrant brain functional connectome in patients with obstructive sleep apnea

Chen L, Fan X, Li H, Ye C, Yu H, Xin H, Gong H, Peng D, Yan L

Neuropsychiatric Disease and Treatment 2018, 14:1059-1070

Published Date: 18 April 2018

Electroconvulsive therapy in 77-year-old patient with pacemaker: a case report

Mędrala T, Pycińska A, Pyciński B, Merk W, Kucia K

Neuropsychiatric Disease and Treatment 2018, 14:1055-1058

Published Date: 17 April 2018

Significant association of BDNF rs6265 G>A polymorphism with susceptibility to epilepsy: a meta-analysis

Xu Y, Li X, Zhuang S, Guo S, Xiang J, Wang L, Zhou L, Wu B

Neuropsychiatric Disease and Treatment 2018, 14:1035-1046

Published Date: 16 April 2018

Does higher severity really correlate with a worse quality of life in obsessive–compulsive disorder? A meta-regression

Pozza A, Lochner C, Ferretti F, Cuomo A, Coluccia A

Neuropsychiatric Disease and Treatment 2018, 14:1013-1023

Published Date: 16 April 2018

Metabolite-related antidepressant action of diterpene ginkgolides in the prefrontal cortex

Hu Q, Shen P, Bai S, Dong M, Liang Z, Chen Z, Wang W, Wang H, Gui S, Li P, Xie P

Neuropsychiatric Disease and Treatment 2018, 14:999-1011

Published Date: 13 April 2018

The functional and structural characteristics of the emotion network in alexithymia

Han D, Li M, Mei MJ, Sun XF

Neuropsychiatric Disease and Treatment 2018, 14:991-998

Published Date: 12 April 2018

The effects of psychoeducational family intervention on coping strategies of relatives of patients with bipolar I disorder: results from a controlled, real-world, multicentric study

Sampogna G, Luciano M, Del Vecchio V, Malangone C, De Rosa C, Giallonardo V, Borriello G, Pocai B, Savorani M, Steardo L Jr, Lampis D, Veltro F, Bartoli F, Bardicchia F, Moroni AM, Ciampini G, Orlandi E, Ferrari S, Biondi S, Iapichino S, Pompili E, Piselli M, Tortorella A, Carrà G, Fiorillo A

Neuropsychiatric Disease and Treatment 2018, 14:977-989

Published Date: 11 April 2018

Insomnia in hospitalized psychiatric patients: prevalence and associated factors

Talih F, Ajaltouni J, Ghandour H, Abu-Mohammad AS, Kobeissy F

Neuropsychiatric Disease and Treatment 2018, 14:969-975

Published Date: 10 April 2018

Prospective interepisodal mood monitoring in patients with affective disorders: a feasibility study [Corrigendum]

Van der Watt ASJ, Suryapranata APSP, Seedat S

Neuropsychiatric Disease and Treatment 2018, 14:967-968

Published Date: 10 April 2018

Comparative effectiveness of switching paroxetine formulation for treatment of major depressive disorder: an open-label multicenter study

Otsubo T, Watanabe Y, Hongo S, Inoue M, Akimoto K, Murakami K, Takahashi R, Kikuchi T

Neuropsychiatric Disease and Treatment 2018, 14:955-966

Published Date: 6 April 2018

Elevated peripheral blood glutamate levels in major depressive disorder

Inoshita M, Umehara H, Watanabe S, Nakataki M, Kinoshita M, Tomioka Y, Tajima A, Numata S, Ohmori T

Neuropsychiatric Disease and Treatment 2018, 14:945-953

Published Date: 6 April 2018

Inhibitory effect of the Kampo medicinal formula Yokukansan on acute stress-induced defecation in rats

Kanada Y, Katayama A, Ikemoto H, Takahashi K, Tsukada M, Nakamura A, Ishino S, Hisamitsu T, Sunagawa M

Neuropsychiatric Disease and Treatment 2018, 14:937-944

Published Date: 6 April 2018

Investigation of variants in estrogen receptor genes and perinatal depression

Tan EC, Lim HW, Chua TE, Tan HS, Lee TMY, Chen HY

Neuropsychiatric Disease and Treatment 2018, 14:919-925

Published Date: 29 March 2018

Ten-year outcome of vagus nerve stimulation-implanted patients with treatment-resistant depression: two Italian cases

Dell'Osso B, Oldani L, Grancini B, Dario A, Altamura AC

Neuropsychiatric Disease and Treatment 2018, 14:915-918

Published Date: 29 March 2018

Psychometric properties of the Patient Dignity Inventory in an acute psychiatric ward: an extension study of the preliminary validation

Di Lorenzo R, Ferri P, Biffarella C, Cabri G, Carretti E, Pollutri G, Spattini L, Del Giovane C, Chochinov HM

Neuropsychiatric Disease and Treatment 2018, 14:903-913

Published Date: 29 March 2018

Serum levels of GPER -1 in euthymic bipolar patients

Orhan FÖ, Kurutaş EB, Doğaner A, Türker E, Taner Özcü SŞ, Güngör M, Çakmak S

Neuropsychiatric Disease and Treatment 2018, 14:855-862

Published Date: 26 March 2018

Aberrant regional brain activities in alcohol dependence: a functional magnetic resonance imaging study

Tu XZ, Wang JJ, Liu XM, Zheng JY

Neuropsychiatric Disease and Treatment 2018, 14:847-853

Published Date: 22 March 2018

Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson’s disease

Hauser RA, Ellenbogen A, Khanna S, Gupta S, Modi NB

Neuropsychiatric Disease and Treatment 2018, 14:839-845

Published Date: 22 March 2018

Continuous performance task in ADHD: Is reaction time variability a key measure?

Levy F, Pipingas A, Harris EV, Farrow M, Silberstein RB

Neuropsychiatric Disease and Treatment 2018, 14:781-786

Published Date: 15 March 2018

Association between etiology and lesion site in ischemic brainstem infarcts: a retrospective observational study

Baran G, Ozdemir Gultekin T, Baran O, Deniz C, Katar S, Babacan Yildiz G, Asil T

Neuropsychiatric Disease and Treatment 2018, 14:757-766

Published Date: 13 March 2018

Repetitive transcranial magnetic stimulation for the treatment of cognitive impairment in frontotemporal dementia: an open-label pilot study

Antczak J, Kowalska K, Klimkowicz-Mrowiec A, Wach B, Kasprzyk K, Banach M, Rzeźnicka-Brzegowy K, Kubica J, Słowik A

Neuropsychiatric Disease and Treatment 2018, 14:749-755

Published Date: 13 March 2018

Novel treatment options in depression and psychosis

Ceskova E, Silhan P

Neuropsychiatric Disease and Treatment 2018, 14:741-747

Published Date: 13 March 2018

Secondary central nervous system lymphoma: spectrum of morphological MRI appearances

Malikova H, Burghardtova M, Koubska E, Mandys V, Kozak T, Weichet J

Neuropsychiatric Disease and Treatment 2018, 14:733-740

Published Date: 12 March 2018

Efficacy, tolerability, and safety of oral paliperidone extended release in the treatment of schizophrenia: a 24-week, open-label, prospective switch study in different settings in Taiwan

Chen CY, Tang TC, Chen TT, Bai YM, Tsai HH, Chen HL, Huang CJ, Chen CK, Chen CC, Hsiao MC, Liu CY, Yeh HS, Chiu NY, Hsiao CC, Chen CS, Su TP

Neuropsychiatric Disease and Treatment 2018, 14:725-732

Published Date: 8 March 2018

Analysis of the association of MIR124-1 and its target gene RGS4 polymorphisms with major depressive disorder and antidepressant response

Zeng D, He S, Yu S, Li G, Ma C, Wen Y, Shen Y, Yu Y, Li H

Neuropsychiatric Disease and Treatment 2018, 14:715-723

Published Date: 8 March 2018

Aggressiveness, violence, homicidality, homicide, and Lyme disease

Bransfield RC

Neuropsychiatric Disease and Treatment 2018, 14:693-713

Published Date: 9 March 2018

The utility of novel outcome measures in a naturalistic evaluation of schizophrenia treatment

Tompsett T, Masters K, Donyai P

Neuropsychiatric Disease and Treatment 2018, 14:681-691

Published Date: 2 March 2018

Evaluating psychiatric readmissions in the emergency department of a large public hospital

Morris DW, Ghose S, Williams E, Brown K, Khan F

Neuropsychiatric Disease and Treatment 2018, 14:671-679

Published Date: 1 March 2018

A cross-sectional study exploring useful indicators for low bone mineral density in male alcoholic patients

Horai T, Hishimoto A, Otsuka I, So T, Mouri K, Shimmyo N, Boku S, Okishio N, Sora I

Neuropsychiatric Disease and Treatment 2018, 14:663-669

Published Date: 28 February 2018

Sex differences in gut microbiota in patients with major depressive disorder

Chen JJ, Zheng P, Liu YY, Zhong XG, Wang HY, Guo YJ, Xie P

Neuropsychiatric Disease and Treatment 2018, 14:647-655

Published Date: 26 February 2018

Childhood trauma and dissociation among women with genito-pelvic pain/penetration disorder

Özen B, Özdemir YO, Beştepe EE

Neuropsychiatric Disease and Treatment 2018, 14:641-646

Published Date: 23 February 2018

Pediatric-onset multiple sclerosis in Egypt: a multi-center registry of 186 patients

Hamdy SM, Abdel-Naseer M, Shalaby NM, Elmazny A, Girgis M, Nada MA, Hassan A, Mourad HS, Hegazy MI, Abdelalim A, Kishk NA, Abokrysha NT, Genedy SA, Essawy EA, Shehata HS

Neuropsychiatric Disease and Treatment 2018, 14:631-640

Published Date: 23 February 2018

Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine

Imagawa H, Nagar SP, Montgomery W, Nakamura T, Sato M, Davis KL

Neuropsychiatric Disease and Treatment 2018, 14:611-621

Published Date: 22 February 2018

IQ discrepancy differentiates levels of fine motor skills and their relationship in children with autism spectrum disorders

Yu TY, Chou W, Chow JC, Lin CH, Tung LC, Chen KL

Neuropsychiatric Disease and Treatment 2018, 14:597-605

Published Date: 20 February 2018

Vitamin D and vitamin D receptor levels in children with attention-deficit/hyperactivity disorder

Sahin N, Altun H, Kurutas EB, Balkan D

Neuropsychiatric Disease and Treatment 2018, 14:581-585

Published Date: 19 February 2018

Drug–drug interactions involving antidepressants: focus on desvenlafaxine

Low Y, Setia S, Lima G

Neuropsychiatric Disease and Treatment 2018, 14:567-580

Published Date: 19 February 2018

Human factors evaluation of a novel digital medicine system in psychiatry

Peters-Strickland T, Hatch A, Adenwala A, Atkinson K, Bartfeld B

Neuropsychiatric Disease and Treatment 2018, 14:553-565

Published Date: 16 February 2018

Prospective interepisodal mood monitoring in patients with affective disorders: a feasibility study

Van der Watt ASJ, Suryapranata APSP, Seedat S

Neuropsychiatric Disease and Treatment 2018, 14:517-524

Published Date: 14 February 2018

Corpus callosum infarction with cognitive dysfunction: two case reports and literature review

Zhang J, Tang Y, Sun Y, Xu Y, Pang L, Li J, Wu T, He M

Neuropsychiatric Disease and Treatment 2018, 14:511-515

Published Date: 13 February 2018

Timing of psychoeducation for patients with depression who were treated with antidepressants: when should patients receive psychoeducation

Tomita T, Kudo S, Sugawara N, Fujii A, Tsuruga K, Sato Y, Ishioka M, Nakamura K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2018, 14:505-510

Published Date: 12 February 2018

Glia maturation factor-β: a potential therapeutic target in neurodegeneration and neuroinflammation

Fan J, Fong T, Chen X, Chen C, Luo P, Xie H

Neuropsychiatric Disease and Treatment 2018, 14:495-504

Published Date: 9 February 2018

The effect of exercise on cancer-related fatigue in cancer survivors: a systematic review and meta-analysis

Kessels E, Husson O, van der Feltz-Cornelis CM

Neuropsychiatric Disease and Treatment 2018, 14:479-494

Published Date: 9 February 2018

Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness

Omori Y, Kanbayashi T, Imanishi A, Tsutsui K, Sagawa Y, Kikuchi YS, Takeshima M, Yoshizawa K, Uemura S, Shimizu T

Neuropsychiatric Disease and Treatment 2018, 14:451-457

Published Date: 8 February 2018

Suicidal drug overdose following stroke in elderly patients: a retrospective population-based cohort study

Chang CH, Chen SJ, Liu CY, Tsai HC

Neuropsychiatric Disease and Treatment 2018, 14:443-450

Published Date: 7 February 2018

The differences between patients with panic disorder and healthy controls in psychophysiological stress profile

Kotianova A, Kotian M, Slepecky M, Chupacova M, Prasko J, Tonhajzerova I

Neuropsychiatric Disease and Treatment 2018, 14:435-441

Published Date: 7 February 2018

Cognitive behavioral group therapy versus psychoeducational intervention in Parkinson’s disease

Berardelli I, Bloise MC, Bologna M, Conte A, Pompili M, Lamis DA, Pasquini M, Fabbrini G

Neuropsychiatric Disease and Treatment 2018, 14:399-405

Published Date: 26 January 2018

Color preferences in participants with high or low hypnotic susceptibility

Yu E, Zhu J, Tan Y, Liao Z, Qiu Y, Zhang B, Wang C, Wang W

Neuropsychiatric Disease and Treatment 2018, 14:393-398

Published Date: 30 January 2018

Self-stigma and treatment effectiveness in patients with anxiety disorders – a mediation analysis

Ociskova M, Prasko J, Vrbova K, Kasalova P, Holubova M, Grambal A, Machu K

Neuropsychiatric Disease and Treatment 2018, 14:383-392

Published Date: 26 January 2018

Adjustment disorder: current perspectives

Zelviene P, Kazlauskas E

Neuropsychiatric Disease and Treatment 2018, 14:375-381

Published Date: 25 January 2018

Oxidative/antioxidative status, lymphocyte DNA damage, and urotensin-2 receptor level in patients with migraine attacks

Yigit M, Sogut O, Tataroglu Ö, Yamanoglu A, Yigit E, Guler EM, Ozer OF, Kocyigit A

Neuropsychiatric Disease and Treatment 2018, 14:367-374

Published Date: 24 January 2018

The impact of age of onset on amygdala intrinsic connectivity in major depression

Clark DL, Konduru N, Kemp A, Bray S, Brown EC, Goodyear B, Ramasubbu R

Neuropsychiatric Disease and Treatment 2018, 14:343-352

Published Date: 22 January 2018

Reflex epilepsy: triggers and management strategies

Okudan ZV, Özkara Ç

Neuropsychiatric Disease and Treatment 2018, 14:327-337

Published Date: 18 January 2018

Systematic review of catatonia treatment

Pelzer ACM, van der Heijden FMMA, den Boer E

Neuropsychiatric Disease and Treatment 2018, 14:317-326

Published Date: 17 January 2018

“Low road” to rehabilitation: a perspective on subliminal sensory neuroprosthetics

Ghai S, Ghai I, Effenberg AO

Neuropsychiatric Disease and Treatment 2018, 14:301-307

Published Date: 17 January 2018

ADHD and lifestyle habits in Czech adults, a national sample

Weissenberger S, Ptacek R, Vnukova M, Raboch J, Klicperova-Baker M, Domkarova L, Goetz M

Neuropsychiatric Disease and Treatment 2018, 14:293-299

Published Date: 15 January 2018

Impact of intravenous thrombolysis on length of hospital stay in cases of acute ischemic stroke

Kasemsap N, Vorasoot N, Kongbunkiat K, Peansukwech U, Tiamkao S, Sawanyawisuth K

Neuropsychiatric Disease and Treatment 2018, 14:259-264

Published Date: 9 January 2018

Altered intrinsic brain activities in patients with acute eye pain using amplitude of low-frequency fluctuation: a resting-state fMRI study

Pan Z, Li H, Bao J, Jiang N, Yuan Q, Freeberg S, Zhu P, Ye L, Ma M, Huang X, Shao Y

Neuropsychiatric Disease and Treatment 2018, 14:251-257

Published Date: 9 January 2018

Functional impairment in patients with major depressive disorder: the 2-year PERFORM study

Hammer-Helmich L, Haro JM, Jönsson B, Tanguy Melac A, Di Nicola S, Chollet J, Milea D, Rive B, Saragoussi D

Neuropsychiatric Disease and Treatment 2018, 14:239-249

Published Date: 9 January 2018

Anxiety and depression in paradoxical insomnia: a case–control study

Liao J, Zhu S, Li X

Neuropsychiatric Disease and Treatment 2018, 14:231-238

Published Date: 8 January 2018

Estimating cost savings of pharmacogenetic testing for depression in real-world clinical settings

Maciel A, Cullors A, Lukowiak AA, Garces J

Neuropsychiatric Disease and Treatment 2018, 14:225-230

Published Date: 8 January 2018

Adherence to riluzole in patients with amyotrophic lateral sclerosis: an observational study

Introna A, D'Errico E, Modugno B, Scarafino A, Fraddosio A, Distaso E, Tempesta I, Mastronardi A, Simone IL

Neuropsychiatric Disease and Treatment 2018, 14:193-203

Published Date: 4 January 2018

Low level of knowledge regarding diagnosis and treatment among inpatients with schizophrenia in Shanghai

Huang J, Chiovenda A, Shao Y, Ma H, Li H, Good MJDV

Neuropsychiatric Disease and Treatment 2018, 14:185-191

Published Date: 4 January 2018

Diagnostic challenges in multiple system atrophy

Obelieniene D, Bauzaite S, Kulakiene I, Keleras E, Eitmonaite I, Rastenyte D

Neuropsychiatric Disease and Treatment 2018, 14:179-184

Published Date: 4 January 2018

The current status of culturally adapted mental health interventions: a practice-focused review of meta-analyses

Rathod S, Gega L, Degnan A, Pikard J, Khan T, Husain N, Munshi T, Naeem F

Neuropsychiatric Disease and Treatment 2018, 14:165-178

Published Date: 4 January 2018

A meta-analysis of data associating DRD4 gene polymorphisms with schizophrenia

Xu F, Wu X, Zhang J, Wang B, Yao J

Neuropsychiatric Disease and Treatment 2018, 14:153-164

Published Date: 3 January 2018

Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies

Weiller E, Weiss C, Watling CP, Edge C, Hobart M, Eriksson H, Fava M

Neuropsychiatric Disease and Treatment 2018, 14:103-115

Published Date: 29 December 2017

Changes of serum uric acid and total bilirubin in elderly patients with major postischemic stroke depression

Gao J, Xu W, Han K, Zhu L, Gao L, Shang XL

Neuropsychiatric Disease and Treatment 2018, 14:83-93

Published Date: 27 December 2017

Quality of life and coping strategies of outpatients with a depressive disorder in maintenance therapy – a cross-sectional study

Holubova M, Prasko J, Ociskova M, Grambal A, Slepecky M, Marackova M, Kamaradova D, Zatkova M

Neuropsychiatric Disease and Treatment 2018, 14:73-82

Published Date: 22 December 2017

An acute bout of housework activities has beneficial effects on executive function

Tsuchiya K, Mitsui S, Fukuyama R, Yamaya N, Fujita T, Shimoda K, Tozato F

Neuropsychiatric Disease and Treatment 2018, 14:61-72

Published Date: 22 December 2017

Plasma complement component 4 increases in patients with major depressive disorder

Wei J, Liu Y, Zhao L, Yang X, Ni P, Wang Y, Li T, Ma X

Neuropsychiatric Disease and Treatment 2018, 14:37-41

Published Date: 20 December 2017

Migraine in young females with irritable bowel syndrome: still a challenge

Georgescu D, Reisz D, Gurban CV, Georgescu LA, Ionita I, Ancusa OE, Lighezan D

Neuropsychiatric Disease and Treatment 2018, 14:21-28

Published Date: 20 December 2017

Brain functional integration: an epidemiologic study on stress-producing dissociative phenomena

Sperandeo R, Monda V, Messina G, Carotenuto M, Maldonato NM, Moretto E, Leone E, De Luca V, Monda M, Messina A

Neuropsychiatric Disease and Treatment 2018, 14:11-19

Published Date: 19 December 2017

Delirium in hemodialysis predicts mortality: a single-center, long-term observational study

Yasui-Furukori N, Tarakita N, Uematsu W, Saito H, Nakamura K, Ohyama C, Sugawara N

Neuropsychiatric Disease and Treatment 2017, 13:3011-3016

Published Date: 14 December 2017

Accurately identifying patients who are excellent candidates or unsuitable for a medication: a novel approach

South C, Rush AJ, Carmody TJ, Jha MK, Trivedi MH

Neuropsychiatric Disease and Treatment 2017, 13:3001-3010

Published Date: 15 December 2017

The Walsh Family Resilience Questionnaire: the Italian version

Rocchi S, Ghidelli C, Burro R, Vitacca M, Scalvini S, Della Vedova AM, Roselli G, Ramponi JP, Bertolotti G

Neuropsychiatric Disease and Treatment 2017, 13:2987-2999

Published Date: 14 December 2017

Differences between autogenous and reactive obsessions in terms of metacognitions and automatic thoughts

Keles Altun İ, Uysal E, Özkorumak Karagüzel E

Neuropsychiatric Disease and Treatment 2017, 13:2977-2985

Published Date: 12 December 2017

Altered emotional prosody processing in patients with Parkinson’s disease after subthalamic nucleus stimulation

Jin Y, Mao Z, Ling Z, Xu X, Xie G, Yu X

Neuropsychiatric Disease and Treatment 2017, 13:2965-2975

Published Date: 11 December 2017

Verbal memory improvement in first-episode psychosis APOE-ε4 carriers: a pleiotropic effect?

Vila-Rodriguez F, Lang DJ, Baitz H, Gicas K, Thornton AE, Ehmann TS, Smith GN, Barr AM, Torres IJ, Kopala LC, MacEwan GW, Müller DJ, Kennedy JL, Honer WG

Neuropsychiatric Disease and Treatment 2017, 13:2945-2953

Published Date: 8 December 2017

Screening for mild cognitive impairment in patients with cardiovascular risk factors

Yaneva-Sirakova T, Traykov L, Petrova J, Gruev I, Vassilev D

Neuropsychiatric Disease and Treatment 2017, 13:2925-2934

Published Date: 5 December 2017

Effect of handedness on auditory attentional performance in ADHD students

Schmidt SL, Carvaho AL, Simoes EN

Neuropsychiatric Disease and Treatment 2017, 13:2921-2924

Published Date: 1 December 2017

Cytokines and depression in cancer patients and caregivers

Li M, Kouzmina E, McCusker M, Rodin D, Boutros PC, Paige CJ, Rodin G

Neuropsychiatric Disease and Treatment 2017, 13:2903-2911

Published Date: 28 November 2017

Altered emotional recognition and expression in patients with Parkinson’s disease

Jin Y, Mao Z, Ling Z, Xu X, Zhang Z, Yu X

Neuropsychiatric Disease and Treatment 2017, 13:2891-2902

Published Date: 27 November 2017

Korsakoff’s syndrome: a critical review

Arts NJM, Walvoort SJW, Kessels RPC

Neuropsychiatric Disease and Treatment 2017, 13:2875-2890

Published Date: 27 November 2017

The effect of errorless learning on quality of life in patients with Korsakoff’s syndrome

Rensen YCM, Egger JIM, Westhoff J, Walvoort SJW, Kessels RPC

Neuropsychiatric Disease and Treatment 2017, 13:2867-2873

Published Date: 27 November 2017

Abnormal regional spontaneous neural activity in visual pathway in retinal detachment patients: a resting-state functional MRI study

Huang X, Li D, Li H, Zhong Y, Freeberg S, Bao J, Zeng X, Shao Y

Neuropsychiatric Disease and Treatment 2017, 13:2849-2854

Published Date: 22 November 2017

Group cognitive–behavioral therapy in insomnia: a cross-sectional case-controlled study

Mao H, Ji Y, Xu Y, Tang G, Yu Z, Xu L, Shen C, Wang W

Neuropsychiatric Disease and Treatment 2017, 13:2841-2848

Published Date: 21 November 2017

Altered microstructure of brain white matter in females with anorexia nervosa: a diffusion tensor imaging study

Hu SH, Feng H, Xu TT, Zhang HR, Zhao ZY, Lai JB, Xu DR, Xu Y

Neuropsychiatric Disease and Treatment 2017, 13:2829-2836

Published Date: 21 November 2017

The efficacy of antipsychotics for prolonged delirium with renal dysfunction

Asano S, Kunii Y, Hoshino H, Osakabe Y, Shiga T, Itagaki S, Miura I, Yabe H

Neuropsychiatric Disease and Treatment 2017, 13:2823-2828

Published Date: 16 November 2017

Immigration-related mental health disorders in refugees 5–18 years old living in Turkey

Yalın Sapmaz Ş, Uzel Tanrıverdi B, Öztürk M, Gözaçanlar Ö, Yörük Ülker G, Özkan Y

Neuropsychiatric Disease and Treatment 2017, 13:2813-2821

Published Date: 10 November 2017

Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia

Brasso C, Bellino S, Bozzatello P, Montemagni C, Rocca P

Neuropsychiatric Disease and Treatment 2017, 13:2767-2779

Published Date: 7 November 2017

Epidemiology and costs of multiple sclerosis in Switzerland: an analysis of health-care claims data, 2011–2015

Blozik E, Rapold R, Eichler K, Reich O

Neuropsychiatric Disease and Treatment 2017, 13:2737-2745

Published Date: 1 November 2017

Effects of dopaminergic drug adjustment on executive function in different clinical stages of Parkinson’s disease

Murakami H, Nohara T, Shozawa H, Owan Y, Kuroda T, Yano S, Kezuka M, Kawamura M, Ono K

Neuropsychiatric Disease and Treatment 2017, 13:2719-2726

Published Date: 25 October 2017

Effects of short-term piano training on measures of finger tapping, somatosensory perception and motor-related brain activity in patients with cerebral palsy

Alves-Pinto A, Ehrlich S, Cheng G, Turova V, Blumenstein T, Lampe R

Neuropsychiatric Disease and Treatment 2017, 13:2705-2718

Published Date: 25 October 2017

Transient global amnesia: current perspectives

Spiegel DR, Smith J, Wade RR, Cherukuru N, Ursani A, Dobruskina Y, Crist T, Busch RF, Dhanani RM, Dreyer N

Neuropsychiatric Disease and Treatment 2017, 13:2691-2703

Published Date: 24 October 2017

Association of TNF-alpha G-308A gene polymorphism with depression: a meta-analysis

Shin KH, Jeong HC, Choi DH, Kim SN, Kim TE

Neuropsychiatric Disease and Treatment 2017, 13:2661-2668

Published Date: 20 October 2017

Bupropion interferes with the image diagnosis of Parkinson's disease

Lin CH, Lane HY

Neuropsychiatric Disease and Treatment 2017, 13:2637-2639

Published Date: 19 October 2017

Differences in serum zinc levels in acutely ill and remitted adolescents and young adults with bulimia nervosa in comparison with healthy controls – a cross-sectional pilot study

Zepf FD, Rao P, Runions K, Stewart RM, Moore JK, Wong JWY, Linden M, Sungurtekin I, Glass F, Gut L, Peetz D, Hintereder G, Schaab M, Poustka F, Wöckel L

Neuropsychiatric Disease and Treatment 2017, 13:2621-2630

Published Date: 17 October 2017

Thalamo–cortical network underlying deep brain stimulation of centromedian thalamic nuclei in intractable epilepsy: a multimodal imaging analysis

Kim SH, Lim SC, Yang DW, Cho JH, Son BC, Kim J, Hong SB, Shon YM

Neuropsychiatric Disease and Treatment 2017, 13:2607-2619

Published Date: 17 October 2017

Coping, schemas, and cardiovascular risks – study protocol

Slepecky M, Kotianova A, Prasko J, Majercak I, Gyorgyova E, Kotian M, Zatkova M, Tonhajzerova I, Chupacova M, Popelkova M

Neuropsychiatric Disease and Treatment 2017, 13:2599-2605

Published Date: 13 October 2017

Relationship of negative and positive core beliefs about the self with dysfunctional attitudes in three aspects of life

Otani K, Suzuki A, Matsumoto Y, Shirata T

Neuropsychiatric Disease and Treatment 2017, 13:2585-2588

Published Date: 12 October 2017

Sporadic hyperekplexia due to self-limiting brainstem encephalopathy

Yilmaz D, Cengiz B

Neuropsychiatric Disease and Treatment 2017, 13:2581-2584

Published Date: 9 October 2017

Mitochondrial multiorgan disorder syndrome score generated from definite mitochondrial disorders

Finsterer J, Zarrouk-Mahjoub S

Neuropsychiatric Disease and Treatment 2017, 13:2569-2579

Published Date: 6 October 2017

Interpersonal sensitivity mediates the effects of child abuse and affective temperaments on depressive symptoms in the general adult population

Otsuka A, Takaesu Y, Sato M, Masuya J, Ichiki M, Kusumi I, Inoue T

Neuropsychiatric Disease and Treatment 2017, 13:2559-2568

Published Date: 5 October 2017

MLC601 in vascular dementia: an efficacy and safety pilot study

Pakdaman H, Amini Harandi A, Gharagozli K, Abbasi M, Ghaffarpour M, Ashrafi F, Delavar Kasmaei H, Amini Harandi A

Neuropsychiatric Disease and Treatment 2017, 13:2551-2557

Published Date: 5 October 2017

19q12q13.2 duplication syndrome: neuropsychiatric long-term follow-up of a new case and literature update

Nacinovich R, Villa N, Broggi F, Tavaniello C, Bomba M, Conconi D, Redaelli S, Sala E, Lavitrano M, Neri F

Neuropsychiatric Disease and Treatment 2017, 13:2545-2550

Published Date: 4 October 2017

Children with borderline intellectual functioning and autism spectrum disorder: developmental trajectories from 4 to 11 years of age

Barnevik Olsson M, Holm A, Westerlund J, Lundholm Hedvall Å, Gillberg C, Fernell E

Neuropsychiatric Disease and Treatment 2017, 13:2519-2526

Published Date: 4 October 2017

Frequencies of circulating B- and T-lymphocytes as indicators for stroke outcomes

Wang Y, Liu J, Wang X, Liu Z, Li F, Chen F, Geng X, Ji Z, Du H, Hu X

Neuropsychiatric Disease and Treatment 2017, 13:2509-2518

Published Date: 3 October 2017

Motivation to change and posttreatment temptation to drink: a multicenter study among alcohol-dependent patients

Fiabane E, Ottonello M, Zavan V, Pistarini C, Giorgi I

Neuropsychiatric Disease and Treatment 2017, 13:2497-2504

Published Date: 3 October 2017

Self-rated cognitive functions following chemotherapy in patients with breast cancer: a 6-month prospective study

Kitahata R, Nakajima S, Uchida H, Hayashida T, Takahashi M, Nio S, Hirano J, Nagaoka M, Suzuki T, Jinno H, Kitagawa Y, Mimura M

Neuropsychiatric Disease and Treatment 2017, 13:2489-2496

Published Date: 3 October 2017

Artesunate prevents rats from the clozapine-induced hepatic steatosis and elevation in plasma triglycerides

Li Y, Su R, Xu S, Huang Q, Xu H

Neuropsychiatric Disease and Treatment 2017, 13:2477-2487

Published Date: 27 September 2017

Laser interstitial thermal therapy for the treatment of epilepsy: evidence to date

Shukla ND, Ho AL, Pendharkar AV, Sussman ES, Halpern CH

Neuropsychiatric Disease and Treatment 2017, 13:2469-2475

Published Date: 26 September 2017

Atypical depression: current perspectives

Łojko D, Rybakowski JK

Neuropsychiatric Disease and Treatment 2017, 13:2447-2456

Published Date: 20 September 2017

Factors associated with bullying victimization among Korean adolescents

Seo HJ, Jung YE, Kim MD, Bahk WM

Neuropsychiatric Disease and Treatment 2017, 13:2429-2435

Published Date: 18 September 2017

Need for medication to complement catecholamines in smoking cessation of hardcore smokers

Kawai A, Kurita M, Nishino S, Hirata E, Sato T, Okubo Y

Neuropsychiatric Disease and Treatment 2017, 13:2419-2424

Published Date: 18 September 2017

Sex differences in obesity and cognitive function in a cognitively normal aging Chinese Han population

Li W, Qiu Q, Sun L, Yue L, Wang T, Li X, Xiao S

Neuropsychiatric Disease and Treatment 2017, 13:2405-2410

Published Date: 14 September 2017

Depression and family support in breast cancer patients

Su JA, Yeh DC, Chang CC, Lin TC, Lai CH, Hu PY, Ho YF, Chen VC, Wang TN, Gossop M

Neuropsychiatric Disease and Treatment 2017, 13:2389-2396

Published Date: 13 September 2017

Triadic interactions in families with preterm children: a comparative study with children born at term

Gatta M, Miscioscia M, Svanellini L, Brianda ME, Guerra G, Battistella PA, Simonelli A

Neuropsychiatric Disease and Treatment 2017, 13:2375-2388

Published Date: 13 September 2017

Application of a stratum-specific likelihood ratio analysis in a screen for depression among a community-dwelling population in Japan

Sugawara N, Kaneda A, Takahashi I, Nakaji S, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2017, 13:2369-2374

Published Date: 12 September 2017

Low uric acid is a risk factor in mild cognitive impairment

Xue L, Liu Y, Xue H, Xue J, Sun K, Wu L, Hou P

Neuropsychiatric Disease and Treatment 2017, 13:2363-2367

Published Date: 11 September 2017

Natural reduced water suppressed anxiety and protected the heightened oxidative stress in rats

Masuda K, Tanaka Y, Kanehisa M, Ninomiya T, Inoue A, Higuma H, Kawashima C, Nakanishi M, Okamoto K, Akiyoshi J

Neuropsychiatric Disease and Treatment 2017, 13:2357-2362

Published Date: 8 September 2017

Cognitive behavioral therapy for somatic symptom disorders in later life: a prospective comparative explorative pilot study in two clinical populations

Verdurmen MJH, Videler AC, Kamperman AM, Khasho D, van der Feltz-Cornelis CM

Neuropsychiatric Disease and Treatment 2017, 13:2331-2339

Published Date: 1 September 2017

Scopolamine alleviates involuntary lingual movements: tardive dyskinesia or dystonia?

Hu JB, Lai JB, Hu SH, Xu Y

Neuropsychiatric Disease and Treatment 2017, 13:2327-2330

Published Date: 31 August 2017

Sociodemographic variables and social values: relationship with work-attendance problems in Brunei public- and private-sector employees

Mundia L, Mahalle S, Matzin R, Zakaria GAN, Abdullah NZM

Neuropsychiatric Disease and Treatment 2017, 13:2307-2319

Published Date: 31 August 2017

Risk of post-traumatic epilepsy after severe head injury in patients with at least one seizure

Chen W, Li MD, Wang GF, Yang XF, Liu L, Meng FG

Neuropsychiatric Disease and Treatment 2017, 13:2301-2306

Published Date: 30 August 2017

Effects of bromadiolone poisoning on the central nervous system

Wang M, Yang Y, Hou Y, Ma W, Jia R, Chen J

Neuropsychiatric Disease and Treatment 2017, 13:2297-2300

Published Date: 30 August 2017

A case of schizophrenia comorbid for tetralogy of Fallot treated with clozapine: further considerations on a role for 22q.11.2 in the proneness for seizures

Kashiwagi H, Ikezawa S, Sumiyoshi T, Kadono A, Segawa K, Takeda K, Omori M, Taguchi H, Hirabayashi N

Neuropsychiatric Disease and Treatment 2017, 13:2271-2273

Published Date: 29 August 2017

Once-monthly paliperidone palmitate in early stage schizophrenia – a retrospective, non-interventional 1-year study of patients with newly diagnosed schizophrenia

Emsley R, Hargarter L, Bergmans P, Uglešić B, Sengül AC, Petralia A, Khannanova A, Cherubin P, Schreiner A

Neuropsychiatric Disease and Treatment 2017, 13:2261-2269

Published Date: 29 August 2017

Early predictors of brain damage in full-term newborns with hypoxic ischemic encephalopathy [Corrigendum]

Alkholy UM, Abdalmonem N, Zaki A, Ali YF, Mohamed SA, Abdelsalam NI, Abu Hashim MI, Abou Sekkien M, Elsherbiny YM

Neuropsychiatric Disease and Treatment 2017, 13:2255-2256

Published Date: 26 August 2017

Fan the flame: trazodone-induced mania in a unipolar depressed patient with stable sertraline treatment

Hu JB, Lai JB, Zheng HZ, Hu SH, Xu Y

Neuropsychiatric Disease and Treatment 2017, 13:2251-2254

Published Date: 24 August 2017

Analyzing a single nucleotide polymorphism in schizophrenia: a meta-analysis approach

Falola O, Osamor VC, Adebiyi M, Adebiyi E

Neuropsychiatric Disease and Treatment 2017, 13:2243-2250

Published Date: 23 August 2017

Antipsychotic-associated weight gain: management strategies and impact on treatment adherence

Dayabandara M, Hanwella R, Ratnatunga S, Seneviratne S, Suraweera C, de Silva VA

Neuropsychiatric Disease and Treatment 2017, 13:2231-2241

Published Date: 22 August 2017

Association between COMT Val158Met and DAT1 polymorphisms and depressive symptoms in the obese population

Bieliński M, Jaracz M, Lesiewska N, Tomaszewska M, Sikora M, Junik R, Kamińska A, Tretyn A, Borkowska A

Neuropsychiatric Disease and Treatment 2017, 13:2221-2229

Published Date: 18 August 2017

Improvements in motor tasks through the use of smartphone technology for individuals with Duchenne muscular dystrophy

Capelini CM, Silva TD, Tonks J, Watson S, Alvarez MPB, Menezes LDC, Favero FM, Caromano FA, Massetti T, de Mello Monteiro CB

Neuropsychiatric Disease and Treatment 2017, 13:2209-2217

Published Date: 18 August 2017

Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: subgroup analysis of a global, randomized, double-blind, Phase III, noninferiority study

Savitz AJ, Xu H, Gopal S, Nuamah I, Ravenstijn P, Hough D, Mathews M, Feng Y, Yu L, Takahashi M, Liu D, Wang G, Yoon J, Chen JJ

Neuropsychiatric Disease and Treatment 2017, 13:2193-2207

Published Date: 17 August 2017

Feasibility of cognitive remediation therapy for adults with autism spectrum disorders: a single-group pilot study

Okuda T, Asano K, Numata N, Hirano Y, Yamamoto T, Tanaka M, Matsuzawa D, Shimizu E, Iyo M, Nakazato M

Neuropsychiatric Disease and Treatment 2017, 13:2185-2191

Published Date: 16 August 2017

Bipolar II disorder as the initial presentation of CADASIL: an underdiagnosed manifestation

Wang J, Li J, Kong F, Lv H, Guo Z

Neuropsychiatric Disease and Treatment 2017, 13:2175-2179

Published Date: 14 August 2017

Can melatonin prevent or improve metabolic side effects during antipsychotic treatments?

Porfirio MC, Gomes de Almeida JP, Stornelli M, Giovinazzo S, Purper-Ouakil D, Masi G

Neuropsychiatric Disease and Treatment 2017, 13:2167-2174

Published Date: 10 August 2017

Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study

Saragoussi D, Touya M, Haro JM, Jönsson B, Knapp M, Botrel B, Florea I, Loft H, Rive B

Neuropsychiatric Disease and Treatment 2017, 13:2151-2165

Published Date: 9 August 2017

Early predictors of brain damage in full-term newborns with hypoxic ischemic encephalopathy

Alkholy UM, Abdalmonem N, Zaki A, Ali YF, Mohamed SA, Abdelsalam NI, Abu Hashim MI, Abou Sekkien M, Elsherbiny YM

Neuropsychiatric Disease and Treatment 2017, 13:2133-2139

Published Date: 8 August 2017

An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis

Kuga A, Tsuji T, Hayashi S, Matsubara M, Fujikoshi S, Tokuoka H, Yoshikawa A, Escobar R, Tanaka K, Azekawa T

Neuropsychiatric Disease and Treatment 2017, 13:2105-2114

Published Date: 4 August 2017

Which psychological, psychophysiological, and anthropometric factors are connected with life events, depression, and quality of life in patients with cardiovascular disease

Slepecky M, Kotianova A, Prasko J, Majercak I, Gyorgyova E, Kotian M, Zatkova M, Popelkova M, Ociskova M, Tonhajzerova I

Neuropsychiatric Disease and Treatment 2017, 13:2093-2104

Published Date: 4 August 2017

Encephalitis with reversible splenial and deep cerebral white matter lesions associated with Epstein–Barr virus infection in adults

Guo YJ, Wang SH, Jiang B, Li JL, Liu L, Wang J, Zhao WQ, Jia J

Neuropsychiatric Disease and Treatment 2017, 13:2085-2092

Published Date: 3 August 2017

Suicidal and homicidal tendencies after Lyme disease: an ignored problem

Munir A, Aadil M, Rehan Khan A

Neuropsychiatric Disease and Treatment 2017, 13:2069-2071

Published Date: 2 August 2017

La belle indifférence revisited: a case report on progressive supranuclear palsy misdiagnosed as conversion disorder

van Meerkerk-Aanen PJ, de Vroege L, Khasho D, Foruz A, van Asseldonk JT, van der Feltz-Cornelis CM

Neuropsychiatric Disease and Treatment 2017, 13:2057-2067

Published Date: 2 August 2017

Safety and efficacy of paliperidone palmitate 1-month formulation in Chinese patients with schizophrenia: a 25-week, open-label, multicenter, Phase IV study

Zhao JP, Li LH, Shi JG, Li Y, Xu XF, Li KQ, Zhang LL, Cai SL, Feng Y, Zhuo JM, Liu WH, Lu HF

Neuropsychiatric Disease and Treatment 2017, 13:2045-2056

Published Date: 2 August 2017

MicroRNA expression profiles in chronic epilepsy rats and neuroprotection from seizures by targeting miR-344a

Liu XX, Liao YH, Wang XX, Zou DH, Luo C, Jian CD, Wu Y

Neuropsychiatric Disease and Treatment 2017, 13:2037-2044

Published Date: 31 July 2017

Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension study

Durgam S, Landbloom RP, Mackle M, Wu X, Mathews M, Nasrallah HA

Neuropsychiatric Disease and Treatment 2017, 13:2021-2035

Published Date: 31 July 2017

Abnormal intrinsic functional hubs in alcohol dependence: evidence from a voxelwise degree centrality analysis

Luo X, Guo LH, Dai XJ, Wang Q, Zhu W, Miao X, Gong H

Neuropsychiatric Disease and Treatment 2017, 13:2011-2020

Published Date: 28 July 2017

Electrophysiological findings of Turkish patients with restless legs syndrome

Özsimsek A, Koyuncuoglu HR

Neuropsychiatric Disease and Treatment 2017, 13:2005-2010

Published Date: 27 July 2017

Involvement of up-regulation of miR-210 in a rat epilepsy model [Corrigendum]

Chen L, Zheng H, Zhang S

Neuropsychiatric Disease and Treatment 2017, 13:2003-2004

Published Date: 26 July 2017

Sleep problems in university students – an intervention

Schlarb AA, Friedrich A, Claßen M

Neuropsychiatric Disease and Treatment 2017, 13:1989-2001

Published Date: 26 July 2017

The economic burden of schizophrenia in Malaysia

Teoh SL, Chong HY, Abdul Aziz S, Chemi N, Othman AR, Md Zaki N, Vanichkulpitak P, Chaiyakunapruk N

Neuropsychiatric Disease and Treatment 2017, 13:1979-1987

Published Date: 28 July 2017

Risperidone-induced reversible neutropenia

Kattalai Kailasam V, Chima V, Nnamdi U, Sharma K, Shah K

Neuropsychiatric Disease and Treatment 2017, 13:1975-1977

Published Date: 25 July 2017

Spontaneous alterations of regional brain activity in patients with adult generalized anxiety disorder

Xia L, Li S, Wang T, Guo Y, Meng L, Feng Y, Cui Y, Wang F, Ma J, Jiang G

Neuropsychiatric Disease and Treatment 2017, 13:1957-1965

Published Date: 20 July 2017

SoCIAL – training cognition in schizophrenia: a pilot study

Palumbo D, Mucci A, Piegari G, D'Alise V, Mazza A, Galderisi S

Neuropsychiatric Disease and Treatment 2017, 13:1947-1956

Published Date: 20 July 2017

The regional neuronal activity in left posterior middle temporal gyrus is correlated with the severity of chronic aphasia

Li J, Du D, Gao W, Sun X, Xie H, Zhang G, Li J, Li H, Li K

Neuropsychiatric Disease and Treatment 2017, 13:1937-1945

Published Date: 20 July 2017

Impact of help-seeking behavior and partner support on postpartum depression among Saudi women

Almutairi AF, Salam M, Alanazi S, Alweldawi M, Alsomali N, Alotaibi N

Neuropsychiatric Disease and Treatment 2017, 13:1929-1936

Published Date: 20 July 2017

Convulsive syncope related to a small dose of quetiapine in an adolescent with bipolar disorder

Lai J, Lu Q, Huang T, Hu S, Xu Y

Neuropsychiatric Disease and Treatment 2017, 13:1905-1908

Published Date: 19 July 2017

Characteristics and predictors of progression in an Egyptian multiple sclerosis cohort: a multicenter registry study

Hamdy SM, Abdel-Naseer M, Shalaby NM, Elmazny AN, Nemr AA, Hassan A, Hegazy MI, Mourad HS, Kishk NA, Nada MA, Abdelalim A, Fouad AM, Shehata HS

Neuropsychiatric Disease and Treatment 2017, 13:1895-1903

Published Date: 18 July 2017

Cost-utility of collaborative care for the treatment of comorbid major depressive disorder in outpatients with chronic physical conditions. A randomized controlled trial in the general hospital setting (CC-DIM)

Goorden M, van der Feltz-Cornelis CM, van Steenbergen-Weijenburg KM, Horn EK, Beekman ATF, Hakkaart-van Roijen L

Neuropsychiatric Disease and Treatment 2017, 13:1881-1893

Published Date: 18 July 2017

Prevalence, symptomatic features, and factors associated with sleep disturbance/insomnia in Japanese patients with type-2 diabetes

Narisawa H, Komada Y, Miwa T, Shikuma J, Sakurai M, Odawara M, Inoue Y

Neuropsychiatric Disease and Treatment 2017, 13:1873-1880

Published Date: 18 July 2017

Excoriation (skin-picking) disorder: a systematic review of treatment options

Lochner C, Roos A, Stein DJ

Neuropsychiatric Disease and Treatment 2017, 13:1867-1872

Published Date: 14 July 2017

Depression in blepharospasm: a question of facial feedback?

Bedarf JR, Kebir S, Michelis JP, Wabbels B, Paus S

Neuropsychiatric Disease and Treatment 2017, 13:1861-1865

Published Date: 14 July 2017

Genetic and epigenetic mechanisms of epilepsy: a review

Chen T, Giri M, Xia ZY, Subedi YN, Li Y

Neuropsychiatric Disease and Treatment 2017, 13:1841-1859

Published Date: 13 July 2017

Anxiety sensitivity as a predictor of broad dimensions of psychopathology after cognitive behavioral therapy for panic disorder

Ino K, Ogawa S, Kondo M, Imai R, Ii T, Furukawa TA, Akechi T

Neuropsychiatric Disease and Treatment 2017, 13:1835-1840

Published Date: 13 July 2017

Real-time functional magnetic resonance imaging in obsessive-compulsive disorder

Gonçalves ÓF, Batistuzzo MC, Sato JR

Neuropsychiatric Disease and Treatment 2017, 13:1825-1834

Published Date: 12 July 2017

The most important psychological and psychosocial needs of Polish multiple sclerosis patients and their significant others

Potemkowski A, Brola W, Ratajczak A, Ratajczak M, Kowalewski M, Lewita M, Kapica-Topczewska K, Tarasiuk J, Stępień A, Gocyla-Dudar K, Zaborski J, Bartosik-Psujek H

Neuropsychiatric Disease and Treatment 2017, 13:1817-1824

Published Date: 12 July 2017

Long-acting formulations delivering aripiprazole: beyond single-value characterizations of steady-state pharmacokinetics

McConnell SA, Desai DN, Faldu SP, Hard ML, Wehr AY, Weiden PJ, von Moltke L

Neuropsychiatric Disease and Treatment 2017, 13:1815-1816

Published Date: 12 July 2017

Sleep disturbances among patients with epilepsy

Staniszewska A, Mąka A, Religioni U, Olejniczak D

Neuropsychiatric Disease and Treatment 2017, 13:1797-1803

Published Date: 10 July 2017

Necrostatin-1 attenuates early brain injury after subarachnoid hemorrhage in rats by inhibiting necroptosis

Chen F, Su X, Lin Z, Lin Y, Yu L, Cai J, Kang D, Hu L

Neuropsychiatric Disease and Treatment 2017, 13:1771-1782

Published Date: 7 July 2017

Attention–memory training yields behavioral and academic improvements in children diagnosed with attention-deficit hyperactivity disorder comorbid with a learning disorder

Farias AC, Cordeiro ML, Felden EPG, Bara TS, Benko CR, Coutinho D, Martins LF, Ferreira RTC, McCracken JT

Neuropsychiatric Disease and Treatment 2017, 13:1761-1769

Published Date: 6 July 2017

Brain regions associated with anosognosia for memory disturbance in Alzheimer’s disease: a magnetic resonance imaging study

Fujimoto H, Matsuoka T, Kato Y, Shibata K, Nakamura K, Yamada K, Narumoto J

Neuropsychiatric Disease and Treatment 2017, 13:1753-1759

Published Date: 5 July 2017

Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity

Huss M, Duhan P, Gandhi P, Chen CW, Spannhuth CW, Kumar V

Neuropsychiatric Disease and Treatment 2017, 13:1741-1751

Published Date: 4 July 2017

Neuroprotective effects of curdione against focal cerebral ischemia reperfusion injury in rats

Li XJ, Liang L, Shi HX, Sun XP, Wang J, Zhang LS

Neuropsychiatric Disease and Treatment 2017, 13:1733-1740

Published Date: 30 June 2017

Reduced prefrontal activation during verbal fluency task in chronic insomnia disorder: a multichannel near-infrared spectroscopy study

Sun JJ, Liu XM, Shen CY, Zhang XQ, Sun GX, Feng K, Xu B, Ren XJ, Ma XY, Liu PZ

Neuropsychiatric Disease and Treatment 2017, 13:1723-1731

Published Date: 30 June 2017

The use of natalizumab for multiple sclerosis

Brandstadter R, Katz Sand I

Neuropsychiatric Disease and Treatment 2017, 13:1691-1702

Published Date: 28 June 2017

Adapting the short form of the Coping Inventory for Stressful Situations into Chinese

Li C, Liu Q, Hu T, Jin X

Neuropsychiatric Disease and Treatment 2017, 13:1669-1675

Published Date: 27 June 2017

The role of microglia in multiple sclerosis

Luo C, Jian C, Liao Y, Huang Q, Wu Y, Liu X, Zou D, Wu Y

Neuropsychiatric Disease and Treatment 2017, 13:1661-1667

Published Date: 26 June 2017

Brain metabolite values in children with breath-holding spells

Calik M, Sen Dokumaci D, Sarikaya S, Demir M, Isik I, Kazanasmaz H, Kaya C, Kandemir H

Neuropsychiatric Disease and Treatment 2017, 13:1655-1660

Published Date: 26 June 2017

Role of SIRT1/PGC-1α in mitochondrial oxidative stress in autistic spectrum disorder

Bu XS, Wu D, Lu XM, Yang L, Xu XY, Wang J, Tang JL

Neuropsychiatric Disease and Treatment 2017, 13:1633-1645

Published Date: 23 June 2017

Rapid infusion of esketamine for unipolar and bipolar depression: a retrospective chart review

Correia-Melo FS, Argolo FC, Araújo-de-Freitas L, Leal GC, Kapczinski F, Lacerda AL, Quarantini LC

Neuropsychiatric Disease and Treatment 2017, 13:1627-1632

Published Date: 21 June 2017

Effects of subthalamic nucleus deep brain stimulation on emotional working memory capacity and mood in patients with Parkinson's disease

Merkl A, Röck E, Schmitz-Hübsch T, Schneider G, Kühn AA

Neuropsychiatric Disease and Treatment 2017, 13:1603-1611

Published Date: 19 June 2017

Stress reactivity and emotion in premenstrual syndrome

Liu Q, Wang Y, van Heck CH, Qiao W

Neuropsychiatric Disease and Treatment 2017, 13:1597-1602

Published Date: 16 June 2017

Clinical features of limbic encephalitis with LGI1 antibody

Wang ML, Cao XY, Liu QX, Ma W, Guo XQ, Liu XW

Neuropsychiatric Disease and Treatment 2017, 13:1589-1596

Published Date: 16 June 2017

Suicide and Lyme and associated diseases

Bransfield RC

Neuropsychiatric Disease and Treatment 2017, 13:1575-1587

Published Date: 16 June 2017

Risk factors for the existence of attention deficit hyperactivity disorder symptoms in children with autism spectrum disorders

Lamanna AL, Craig F, Matera E, Simone M, Buttiglione M, Margari L

Neuropsychiatric Disease and Treatment 2017, 13:1559-1567

Published Date: 15 June 2017

De Ritis ratio (AST/ALT) as an independent predictor of poor outcome in patients with acute ischemic stroke

Gao F, Chen C, Lu J, Zheng J, Ma XC, Yuan XY, Huo K, Han JF

Neuropsychiatric Disease and Treatment 2017, 13:1551-1557

Published Date: 15 June 2017

Intelligence profiles of Chinese school-aged boys with high-functioning ASD and ADHD

Li G, Jiang W, Du Y, Rossbach K

Neuropsychiatric Disease and Treatment 2017, 13:1541-1549

Published Date: 15 June 2017

Burnout and compassion fatigue: prevalence and associations among Israeli burn clinicians

Haik J, Brown S, Liran A, Visentin D, Sokolov A, Zilinsky I, Kornhaber R

Neuropsychiatric Disease and Treatment 2017, 13:1533-1540

Published Date: 15 June 2017

Pituitary abscess: report of two cases and review of the literature

Liu Y, Liu F, Liang Q, Li Y, Wang ZF

Neuropsychiatric Disease and Treatment 2017, 13:1521-1526

Published Date: 13 June 2017

Effects of Canon chord progression on brain activity and motivation are dependent on subjective feelings, not the chord progression per se

Kayashima Y, Yamamuro K, Makinodan M, Nakanishi Y, Wanaka A, Kishimoto T

Neuropsychiatric Disease and Treatment 2017, 13:1499-1508

Published Date: 12 June 2017

Sleep apnea leading to Parkinson’s disease – an important association

Shafqat MN, Aadil M, Shoaib M

Neuropsychiatric Disease and Treatment 2017, 13:1491-1492

Published Date: 9 June 2017

PAC1 receptor (ADCYAP1R1) genotype and problematic alcohol use in a sample of young women

Dragan WŁ, Czerski PM, Dragan M

Neuropsychiatric Disease and Treatment 2017, 13:1483-1489

Published Date: 8 June 2017

Disrupted small-world brain functional network topology in male patients with severe obstructive sleep apnea revealed by resting-state fMRI

Chen L, Fan X, Li H, Nie S, Gong H, Zhang W, Zeng X, Long P, Peng D

Neuropsychiatric Disease and Treatment 2017, 13:1471-1482

Published Date: 8 June 2017

Regional impairment of intrinsic functional connectivity strength in patients with chronic primary insomnia

Huang S, Zhou F, Jiang J, Huang M, Zeng X, Ding S, Gong H

Neuropsychiatric Disease and Treatment 2017, 13:1449-1462

Published Date: 6 June 2017

Ictal blinking, an under-recognized phenomenon: our experience and literature review

Saporito MAN, Vitaliti G, Pavone P, Di Stefano G, Striano P, Caraballo RH, Falsaperla R

Neuropsychiatric Disease and Treatment 2017, 13:1435-1439

Published Date: 31 May 2017

Effects of stimulus parameters on motor seizure duration in electroconvulsive therapy

Joo SW, Joo YH, Kim CY, Lee JS

Neuropsychiatric Disease and Treatment 2017, 13:1427-1434

Published Date: 29 May 2017